BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy8978
(252 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 145 bits (367), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 81/236 (34%), Positives = 130/236 (55%), Gaps = 13/236 (5%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G S WPW+VAL ++ CG L++ W+++AAHC+ + N + + L +
Sbjct: 4 GSDSREGAWPWVVALY--FDDQQVCGASLVSRDWLVSAAHCVYGR--NMEPSKWKAVLGL 59
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+ S ET++ D + + P ++++ NDIA++ L K Y +++P+CLP+
Sbjct: 60 HMASNLTSPQIETRLID----QIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPE 115
Query: 134 AGD-FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQ-NIFDSNLCAGG 191
F +I + GWG L Y G +DVL E +P+ +C++Q + NI ++ +CAG
Sbjct: 116 ENQVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNITENMVCAGY 175
Query: 192 YKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWI 245
GG DSCQGDSGGPL+ Q + +W + GV S+G C PGVY +V ++ WI
Sbjct: 176 EAGGVDSCQGDSGGPLMCQE-NNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWI 230
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 145 bits (366), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 89/244 (36%), Positives = 131/244 (53%), Gaps = 20/244 (8%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRT 68
++I G+ + WPW V+L+ + +FCGG LINE WV+TAAHC T
Sbjct: 14 SRIVNGEEAVPGSWPWQVSLQDKTGF-HFCGGSLINENWVVTAAHC----------GVTT 62
Query: 69 SDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRP 128
SD++V GE+D +E K+ + A + +++ NDI L++LS A ++ V
Sbjct: 63 SDVVVA-GEFDQGSSSE-KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSA 120
Query: 129 VCLPQAG-DFYEDQIGIVTGWGTLSYGGPRS-DVLMEVPIPVWRLTECRKQFSQNIFDSN 186
VCLP A DF + TGWG Y + D L + +P+ T C+K + I D+
Sbjct: 121 VCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAM 180
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CG-KTPGVYVQVNKYLRW 244
+CAG G SC GDSGGPL+ ++ + WT++G+VSWG C TPGVY +V + W
Sbjct: 181 ICAGA--SGVSSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNW 237
Query: 245 IYNT 248
+ T
Sbjct: 238 VQQT 241
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 145 bits (365), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 87/258 (33%), Positives = 138/258 (53%), Gaps = 16/258 (6%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K A+I G+ ++ PW +A+ FCGG L+ W++TAAHC+ Q +D
Sbjct: 151 KLMAQIFNGRPAQKGTTPW-IAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPEDPT 209
Query: 66 RRTSDLI------VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK 119
R SDL+ + LG++ + +E + + ++P++ +END+ALV+L +
Sbjct: 210 LRDSDLLSPSDFKIILGKHWRLRSDENE-QHLGVKHTTLHPQYDPNTFENDVALVELLES 268
Query: 120 AQYNSFVRPVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS 179
N+FV P+CLP+ G E + IV+GWG + + LME+ IP+ + C+K ++
Sbjct: 269 PVLNAFVMPICLPE-GPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYA 326
Query: 180 ---QNIFDSNLCAGGYKGGTDSCQGDSGGPLL-LQRPDKQWTIIGVVSWGIGCGKTP--G 233
+ + +CAG +GG D+C GDSGGP++ L R QW ++G VSWG CGK G
Sbjct: 327 PLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYG 386
Query: 234 VYVQVNKYLRWIYNTAKV 251
VY ++ WI V
Sbjct: 387 VYSYIHHNKDWIQRVTGV 404
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 144 bits (364), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 123/241 (51%), Gaps = 6/241 (2%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++ +WPW V+L + + CG LI+ W+++AAHC D +
Sbjct: 4 GTDADEGEWPWQVSL-HALGQGHICGASLISPNWLVSAAHCYID--DRGFRYSDPTQWTA 60
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
LG +D S+ + V + + +P F++ ++ DIAL++L K A+Y+S VRP+CLP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 134 AGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + I VTGWG YGG + +L + I V + T C Q I +C G
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQITPRMMCVGFL 180
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNTAK 250
GG DSCQGDSGGPL D + GVVSWG GC + PGVY ++ + WI
Sbjct: 181 SGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTG 240
Query: 251 V 251
V
Sbjct: 241 V 241
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 144 bits (363), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 89/242 (36%), Positives = 129/242 (53%), Gaps = 20/242 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + WPW V+L+ + +FCGG LINE WV+TAAHC TSD
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGF-HFCGGSLINENWVVTAAHC----------GVTTSD 49
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
++V GE+D +E K+ + A + +++ NDI L++LS A ++ V VC
Sbjct: 50 VVVA-GEFDQGSSSE-KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVC 107
Query: 131 LPQAG-DFYEDQIGIVTGWGTLSYGGPRS-DVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP A DF + TGWG Y + D L + +P+ T C+K + I D+ +C
Sbjct: 108 LPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMIC 167
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CG-KTPGVYVQVNKYLRWIY 246
AG G SC GDSGGPL+ ++ + WT++G+VSWG C TPGVY +V + W+
Sbjct: 168 AGA--SGVSSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 224
Query: 247 NT 248
T
Sbjct: 225 QT 226
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 144 bits (362), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 84/237 (35%), Positives = 127/237 (53%), Gaps = 13/237 (5%)
Query: 14 GQASEVNDWPWLVALKRQY--ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G + + ++P+ ++ + + +FCG + NE + +TA HC+ S L
Sbjct: 4 GTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDD-----YENPSGL 58
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
+ GE D S VNE I + + ++ F +NDI+L++LS +N V P+ L
Sbjct: 59 QIVAGELDMS-VNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIAL 117
Query: 132 PQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNLCAG 190
P+ G + IVTGWGT S GG DVL +V +P+ +CR + + I DS +CAG
Sbjct: 118 PEQGHTATGDV-IVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADEILDSMICAG 176
Query: 191 GYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWI 245
+GG DSCQGDSGGPL + + G+VSWG GC + PGVY +V+ ++ WI
Sbjct: 177 VPEGGKDSCQGDSGGPLAASDTGSTY-LAGIVSWGYGCARPGYPGVYTEVSYHVDWI 232
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 144 bits (362), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 122/241 (50%), Gaps = 6/241 (2%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++ +WPW V+L + + CG LI+ W+++AAHC D +
Sbjct: 4 GTDADEGEWPWQVSL-HALGQGHICGASLISPNWLVSAAHCYID--DRGFRYSDPTQWTA 60
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
LG +D S+ + V + + +P F++ ++ DIAL++L K A+Y+S VRP+CLP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 134 AGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + I VTGWG YGG + +L + I V T C Q I +C G
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFL 180
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNTAK 250
GG DSCQGDSGGPL D + GVVSWG GC + PGVY ++ + WI
Sbjct: 181 SGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTG 240
Query: 251 V 251
V
Sbjct: 241 V 241
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 143 bits (360), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 91/262 (34%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 1 CGRNGKQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKID 60
CGR +I G+ + + WPW V+L+ Y+ + CGG L++ WVLTAAHC ++
Sbjct: 108 CGRRKLPVDRIVGGRDTSLGRWPWQVSLR--YDGAHLCGGSLLSGDWVLTAAHCFPERN- 164
Query: 61 NALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYE---NDIALVQLS 117
R S V G + + ++ Y F + N E NDIALV LS
Sbjct: 165 -----RVLSRWRVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLS 219
Query: 118 KKAQYNSFVRPVCLPQAGDFYED-QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRK 176
+++PVCLP AG D +I VTGWG Y G ++ VL E +P+ C
Sbjct: 220 SPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNG 279
Query: 177 Q--FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRP---DKQWTIIGVVSWGIGC--G 229
+ I CAG +GG D+CQGDSGGP + + +W + G+VSWG GC
Sbjct: 280 ADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALA 339
Query: 230 KTPGVYVQVNKYLRWIYNTAKV 251
+ PGVY +V+ + WI+ K
Sbjct: 340 QKPGVYTKVSDFREWIFQAIKT 361
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 143 bits (360), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 91/262 (34%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 1 CGRNGKQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKID 60
CGR +I G+ + + WPW V+L+ Y+ + CGG L++ WVLTAAHC ++
Sbjct: 108 CGRRKLPVDRIVGGRDTSLGRWPWQVSLR--YDGAHLCGGSLLSGDWVLTAAHCFPERN- 164
Query: 61 NALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYE---NDIALVQLS 117
R S V G + + ++ Y F + N E NDIALV LS
Sbjct: 165 -----RVLSRWRVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLS 219
Query: 118 KKAQYNSFVRPVCLPQAGDFYED-QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRK 176
+++PVCLP AG D +I VTGWG Y G ++ VL E +P+ C
Sbjct: 220 SPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNG 279
Query: 177 Q--FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRP---DKQWTIIGVVSWGIGC--G 229
+ I CAG +GG D+CQGDSGGP + + +W + G+VSWG GC
Sbjct: 280 ADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALA 339
Query: 230 KTPGVYVQVNKYLRWIYNTAKV 251
+ PGVY +V+ + WI+ K
Sbjct: 340 QKPGVYTKVSDFREWIFQAIKT 361
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 142 bits (358), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 84/225 (37%), Positives = 124/225 (55%), Gaps = 24/225 (10%)
Query: 26 VALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNE 85
V+L Y +FCGG L+NE WV++AAHC K +++ VRLGE++ KV E
Sbjct: 16 VSLNSGY---HFCGGSLVNENWVVSAAHCYKSRVE------------VRLGEHNI-KVTE 59
Query: 86 TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIGIV 145
I ++ + +P +S N +NDI L++LSK A N++V+PV LP + + V
Sbjct: 60 GSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP-AGTMCTV 118
Query: 146 TGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGG 205
+GWG SD L + IP+ ++C + I ++ CAG +GG DSCQGDSGG
Sbjct: 119 SGWGNTMSSTADSDKLQCLNIPILSYSDCNDSYPGMITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 206 PLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
P++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 179 PVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFSDWLTST 218
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 142 bits (358), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 85/253 (33%), Positives = 135/253 (53%), Gaps = 16/253 (6%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ ++ PW +A+ FCGG L+ W++TAAHC+ Q +D R SD
Sbjct: 1 IFNGRPAQKGTTPW-IAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSD 59
Query: 71 LI------VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
L+ + LG++ + +E + + ++P++ +END+ALV+L + N+
Sbjct: 60 LLSPSDFKIILGKHWRLRSDENE-QHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNA 118
Query: 125 FVRPVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS---QN 181
FV P+CLP+ G E + IV+GWG + + LME+ IP+ + C+K ++ +
Sbjct: 119 FVMPICLPE-GPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKK 176
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLL-LQRPDKQWTIIGVVSWGIGCGKTP--GVYVQV 238
+ +CAG +GG D+C GDSGGP++ L R QW ++G VSWG CGK GVY +
Sbjct: 177 VTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYI 236
Query: 239 NKYLRWIYNTAKV 251
+ WI V
Sbjct: 237 HHNKDWIQRVTGV 249
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 142 bits (358), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 129/241 (53%), Gaps = 24/241 (9%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G + P V+L Y +FCGG L+NE WV++AAHC K +++
Sbjct: 20 KIVGGYECKPYSQPHQVSLNSGY---HFCGGSLVNENWVVSAAHCYKSRVE--------- 67
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE++ KV E I ++ + +P +S N +NDI L++LSK A N++V+PV
Sbjct: 68 ---VRLGEHNI-KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPV 123
Query: 130 CLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + + V+GWG S+ L + IP+ ++C + I ++ CA
Sbjct: 124 ALPTSCA-PAGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCA 182
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + GVVSWG GC + PGVY +V + W+ +
Sbjct: 183 GYLEGGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 237
Query: 248 T 248
T
Sbjct: 238 T 238
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 142 bits (357), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 133/245 (54%), Gaps = 25/245 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ + D PW V L ++ CG VLI+ WVLTAAHC+ + + L+V
Sbjct: 4 GKMTRRGDSPWQVVL-LDSKKKLACGAVLIHPSWVLTAAHCMDE----------SKKLLV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGEYD + + ++ D+ + V+P +S+ +NDIAL+ L++ A + + P+CLP
Sbjct: 53 RLGEYDLRRWEKWEL-DLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPD 111
Query: 134 AGDFYED-----QIGIVTGWGTLSYGGP-----RSDVLMEVPIPVWRLTECRKQFSQNIF 183
+G + Q +VTGWG S R+ VL + IPV EC + S +
Sbjct: 112 SGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVS 171
Query: 184 DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKY 241
++ LCAG D+C+GDSGGP++ W ++G+VSWG GCG GVY +V++Y
Sbjct: 172 ENMLCAGILGDRQDACEGDSGGPMVASF-HGTWFLVGLVSWGEGCGLLHNYGVYTKVSRY 230
Query: 242 LRWIY 246
L WI+
Sbjct: 231 LDWIH 235
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 142 bits (357), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 84/228 (36%), Positives = 124/228 (54%), Gaps = 24/228 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P V+L Y FCGG L+NE WV++AAHC K +++ VRLGE++ K
Sbjct: 13 PHQVSLNSGYH---FCGGSLVNENWVVSAAHCYKSRVE------------VRLGEHNI-K 56
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
V E I ++ + +P +S N +NDI L++LSK A N++V+PV LP + +
Sbjct: 57 VTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP-AGTM 115
Query: 143 GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGD 202
V+GWG S+ L + IP+ ++C + I ++ CAG +GG DSCQGD
Sbjct: 116 CTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 203 SGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
SGGP++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 176 SGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 142 bits (357), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 133/245 (54%), Gaps = 25/245 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ + D PW V L ++ CG VLI+ WVLTAAHC+ + + L+V
Sbjct: 4 GKMTRRGDSPWQVVL-LDSKKKLACGAVLIHPSWVLTAAHCMDE----------SKKLLV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGEYD + + ++ D+ + V+P +S+ +NDIAL+ L++ A + + P+CLP
Sbjct: 53 RLGEYDLRRWEKWEL-DLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPD 111
Query: 134 AGDFYED-----QIGIVTGWGTLSYGGP-----RSDVLMEVPIPVWRLTECRKQFSQNIF 183
+G + Q +VTGWG S R+ VL + IPV EC + S +
Sbjct: 112 SGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVS 171
Query: 184 DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKY 241
++ LCAG D+C+GDSGGP++ W ++G+VSWG GCG GVY +V++Y
Sbjct: 172 ENMLCAGILGDRQDACEGDSGGPMVASF-HGTWFLVGLVSWGEGCGLLHNYGVYTKVSRY 230
Query: 242 LRWIY 246
L WI+
Sbjct: 231 LDWIH 235
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 141 bits (356), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 84/228 (36%), Positives = 124/228 (54%), Gaps = 24/228 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P V+L Y FCGG L+NE WV++AAHC K +++ VRLGE++ K
Sbjct: 13 PHQVSLNSGYH---FCGGSLVNENWVVSAAHCYKSRVE------------VRLGEHNI-K 56
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
V E I ++ + +P +S N +NDI L++LSK A N++V+PV LP + +
Sbjct: 57 VTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP-AGTM 115
Query: 143 GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGD 202
V+GWG S+ L + IP+ ++C + I ++ CAG +GG DSCQGD
Sbjct: 116 CTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 203 SGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
SGGP++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 176 SGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 141 bits (355), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 126/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + Y NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 141 bits (355), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 89/242 (36%), Positives = 127/242 (52%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G + N P+ V+L Y FCGG LIN++WV++AAHC K +I
Sbjct: 22 KIVGGYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ--------- 69
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE++ + V E + AA + +P F + NDI L++LS + N+ V V
Sbjct: 70 ---VRLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATV 125
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG TLS G D+L + P+ +C + I D+ +C
Sbjct: 126 ALPSSCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVC 184
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIY 246
G +GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI
Sbjct: 185 VGFLEGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 239
Query: 247 NT 248
+T
Sbjct: 240 DT 241
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 140 bits (354), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 84/228 (36%), Positives = 122/228 (53%), Gaps = 24/228 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P V+L Y FCGG L+NE WV++AAHC K ++ VRLGE++ K
Sbjct: 13 PHQVSLNSGYH---FCGGSLVNENWVVSAAHCYKSRV------------AVRLGEHNI-K 56
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
V E I ++ + +P +S N +NDI L++LSK A N++V+PV LP + +
Sbjct: 57 VTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAP-AGTM 115
Query: 143 GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGD 202
V+GWG D L + IP+ ++C + I ++ CAG +GG DSCQGD
Sbjct: 116 CTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 203 SGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
SGGP++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 176 SGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 140 bits (354), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 83/228 (36%), Positives = 123/228 (53%), Gaps = 24/228 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P V+L Y FCGG L+NE WV++AAHC K +++ VRLGE++ K
Sbjct: 13 PHQVSLNSGYH---FCGGSLVNENWVVSAAHCYKSRVE------------VRLGEHNI-K 56
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
V E I ++ + +P +S N +NDI L++LSK A N++V+PV LP + +
Sbjct: 57 VTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALPSSCAP-AGTM 115
Query: 143 GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGD 202
V+GWG + L + IP+ ++C + I ++ CAG +GG DSCQGD
Sbjct: 116 CTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 203 SGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
SGGP++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 176 SGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 140 bits (354), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 127/238 (53%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E N P+ V+L Y +FCGG LI+E+WV++AAHC K +I V
Sbjct: 4 GYTCEENSLPYQVSLNSGY---HFCGGSLISEQWVVSAAHCYKTRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ KV E I AA + +P+++ +NDI L++LS A N+ V + LP
Sbjct: 49 RLGEHNI-KVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + +++GWG TLS+G D L + PV EC+ + I +S C G
Sbjct: 108 APPAAGTEC-LISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQ D+GGP++ + GVVSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQRDAGGPVVCNG-----QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDT 219
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 140 bits (353), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 85/241 (35%), Positives = 121/241 (50%), Gaps = 6/241 (2%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++ +WPW V+L + + CG LI+ W+++AAHC D +
Sbjct: 4 GTDADEGEWPWQVSL-HALGQGHICGASLISPNWLVSAAHCYID--DRGFRYSDPTQWTA 60
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
LG +D S+ + V + + +P F++ ++ DIAL++L K A+Y+S VRP+ LP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPD 120
Query: 134 AGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + I VTGWG YGG + +L + I V T C Q I +C G
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFL 180
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNTAK 250
GG DSCQGDSGGPL D + GVVSWG GC + PGVY ++ + WI
Sbjct: 181 SGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTG 240
Query: 251 V 251
V
Sbjct: 241 V 241
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 140 bits (353), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 83/228 (36%), Positives = 123/228 (53%), Gaps = 24/228 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P V+L Y FCGG L+NE WV++AAHC K +++ VRLGE++ K
Sbjct: 13 PHQVSLNSGYH---FCGGSLVNENWVVSAAHCYKTRVE------------VRLGEHNI-K 56
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
V E I ++ + +P +S N +NDI L++LSK A N++V+PV LP + +
Sbjct: 57 VTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAP-AGTM 115
Query: 143 GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGD 202
V+GWG + L + IP+ ++C + I ++ CAG +GG DSCQGD
Sbjct: 116 CTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 203 SGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
SGGP++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 176 SGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTST 218
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 140 bits (353), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 83/228 (36%), Positives = 123/228 (53%), Gaps = 24/228 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P V+L Y FCGG L+NE WV++AAHC K +++ VRLGE++ K
Sbjct: 13 PHQVSLNSGYH---FCGGSLVNENWVVSAAHCYKSRVE------------VRLGEHNI-K 56
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
V E I ++ + +P +S N +NDI L++LSK A N++V+PV LP + +
Sbjct: 57 VTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAP-AGTM 115
Query: 143 GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGD 202
V+GWG + L + IP+ ++C + I ++ CAG +GG DSCQGD
Sbjct: 116 CTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 203 SGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
SGGP++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 176 SGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 140 bits (352), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 83/225 (36%), Positives = 123/225 (54%), Gaps = 24/225 (10%)
Query: 26 VALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNE 85
V+L Y FCGG L+NE WV++AAHC K +++ VRLGE++ KV E
Sbjct: 31 VSLNSGYH---FCGGSLVNENWVVSAAHCYKSRVE------------VRLGEHNI-KVTE 74
Query: 86 TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIGIV 145
I ++ + +P +S N +NDI L++LSK A N++V+PV LP + + V
Sbjct: 75 GSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP-AGTMCTV 133
Query: 146 TGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGG 205
+GWG S+ L + IP+ ++C + I ++ CAG +GG DSCQGDSGG
Sbjct: 134 SGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGG 193
Query: 206 PLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
P++ + GVVSWG GC + PGVY +V + W+ +T
Sbjct: 194 PVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 233
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 140 bits (352), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E N P+ V+L Y +FCGG LINE+WV++A HC K +I V
Sbjct: 4 GYNCEENSVPYQVSLNSGY---HFCGGSLINEQWVVSAGHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ +V E I AA + +P++ + NDI L++LS +A N+ V + LP
Sbjct: 49 RLGEHNI-EVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + +++GWG T S G D L + PV +C + I + C G
Sbjct: 108 APPATGTKC-LISGWGNTASSGADXPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + GVVSWG GC + PGVY +V Y++WI NT
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNT 219
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 139 bits (351), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 85/232 (36%), Positives = 123/232 (53%), Gaps = 25/232 (10%)
Query: 20 NDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYD 79
N + +L+ Y FCGG LI+ WV++AAHC K +I VRLGE++
Sbjct: 10 NSASYQASLQSGYH---FCGGSLISSTWVVSAAHCYKSRIQ------------VRLGEHN 54
Query: 80 FSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYE 139
+ VNE I + + ++P ++ +N +NDI L++LSK A NS+V V LP +
Sbjct: 55 IA-VNEGTEQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSCASSG 113
Query: 140 DQIGIVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDS 198
+ +V+GWG LS D L + +P+ + C + I + CAG +GG DS
Sbjct: 114 TRC-LVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAYPGQITSNMFCAGFMEGGKDS 172
Query: 199 CQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
CQGDSGGP++ + GVVSWG GC + PGVY +V Y WI +T
Sbjct: 173 CQGDSGGPVVCNG-----QLQGVVSWGYGCAQRNKPGVYTKVCNYRSWISST 219
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 139 bits (350), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E N P+ V+L Y +FCGG LINE+WV++A HC K +I V
Sbjct: 4 GYNCEENSVPYQVSLNSGY---HFCGGSLINEQWVVSAGHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ +V E I AA + +P++ + NDI L++LS +A N+ V + LP
Sbjct: 49 RLGEHNI-EVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + +++GWG T S G D L + PV +C + I + C G
Sbjct: 108 APPATGTKC-LISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+GG DSCQGD+GGP++ + GVVSWG GC + PGVY +V Y++WI NT
Sbjct: 167 EGGKDSCQGDAGGPVVCNG-----QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNT 219
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 139 bits (350), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 128/242 (52%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G + N P+ V+L Y +FCGG LIN++WV++AAHC K +I
Sbjct: 10 KIVGGYTCQENSVPYQVSLNSGY---HFCGGSLINDQWVVSAAHCYKSRIQ--------- 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE++ + V E + AA + +P F + NDI L++LS + N+ V V
Sbjct: 58 ---VRLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATV 113
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG TLS G D+L + P+ +C + I D+ +C
Sbjct: 114 ALPSSCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVC 172
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIY 246
G +GG DSCQGD+GGP++ + G+VSWG GC PGVY +V Y+ WI
Sbjct: 173 VGFLEGGKDSCQGDAGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 227
Query: 247 NT 248
+T
Sbjct: 228 DT 229
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 126/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + Y NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C S I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASSSFIITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG D+CQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDACQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 86/248 (34%), Positives = 130/248 (52%), Gaps = 23/248 (9%)
Query: 14 GQASEVNDWPWLVALK----RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
G ++E WPW+V+L+ R + CGG+L+N WVLTAAHC K K ++ +
Sbjct: 4 GMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNK-------KKVT 56
Query: 70 DLIVRLGEYDF----SKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSF 125
D + G + +K + + + + ++ ++ NDIAL++++ F
Sbjct: 57 DWRLIFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPF 116
Query: 126 VRPVCLPQ--AGDFYEDQIGIVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECR--KQFSQ 180
+ P CLPQ AG Q VTGWG L GPR S L E + + L C + ++
Sbjct: 117 IGPGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNG 176
Query: 181 NIFDSNLCAGGYKGGTDSCQGDSGGPLLLQ-RPDKQWTIIGVVSWGIGC--GKTPGVYVQ 237
I +N+CAG +G D+CQGDSGGPL+ + R + + ++G+ SWG+GC K PGVY
Sbjct: 177 RIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTS 236
Query: 238 VNKYLRWI 245
YL WI
Sbjct: 237 TWPYLNWI 244
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 138 bits (348), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 138 bits (348), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 126/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E N P+ V+L +FCGG LI+E+WV++AAHC K +I V
Sbjct: 4 GYTCEENSLPYQVSLN---SGSHFCGGSLISEQWVVSAAHCYKTRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ KV E I AA + +P+++ +NDI L++LS A N+ V + LP
Sbjct: 49 RLGEHNI-KVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + +++GWG TLS+G D L + PV EC+ + I +S C G
Sbjct: 108 APPAAGTEC-LISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQ D+GGP++ + GVVSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQRDAGGPVVCNG-----QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDT 219
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 138 bits (347), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 138 bits (347), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 126/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y +FCGG LIN++WV++AAHC K +I V
Sbjct: 14 GYTCQENSVPYQVSLNSGY---HFCGGSLINDQWVVSAAHCYKSRIQ------------V 58
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 59 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 117
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 118 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 176
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 177 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 229
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 138 bits (347), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 126/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y +FCGG LIN++WV++AAHC K +I V
Sbjct: 12 GYTCQENSVPYQVSLNSGY---HFCGGSLINDQWVVSAAHCYKSRIQ------------V 56
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 57 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 115
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 116 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 174
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 175 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 227
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 138 bits (347), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 138 bits (347), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 12 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 56
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 57 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 115
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 116 SCAPAGTQC-LISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASYPGKITDNMVCVGFL 174
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 175 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 227
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 138 bits (347), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E N P+ V+L +FCGG LI+E+WV++AAHC K +I V
Sbjct: 4 GYTCEENSLPYQVSLN---SGSHFCGGSLISEQWVVSAAHCYKTRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ KV E I A + +P+++ +NDI L++LS A N+ V + LP
Sbjct: 49 RLGEHNI-KVLEGNEQFINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
A + +++GWG TLS+G D L + PV EC+ + I +S C G
Sbjct: 108 APPAAGTEC-LISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQ DSGGP++ + GVVSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQRDSGGPVVCNG-----QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDT 219
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 138 bits (347), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V + LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 137 bits (345), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 88/252 (34%), Positives = 125/252 (49%), Gaps = 19/252 (7%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + + WPW V+L+ Y+ + CGG L++ WVLTAAHC ++ R S
Sbjct: 1 IVGGRDTSLGRWPWQVSLR--YDGAHLCGGSLLSGDWVLTAAHCFPERN------RVLSR 52
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYE---NDIALVQLSKKAQYNSFVR 127
V G + + ++ Y F + N E NDIALV LS +++
Sbjct: 53 WRVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQ 112
Query: 128 PVCLPQAGDFYED-QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ--FSQNIFD 184
PVCLP AG D +I VTGWG Y G ++ VL E +P+ C + I
Sbjct: 113 PVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKP 172
Query: 185 SNLCAGGYKGGTDSCQGDSGGPLLLQRP---DKQWTIIGVVSWGIGC--GKTPGVYVQVN 239
CAG +GG D+CQGDSGGP + + +W + G+VSWG GC + PGVY +V+
Sbjct: 173 KMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVS 232
Query: 240 KYLRWIYNTAKV 251
+ WI+ K
Sbjct: 233 DFREWIFQAIKT 244
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 137 bits (345), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 120/242 (49%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 14 KIVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ--------- 61
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 62 ---VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASI 117
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG T S G DVL + P+ + C+ + I + C
Sbjct: 118 SLPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFC 176
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 177 AGYLEGGKDSCQGDSGGPVVCSG-----KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 231
Query: 247 NT 248
T
Sbjct: 232 QT 233
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 137 bits (345), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCXKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE + + V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGEDNINVV-EGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GXLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 137 bits (345), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 120/242 (49%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 5 KIVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ--------- 52
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 53 ---VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASI 108
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG T S G DVL + P+ + C+ + I + C
Sbjct: 109 SLPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFC 167
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 168 AGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 222
Query: 247 NT 248
T
Sbjct: 223 QT 224
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 137 bits (344), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 120/242 (49%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 6 KIVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ--------- 53
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 54 ---VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASI 109
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG T S G DVL + P+ + C+ + I + C
Sbjct: 110 SLPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFC 168
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 169 AGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 223
Query: 247 NT 248
T
Sbjct: 224 QT 225
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 137 bits (344), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 124/242 (51%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G N P+ V+L +FCGG LIN +WV++AAHC K +I
Sbjct: 8 KIVGGYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ--------- 55
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE++ V E I AA + +P F+ +NDI L++LS A NS V V
Sbjct: 56 ---VRLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATV 111
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP++ + +++GWG T S G +L + PV + C+ + I + +C
Sbjct: 112 SLPRSCAAAGTEC-LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMIC 170
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 171 VGFLEGGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 225
Query: 247 NT 248
T
Sbjct: 226 QT 227
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 137 bits (344), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGD+GGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDAGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 137 bits (344), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 120/242 (49%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ--------- 67
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 68 ---VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASI 123
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG T S G DVL + P+ + C+ + I + C
Sbjct: 124 SLPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFC 182
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 183 AGYLEGGKDSCQGDSGGPVVCSG-----KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Query: 247 NT 248
T
Sbjct: 238 QT 239
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 136 bits (343), Expect = 9e-33, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 12 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 56
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 57 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 115
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 116 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 174
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQG+SGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 175 EGGKDSCQGNSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 227
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 124/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+V WG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVEWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 126/241 (52%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G + N P+ V+L Y FCGG LIN++WV++AAHC K +I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ + V E + AA + +P F + N+I L++LS + N+ V V
Sbjct: 48 --VRLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVA 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG TLS G D+L + P+ +C + I D+ +C
Sbjct: 105 LPSSCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 136 bits (342), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 91/232 (39%), Positives = 129/232 (55%), Gaps = 24/232 (10%)
Query: 20 NDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYD 79
+ WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++ R S V LG +
Sbjct: 27 HSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS-------PRPSSYKVILGAHQ 78
Query: 80 FSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFY 138
+VN E V +I + + + P DIAL++LS A V P CLP
Sbjct: 79 --EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLPSPNYVV 130
Query: 139 EDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQNIFDSNLCAGGYKGG 195
D+ +TGWG + G + +LME +PV C R +F + + + LCAG GG
Sbjct: 131 ADRTECFITGWGE-TQGTFGAGLLMEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGG 189
Query: 196 TDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWI 245
TDSCQGDSGGPL+ DK + + GV SWG+GC + PGVYV+V++++ WI
Sbjct: 190 TDSCQGDSGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 240
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 136 bits (342), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 124/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+V WG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVKWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 136 bits (342), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 134/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ + +FCGG LI+ WVLTAAHC+++
Sbjct: 12 KCPGRVVGGCVAHPHSWPWQVSLRTRFGQ-HFCGGTLISPEWVLTAAHCLEKS------- 63
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 64 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 115
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 116 KVIPACLPSPNYMVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 174
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGDSGGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 175 VQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 233
Query: 240 KYLRWI 245
+++ WI
Sbjct: 234 RFVTWI 239
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 136 bits (342), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 124/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGD GGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDCGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 136 bits (342), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 125/238 (52%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + N+I L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 89/242 (36%), Positives = 120/242 (49%), Gaps = 25/242 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
KI G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ--------- 67
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 68 ---VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASI 123
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG T S G DVL + P+ + C+ + I + C
Sbjct: 124 SLPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFC 182
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG DSCQGD+GGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 183 AGYLEGGKDSCQGDAGGPVVCSG-----KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Query: 247 NT 248
T
Sbjct: 238 QT 239
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 123/241 (51%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L +FCGG LIN +WV++AAHC K +I
Sbjct: 1 IVGGYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ V E I AA + +P F+ +NDI L++LS A NS V V
Sbjct: 48 --VRLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP++ + +++GWG T S G +L + PV + C+ + I + +C
Sbjct: 105 LPRSCAAAGTEC-LISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GFLQGGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 130/238 (54%), Gaps = 17/238 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++ WPW+V L Y+ CG L++ W+++AAHC+ + N + T+ L +
Sbjct: 4 GSDAKEGAWPWVVGLY--YDDRLLCGASLVSSDWLVSAAHCVYGR--NLEPSKWTAILGL 59
Query: 74 RLGEYDFSKVNETKVTDIPAA--AMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
+ K N T +P + + P ++ + +NDIA++ L K Y +++P+ L
Sbjct: 60 HM------KSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISL 113
Query: 132 PQAGD-FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQ-NIFDSNLCA 189
P+ F + + GWGT+ Y G +D+L E +P+ C++Q + NI ++ +CA
Sbjct: 114 PEENQVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITENMICA 173
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWI 245
G +GG DSCQGDSGGPL+ Q + +W + GV S+G C PGVY +V+++ WI
Sbjct: 174 GYEEGGIDSCQGDSGGPLMCQE-NNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWI 230
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 125/241 (51%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G + N P+ V+L Y FCGG LIN++WV++AAHC K +I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ + V E + AA + +P F + NDI L++LS + N+ V V
Sbjct: 48 --VRLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVA 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG TLS G D+L + P+ +C + I D+ +C
Sbjct: 105 LPSSCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYN 247
G +GG SCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI +
Sbjct: 164 GFLEGGKSSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 122/238 (51%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G N P+ V+L +FCGG LIN +WV++AAHC K +I V
Sbjct: 4 GYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ V E I AA + +P F+ +NDI L++LS A NS V V LP+
Sbjct: 49 RLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ + +++GWG T S G +L + PV + C+ + I + +C G
Sbjct: 108 SCAAAGTEC-LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI T
Sbjct: 167 EGGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQT 219
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V V
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCAGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 135 bits (340), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 118/238 (49%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G N P+ V+L Y FCGG LIN +WV++AAHC K I V
Sbjct: 4 GYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE D V E I A+ V+P ++ NDI L++L A NS V + LP
Sbjct: 49 RLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG T S G DVL + P+ + C+ + I + CAG
Sbjct: 108 SCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI T
Sbjct: 167 EGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQT 219
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 135 bits (340), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 135 bits (340), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 123/241 (51%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L +FCGG LIN +WV++AAHC K +I
Sbjct: 1 IVGGYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ V E I AA + +P F+ +NDI L++LS A NS V V
Sbjct: 48 --VRLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP++ + +++GWG T S G +L + PV + C+ + I + +C
Sbjct: 105 LPRSCAAAGTEC-LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 135 bits (340), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 16 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS------- 67
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 68 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 119
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 120 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 178
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGDSGGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 179 VQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 237
Query: 240 KYLRWI 245
+++ WI
Sbjct: 238 RFVTWI 243
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 135 bits (339), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 13 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS------- 64
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 65 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 116
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 117 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 175
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGDSGGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 176 VQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 234
Query: 240 KYLRWI 245
+++ WI
Sbjct: 235 RFVTWI 240
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 135 bits (339), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 123/241 (51%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L +FCGG LIN +WV++AAHC K +I
Sbjct: 1 IVGGYTCAANSVPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ V E I AA + +P F+ +NDI L++LS A NS V V
Sbjct: 48 --VRLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP++ + +++GWG T S G +L + PV + C+ + I + +C
Sbjct: 105 LPRSCAAAGTEC-LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAYPGQITGNMICV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 135 bits (339), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSG-----KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 134 bits (338), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 91/246 (36%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 16 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS------- 67
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 68 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 119
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 120 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 178
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGD+GGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 179 VQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 237
Query: 240 KYLRWI 245
+++ WI
Sbjct: 238 RFVTWI 243
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 134 bits (338), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 87/240 (36%), Positives = 129/240 (53%), Gaps = 20/240 (8%)
Query: 14 GQASEVNDWPWLVALK-RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLR---RTS 69
G S +WPW V+L+ + + + CGG LI +WVLTAAHC + L L+ R
Sbjct: 4 GTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCF-----DGLPLQDVWRIY 58
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
I+ L D +K +T + I + + SE N+ DIAL++L +Y F +P+
Sbjct: 59 SGILELS--DITK--DTPFSQIKEIIIHQNYKVSEGNH--DIALIKLQAPLEYTEFQKPI 112
Query: 130 CLPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQ-NIFDSNL 187
LP GD VTGWG G ++L +V IP+ EC+K++ I +
Sbjct: 113 SLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMV 172
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
CAG +GG D+C+GDSGGPL+ + + W ++G+ SWG GC + PGVY +V +Y+ WI
Sbjct: 173 CAGYKEGGKDACKGDSGGPLVCKH-NGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 134 bits (337), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 91/246 (36%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 15 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS------- 66
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 67 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 118
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 119 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 177
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGD+GGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 178 VQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 236
Query: 240 KYLRWI 245
+++ WI
Sbjct: 237 RFVTWI 242
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 134 bits (337), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 91/246 (36%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 13 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS------- 64
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 65 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 116
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 117 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 175
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGD+GGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 176 VQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 234
Query: 240 KYLRWI 245
+++ WI
Sbjct: 235 RFVTWI 240
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 134 bits (337), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 91/246 (36%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 14 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKS------- 65
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 66 PRPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 117
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 118 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 176
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGD+GGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 177 VQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 235
Query: 240 KYLRWI 245
+++ WI
Sbjct: 236 RFVTWI 241
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 134 bits (336), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 118/241 (48%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGD GGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDXGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 134 bits (336), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 90/257 (35%), Positives = 139/257 (54%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRR 67
+I +GQ +EV PW V L R+ ++ CG LI++RWVLTAAHC+ D +
Sbjct: 48 GRIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTV-- 105
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAA-AMKVYPRFS-EQNYENDIALVQLSKKAQYNSF 125
DL+VR+G++ ++ E KV I + ++PR++ ++N + DIAL++L + + + +
Sbjct: 106 -DDLLVRIGKHSRTRY-ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDY 163
Query: 126 VRPVCLPQ----AGDFYEDQIGIVTGWG------TLSYGGPRSDVLMEVPIPVWRLTECR 175
+ PVCLP A + G VTGWG T S + VL V +P+ C+
Sbjct: 164 IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK 223
Query: 176 KQFSQNIFDSNLCAGGYKGGT----DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CA GYK G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 224 ASTRIRITDNMFCA-GYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDR 282
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 283 DGKYGFYTHVFRLKKWI 299
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 133 bits (335), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 133/246 (54%), Gaps = 24/246 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
K ++ G + + WPW V+L+ ++ +FCGG LI+ WVLTAAHC+++
Sbjct: 557 KCPGRVVGGCVAHPHSWPWQVSLRTRFGM-HFCGGTLISPEWVLTAAHCLEKSP------ 609
Query: 66 RRTSDLIVRLGEYDFSKVN-ETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
R S V LG + +VN E V +I + + + P DIAL++LS A
Sbjct: 610 -RPSSYKVILGAHQ--EVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITD 660
Query: 125 FVRPVCLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC-RKQF-SQN 181
V P CLP D+ +TGWG + G + +L E +PV C R +F +
Sbjct: 661 KVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCNRYEFLNGR 719
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVN 239
+ + LCAG GGTDSCQGDSGGPL+ DK + + GV SWG+GC + PGVYV+V+
Sbjct: 720 VQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDK-YILQGVTSWGLGCARPNKPGVYVRVS 778
Query: 240 KYLRWI 245
+++ WI
Sbjct: 779 RFVTWI 784
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 133 bits (335), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 85/255 (33%), Positives = 133/255 (52%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK-- 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 231 TPGVYVQVNKYLRWI 245
PG Y V + +WI
Sbjct: 236 KPGFYTHVFRLKKWI 250
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 133 bits (334), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 87/240 (36%), Positives = 128/240 (53%), Gaps = 20/240 (8%)
Query: 14 GQASEVNDWPWLVALK-RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLR---RTS 69
G S +WPW V+L+ + + + CGG LI +WVLTAAHC + L L+ R
Sbjct: 4 GTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCF-----DGLPLQDVWRIY 58
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
I+ L D +K +T + I + + SE N+ DIAL++L Y F +P+
Sbjct: 59 SGILNLS--DITK--DTPFSQIKEIIIHQNYKVSEGNH--DIALIKLQAPLNYTEFQKPI 112
Query: 130 CLPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQ-NIFDSNL 187
LP GD VTGWG G ++L +V IP+ EC+K++ I +
Sbjct: 113 SLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMV 172
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
CAG +GG D+C+GDSGGPL+ + + W ++G+ SWG GC + PGVY +V +Y+ WI
Sbjct: 173 CAGYKEGGKDACKGDSGGPLVCKH-NGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 133 bits (334), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 122/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L +FCGG LIN +WV++AAHC K +I
Sbjct: 1 IVGGYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ V E I AA + +P F+ +NDI L++LS A S V V
Sbjct: 48 --VRLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP++ + +++GWG T S G +L + PV + C+ + I + +C
Sbjct: 105 LPRSCAAAGTEC-LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 133 bits (334), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 118/241 (48%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A S V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 132 bits (333), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 90/255 (35%), Positives = 138/255 (54%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +GQ +EV PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTV---D 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAA-AMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVR 127
DL+VR+G++ ++ E KV I + ++PR++ ++N + DIAL++L + + + ++
Sbjct: 58 DLLVRIGKHSRTRY-ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 116
Query: 128 PVCLPQ----AGDFYEDQIGIVTGWG------TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
PVCLP A + G VTGWG T S + VL V +P+ C+
Sbjct: 117 PVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKAS 176
Query: 178 FSQNIFDSNLCAGGYKGGT----DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CA GYK G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 177 TRIRITDNMFCA-GYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 132 bits (333), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 91/263 (34%), Positives = 141/263 (53%), Gaps = 33/263 (12%)
Query: 7 QTAKIDKGQASEVNDWPW--LVALKRQYERDNF-CGGVLINERWVLTAAHCIKQKIDNAL 63
+ KI G + ++PW ++ K + F CGG LIN R+++TAAHC+ +
Sbjct: 19 EADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGR----- 73
Query: 64 VLRRTSDL-IVRLGEYDFSKVNET----------KVTDIPAAAMKVYPRFSE--QNYEND 110
VLR L VRLGE++ + + K D+ +P + + ++ +D
Sbjct: 74 VLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHD 133
Query: 111 IALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIG---IVTGWGTLSYGGPRSDVLMEVPIP 167
IAL++L+++ ++ +++RPVCLPQ + E Q+G V GWG G S + ++ +P
Sbjct: 134 IALIRLNRQVEFTNYIRPVCLPQPNE--EVQVGQRLTVVGWGRTETG-QYSTIKQKLAVP 190
Query: 168 VWRLTECRKQFSQ---NIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW 224
V +C K F + S LCAGG K DSC GDSGGPLL +R ++Q+ + G+VS+
Sbjct: 191 VVHAEQCAKTFGAAGVRVRSSQLCAGGEKA-KDSCGGDSGGPLLAERANQQFFLEGLVSF 249
Query: 225 GIGCGKT--PGVYVQVNKYLRWI 245
G CG PG+Y +V KY WI
Sbjct: 250 GATCGTEGWPGIYTKVGKYRDWI 272
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 132 bits (333), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 90/255 (35%), Positives = 138/255 (54%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +GQ +EV PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTV---D 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAA-AMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVR 127
DL+VR+G++ ++ E KV I + ++PR++ ++N + DIAL++L + + + ++
Sbjct: 58 DLLVRIGKHSRTRY-ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 116
Query: 128 PVCLPQ----AGDFYEDQIGIVTGWG------TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
PVCLP A + G VTGWG T S + VL V +P+ C+
Sbjct: 117 PVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKAS 176
Query: 178 FSQNIFDSNLCAGGYKGGT----DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CA GYK G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 177 TRIRITDNMFCA-GYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 85/238 (35%), Positives = 123/238 (51%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + N P+ V+L Y FCGG LIN++WV++AAHC K +I V
Sbjct: 4 GYTCQENSVPYQVSLNSGYH---FCGGSLINDQWVVSAAHCYKSRIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE++ + V E + AA + +P F + NDI L++LS + N+ V V LP
Sbjct: 49 RLGEHNIN-VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG TLS G D+L + P+ +C + I D+ +C G
Sbjct: 108 SCAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIYNT 248
+GG SCQGDSGGP++ + G+VSWG GC P VY +V Y+ WI +T
Sbjct: 167 EGGKGSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPDVYTKVCNYVDWIQDT 219
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 132 bits (331), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 85/249 (34%), Positives = 131/249 (52%), Gaps = 20/249 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD 184
VCLP A G VTGWG L G S VL V +P+ C+ I D
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKEKGQPS-VLQVVNLPIVERPVCKDSTRIRITD 176
Query: 185 SNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP--GVYV 236
+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC + G Y
Sbjct: 177 NMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYT 234
Query: 237 QVNKYLRWI 245
V + +WI
Sbjct: 235 HVFRLKKWI 243
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 132 bits (331), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/254 (33%), Positives = 132/254 (51%), Gaps = 30/254 (11%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI------KQKIDNALV 64
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ K +N
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN--- 57
Query: 65 LRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYN 123
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++
Sbjct: 58 -----DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 124 SFVRPVCLPQ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS 179
++ PVCLP A G VTGWG L G S VL V +P+ C+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQPS-VLQVVNLPIVERPVCKDSTR 171
Query: 180 QNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP- 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 172 IRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGK 229
Query: 233 -GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 230 YGFYTHVFRLKKWI 243
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 132 bits (331), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 83/249 (33%), Positives = 130/249 (52%), Gaps = 19/249 (7%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD 184
VCLP A G VTGWG L + VL V +P+ C+ I D
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKDSTRIRITD 177
Query: 185 SNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP--GVYV 236
+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC + G Y
Sbjct: 178 NMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYT 235
Query: 237 QVNKYLRWI 245
V + +WI
Sbjct: 236 HVFRLKKWI 244
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 131 bits (330), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 75/247 (30%), Positives = 131/247 (53%), Gaps = 25/247 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ ++ +PW V L + D FCGG ++NE+W++TAAHC++ + + V
Sbjct: 4 GEDAKPGQFPWQVVLNGKV--DAFCGGSIVNEKWIVTAAHCVETGVK----------ITV 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ----NYENDIALVQLSKKAQYNSFVRPV 129
GE++ + ET+ T+ +++ P + Y +DIAL++L + NS+V P+
Sbjct: 52 VAGEHN---IEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPI 108
Query: 130 CLPQ---AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
C+ F + G V+GWG + + G + VL + +P+ C + I+++
Sbjct: 109 CIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNM 168
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRW 244
CAG ++GG DSCQGDSGGP + + + + G++SWG C G+Y +V++Y+ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNW 227
Query: 245 IYNTAKV 251
I K+
Sbjct: 228 IKEKTKL 234
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 131 bits (330), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 81/248 (32%), Positives = 129/248 (52%), Gaps = 27/248 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ ++ +PW V L + D FCGG +INE+WV+TAAHCI+ + + V
Sbjct: 4 GENAKPGQFPWQVLLNGKI--DAFCGGSIINEKWVVTAAHCIEPGVK----------ITV 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ----NYENDIALVQLSKKAQYNSFVRPV 129
GEY+ ET+ T+ ++ P S Y +DIAL++L + NS+V P+
Sbjct: 52 VAGEYN---TEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPI 108
Query: 130 CLPQ---AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
C+ F + G V+GWG + G + +L + +P+ C + I+ +
Sbjct: 109 CIADKEYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKFTIYSNM 168
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGC---GKTPGVYVQVNKYLR 243
CAG ++GG DSCQGDSGGP + + + + G++SWG C GK G+Y +V++Y+
Sbjct: 169 FCAGFHEGGKDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAVKGKY-GIYTKVSRYVN 226
Query: 244 WIYNTAKV 251
WI K+
Sbjct: 227 WIKEKTKL 234
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 131 bits (329), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 117/238 (49%), Gaps = 25/238 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G N P+ V+L Y FCGG LI+ +WV++AAHC K I V
Sbjct: 4 GYTCGANTVPYQVSLNSGYH---FCGGSLIDSQWVVSAAHCYKSGIQ------------V 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
RLGE D V E I A+ V+P + NDI L++L A +S V + LP
Sbjct: 49 RLGE-DNINVVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPT 107
Query: 134 AGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ Q +++GWG T S G DVL + P+ + C+ + I + CAG
Sbjct: 108 SCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI T
Sbjct: 167 EGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQT 219
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 130 bits (328), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 117/241 (48%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGC--GKTPGVYVQVNKYLRWIYN 247
G +G DSCQGDSGGP++ + G+VSWG GC PGVY +V Y+ WI
Sbjct: 164 YGLEGKGDSCQGDSGGPVVCSGK-----LQGIVSWGSGCQAKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 130 bits (328), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 86/260 (33%), Positives = 134/260 (51%), Gaps = 35/260 (13%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI------KQKIDNALV 64
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ K I+N
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIEN--- 57
Query: 65 LRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYN 123
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++
Sbjct: 58 -----DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 124 SFVRPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTE 173
++ PVCLP A G VTGWG L + G + VL V +P+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 174 CRKQFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIG 227
C+ I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG G
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Query: 228 CGKTP--GVYVQVNKYLRWI 245
C + G Y V + +WI
Sbjct: 231 CDRDGKYGFYTHVFRLKKWI 250
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 130 bits (328), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 83/249 (33%), Positives = 132/249 (53%), Gaps = 19/249 (7%)
Query: 11 IDKGQASEVNDWPWLVALK----RQYERDNFCGGVLINERWVLTAAHC--IKQKIDNALV 64
I GQ + WPW+V+L+ R + CGG L+N +W+LTAAHC IK+K+ + +
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 65 LRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS 124
+ ++ E+ +K + + + + ++ ++S + NDIAL++++
Sbjct: 61 IFGAKEV-----EWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGH 115
Query: 125 FVRPVCLPQ--AGDFYEDQIGIVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECR--KQFS 179
F+ P CLPQ AG Q V GWG L R S +L E + + L C + ++
Sbjct: 116 FIGPGCLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYN 175
Query: 180 QNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQ-RPDKQWTIIGVVSWGIGC--GKTPGVYV 236
I +N+CAG +G D+CQGDSGGPL+ + + + ++G+ SWG+GC K PGVY
Sbjct: 176 GRIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYT 235
Query: 237 QVNKYLRWI 245
YL WI
Sbjct: 236 STWSYLNWI 244
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 130 bits (328), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 85/249 (34%), Positives = 130/249 (52%), Gaps = 20/249 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ + + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD 184
VCLP A G VTGWG L G S VL V +P+ C+ I D
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETGQPS-VLQVVNLPIVERPVCKDSTRIRITD 176
Query: 185 SNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP--GVYV 236
+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC + G Y
Sbjct: 177 NMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYT 234
Query: 237 QVNKYLRWI 245
V + +WI
Sbjct: 235 HVFRLKKWI 243
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 130 bits (328), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 74/247 (29%), Positives = 131/247 (53%), Gaps = 25/247 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ ++ +PW V L + D FCGG ++NE+W++TAAHC++ + + V
Sbjct: 4 GEDAKPGQFPWQVVLNGKV--DAFCGGSIVNEKWIVTAAHCVETGVK----------ITV 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ----NYENDIALVQLSKKAQYNSFVRPV 129
GE++ + ET+ T+ +++ P + Y +DIAL++L + NS+V P+
Sbjct: 52 VAGEHN---IEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPI 108
Query: 130 CLPQ---AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
C+ F + G V+GWG + + G + VL + +P+ C + I+++
Sbjct: 109 CIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNM 168
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRW 244
CAG ++GG DSCQGD+GGP + + + + G++SWG C G+Y +V++Y+ W
Sbjct: 169 FCAGFHEGGRDSCQGDAGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNW 227
Query: 245 IYNTAKV 251
I K+
Sbjct: 228 IKEKTKL 234
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 130 bits (328), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 119/240 (49%), Gaps = 26/240 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ + I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT-PGVYVQVNKYLRWIYNT 248
G +GG DSCQGDSGGP++ + G+VSWG GC K PGVY +V Y+ WI T
Sbjct: 164 -GLEGG-DSCQGDSGGPVVCSGK-----LQGIVSWGSGCAKNKPGVYTKVCNYVSWIKQT 216
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 130 bits (327), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 31 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 87
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 88 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 147
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 148 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 207
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 208 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 265
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 266 DGKYGFYTHVFRLKKWI 282
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 130 bits (327), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 85/255 (33%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+CQGDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 31 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 87
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 88 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 147
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 148 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 207
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 208 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 265
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 266 DGKYGFYTHVFRLKKWI 282
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 75/247 (30%), Positives = 130/247 (52%), Gaps = 25/247 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ ++ +PW V L + D FCGG ++NE+W++TAAHC++ + + V
Sbjct: 4 GEDAKPGQFPWQVVLNGKV--DAFCGGSIVNEKWIVTAAHCVETGVK----------ITV 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRF----SEQNYENDIALVQLSKKAQYNSFVRPV 129
GE++ + ET+ T+ +++ P + Y +DIAL++L + NS+V P+
Sbjct: 52 VAGEHN---IEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPI 108
Query: 130 CLPQ---AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
C+ F + G V+GWG + + G + VL + +P+ C + I ++
Sbjct: 109 CIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTITNNM 168
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRW 244
CAG ++GG DSCQGDSGGP + + + + G++SWG C G+Y +V++Y+ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNW 227
Query: 245 IYNTAKV 251
I K+
Sbjct: 228 IKEKTKL 234
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 29 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 85
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 86 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 145
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 146 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 206 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 263
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 264 DGKYGFYTHVFRLKKWI 280
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 75/247 (30%), Positives = 130/247 (52%), Gaps = 25/247 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ ++ +PW V L + D FCGG ++NE+W++TAAHC++ + + V
Sbjct: 4 GEDAKPGQFPWQVVLNGKV--DAFCGGSIVNEKWIVTAAHCVETGVK----------ITV 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ----NYENDIALVQLSKKAQYNSFVRPV 129
GE++ + ET+ T+ +++ P + Y +DIAL++L + NS+V P+
Sbjct: 52 VAGEHN---IEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPI 108
Query: 130 CLPQ---AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
C+ F + G V+GWG + + G + VL + +P+ C + I ++
Sbjct: 109 CIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTITNNM 168
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRW 244
CAG ++GG DSCQGDSGGP + + + + G++SWG C G+Y +V++Y+ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNW 227
Query: 245 IYNTAKV 251
I K+
Sbjct: 228 IKEKTKL 234
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 29 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 85
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 86 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 145
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 146 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 206 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 263
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 264 DGKYGFYTHVFRLKKWI 280
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 28 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 84
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 85 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 144
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 145 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 204
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 205 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 262
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 263 DGKYGFYTHVFRLKKWI 279
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ D
Sbjct: 35 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 91
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 92 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 151
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 152 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 211
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 212 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 269
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 270 DGKYGFYTHVFRLKKWI 286
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 130 bits (327), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ D
Sbjct: 29 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 85
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 86 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 145
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 146 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 206 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 263
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 264 DGKYGFYTHVFRLKKWI 280
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 130 bits (327), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 130 bits (326), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 86/258 (33%), Positives = 136/258 (52%), Gaps = 27/258 (10%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 29 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 85
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPA-AAMKVYPRFS-EQNYENDIALVQLSKKAQYNSF 125
+DL+VR+G++ ++ E + I + ++PR++ +N + DIAL++L K ++ +
Sbjct: 86 ENDLLVRIGKHSRTRY-EANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY 144
Query: 126 VRPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECR 175
+ PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 145 IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK 204
Query: 176 KQFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCG 229
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC
Sbjct: 205 DSTRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 262
Query: 230 KTP--GVYVQVNKYLRWI 245
+ G Y V + +WI
Sbjct: 263 RDGKYGFYTHVFRLKKWI 280
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 130 bits (326), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 75/247 (30%), Positives = 130/247 (52%), Gaps = 25/247 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ ++ +PW V L + D FCGG ++NE+W++TAAHC++ + + V
Sbjct: 4 GEDAKPGQFPWQVVLNGKV--DAFCGGSIVNEKWIVTAAHCVETGVK----------ITV 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRF----SEQNYENDIALVQLSKKAQYNSFVRPV 129
GE++ + ET+ T+ +++ P + Y +DIAL++L + NS+V P+
Sbjct: 52 VAGEHN---IEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPI 108
Query: 130 CLPQ---AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
C+ F + G V+GWG + + G + VL + +P+ C + I ++
Sbjct: 109 CIADKEYTNIFLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKFTITNNM 168
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRW 244
CAG ++GG DSCQGDSGGP + + + + G++SWG C G+Y +V++Y+ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNW 227
Query: 245 IYNTAKV 251
I K+
Sbjct: 228 IKEKTKL 234
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 130 bits (326), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ D
Sbjct: 35 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 91
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 92 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 151
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 152 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 211
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 212 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 269
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 270 DGKYGFYTHVFRLKKWI 286
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 130 bits (326), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ D
Sbjct: 164 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 220
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 221 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 280
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 281 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 340
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 341 STRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 398
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 399 DGKYGFYTHVFRLKKWI 415
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 130 bits (326), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 85/249 (34%), Positives = 131/249 (52%), Gaps = 22/249 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD 184
VCLP A G VTGWG L G P VL V +P+ C+ I D
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLK-GQP--SVLQVVNLPIVERPVCKDSTRIRITD 174
Query: 185 SNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP--GVYV 236
+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC + G Y
Sbjct: 175 NMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYT 232
Query: 237 QVNKYLRWI 245
V + +WI
Sbjct: 233 HVFRLKKWI 241
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 129 bits (325), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 83/253 (32%), Positives = 130/253 (51%), Gaps = 21/253 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAGGYKGGT---DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP-- 232
I D+ CAG T D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKY 237
Query: 233 GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 238 GFYTHVFRLKKWI 250
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 129 bits (325), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 129 bits (325), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 88/264 (33%), Positives = 131/264 (49%), Gaps = 24/264 (9%)
Query: 1 CGRNGKQTAKIDK----GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCI 55
C + + T KI G AS +WPW V L + + CGG +I +W+LTAAHC
Sbjct: 374 CKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF 433
Query: 56 KQKIDNALVLRRTSDLIVRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALV 114
+++ +LR V G + S++ E T + + + +E Y DIAL+
Sbjct: 434 -YGVESPKILR------VYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALL 484
Query: 115 QLSKKAQYNSFVRPVCLPQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRL 171
+L Y RP+CLP GD Y D VTGWG + L + IP+
Sbjct: 485 KLETTVNYTDSQRPICLPSKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTN 542
Query: 172 TECRKQF-SQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK 230
EC+K++ I +CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC +
Sbjct: 543 EECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQ 601
Query: 231 --TPGVYVQVNKYLRWIYNTAKVI 252
PGVY V +Y+ WI + +
Sbjct: 602 RERPGVYTNVVEYVDWILEKTQAV 625
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 129 bits (325), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 83/247 (33%), Positives = 126/247 (51%), Gaps = 20/247 (8%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
+ S++ E T + + + +E Y DIAL++L Y RP+CL
Sbjct: 63 ------NQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYTDSQRPICL 114
Query: 132 PQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNL 187
P GD Y D VTGWG + L + IP+ EC+K++ I +
Sbjct: 115 PSKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMI 172
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 173 CAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
Query: 246 YNTAKVI 252
+ +
Sbjct: 232 LEKTQAV 238
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KFGFYTHVFRLKKWI 250
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 83/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ D
Sbjct: 48 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 104
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 105 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 164
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 165 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 224
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GD+GGP +++ P + +W +G+VSWG GC +
Sbjct: 225 STRIRITDNMFCAGYKPDEGKRG--DACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDR 282
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 283 DGKYGFYTHVFRLKKWI 299
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 86/256 (33%), Positives = 135/256 (52%), Gaps = 27/256 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPA-AAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVR 127
DL+VR+G++ ++ E + I + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 58 DLLVRIGKHSRTRY-EANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 128 PVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQ 177
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 178 FSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKT 231
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 177 TRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRD 234
Query: 232 P--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 235 GKYGFYTHVFRLKKWI 250
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 129 bits (324), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 83/257 (32%), Positives = 133/257 (51%), Gaps = 25/257 (9%)
Query: 9 AKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRR 67
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 30 GRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT--- 86
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFV 126
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 87 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 146
Query: 127 RPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRK 176
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 147 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 206
Query: 177 QFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK 230
I D+ CAG G +G D+C+GD+GGP +++ P + +W +G+VSWG GC +
Sbjct: 207 STRIRITDNMFCAGYKPDEGKRG--DACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDR 264
Query: 231 TP--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 265 DGKYGFYTHVFRLKKWI 281
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 129 bits (324), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGK-- 230
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 231 TPGVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KIGFYTHVFRLKKWI 250
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 129 bits (324), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 86/256 (33%), Positives = 135/256 (52%), Gaps = 27/256 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPA-AAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVR 127
DL+VR+G++ ++ E + I + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 58 DLLVRIGKHSRTRY-EANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 128 PVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQ 177
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 178 FSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKT 231
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 177 TRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRD 234
Query: 232 P--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 235 GKYGFYTHVFRLKKWI 250
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 129 bits (324), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 129 bits (323), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 83/256 (32%), Positives = 133/256 (51%), Gaps = 25/256 (9%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRT 68
+I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---E 57
Query: 69 SDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVR 127
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++
Sbjct: 58 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 117
Query: 128 PVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQ 177
PVCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 177
Query: 178 FSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKT 231
I D+ CAG G +G D+C+GD+GGP +++ P + +W +G+VSWG GC +
Sbjct: 178 TRIRITDNMFCAGYKPDEGKRG--DACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRD 235
Query: 232 P--GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 GKYGFYTHVFRLKKWI 251
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 129 bits (323), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 82/225 (36%), Positives = 117/225 (52%), Gaps = 24/225 (10%)
Query: 26 VALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNE 85
V+L Y +FCGG L+++ WV++AAHC K VLR VRLGE+ +VNE
Sbjct: 16 VSLNSGY---HFCGGSLVSKDWVVSAAHCYKS------VLR------VRLGEHHI-RVNE 59
Query: 86 TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIGIV 145
I ++++ +P +S N NDI L++L+K A N +V V LP + + V
Sbjct: 60 GTEQYISSSSVIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALPTECAA-DATMCTV 118
Query: 146 TGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGG 205
+GWG D L + +P+ +C + I S CAG +GG DSCQGDSGG
Sbjct: 119 SGWGNTMSSVADGDKLQCLSLPILSHADCANSYPGMITQSMFCAGYLEGGKDSCQGDSGG 178
Query: 206 PLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
P++ + GVVSWG GC + PGVY +V W+ +T
Sbjct: 179 PVVCNG-----VLQGVVSWGYGCAERDHPGVYAKVCVLSGWVRDT 218
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 129 bits (323), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 119/242 (49%), Gaps = 26/242 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQY-NSFVRPV 129
VRLGE D V E I A+ V+P ++ NDI L++L A +S V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASI 104
Query: 130 CLPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP + Q +++GWG T S G DVL + P+ + C+ + I + C
Sbjct: 105 SLPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFC 163
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 AGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 218
Query: 247 NT 248
T
Sbjct: 219 QT 220
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 129 bits (323), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 129/233 (55%), Gaps = 14/233 (6%)
Query: 21 DWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDF 80
++PW V+++R+ +FCGG +IN+RWV+ AAHC++ + ALV L+V GE+D
Sbjct: 11 EFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAP-ALV-----SLVV--GEHDS 62
Query: 81 SKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED 140
S + + T ++ V + END+++++ + ++ V P+C P + Y
Sbjct: 63 SAASTVRQTH-DVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPANDYVY 121
Query: 141 QIGIVTGWGTLSYGGPRSD-VLMEVPIPVWRLTECRKQF-SQNIFDSNLCAGGYKGGT-- 196
+ +GWGT++ GG VL V + + C + S I+D +CA G T
Sbjct: 122 RKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDMICATDNTGMTDR 181
Query: 197 DSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT-PGVYVQVNKYLRWIYNT 248
DSCQGDSGGPL ++ ++++G+VSWGIGC PGVY +V + WI +T
Sbjct: 182 DSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCASGYPGVYSRVGFHAGWITDT 234
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 128 bits (322), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 86/256 (33%), Positives = 133/256 (51%), Gaps = 27/256 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGC---G 229
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC G
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDG 235
Query: 230 KTPGVYVQVNKYLRWI 245
K G Y V + +WI
Sbjct: 236 KY-GFYTHVFRLKKWI 250
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 24/249 (9%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLG---EYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
+ + F V E + D + +E Y DIAL++L Y RP+
Sbjct: 63 NQAEIKEDTSFFGVQEIIIHD--------QYKMAESGY--DIALLKLETTVNYADSQRPI 112
Query: 130 CLPQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDS 185
CLP GD Y D VTGWG + + L + IP+ EC+K++ I
Sbjct: 113 CLPSKGDRNVIYTD--CWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK 170
Query: 186 NLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLR 243
+CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVD 229
Query: 244 WIYNTAKVI 252
WI + +
Sbjct: 230 WILEKTQAV 238
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GD+GGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 128 bits (321), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 81/250 (32%), Positives = 130/250 (52%), Gaps = 28/250 (11%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G ++ WPW V++ YE + CGG L++E+WVL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSIT--YEGVHVCGGSLVSEQWVLSAAHCFPSE-------HHKEA 51
Query: 71 LIVRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
V+LG + +E KV+ + + +P + ++ + DIAL+QLS+ ++ ++RP+
Sbjct: 52 YEVKLGAHQLDSYSEDAKVSTL--KDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 130 CLPQAGDFYEDQIG-IVTGWG----TLSYGGPRSDVLMEVPIPVWRLT-------ECRKQ 177
LP A + + + VTGWG ++S P+ +EVP+ + R T + + +
Sbjct: 110 SLPAANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPL-ISRETCNALYNIDAKPE 168
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + +CAG +GG D+CQGDSGGPL + W + G+VSWG CG PGVY
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYLTGIVSWGDACGARNRPGVY 227
Query: 236 VQVNKYLRWI 245
+ Y WI
Sbjct: 228 TLASSYASWI 237
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 128 bits (321), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 18/246 (7%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGI- 61
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
L + + ++ +T + + + +E Y DIAL++L Y RP+CLP
Sbjct: 62 --LNQAEIAE--DTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYADSQRPICLP 115
Query: 133 QAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNLC 188
GD Y D VTGWG + L + IP+ EC+K++ I +C
Sbjct: 116 SKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMIC 173
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWIL 232
Query: 247 NTAKVI 252
+ +
Sbjct: 233 EKTQAV 238
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 84/239 (35%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 17 SEVNDWPWLVALKRQYERDNFC-GGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRL 75
S N P+ V+L +FC GG LIN +WV++AAHC S + VRL
Sbjct: 8 SAANSIPYQVSLN---SGSHFCSGGSLINSQWVVSAAHC-----------SYKSRIQVRL 53
Query: 76 GEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAG 135
GE++ V E I AA + +P F+ +NDI L++LS A NS V V LP++
Sbjct: 54 GEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC 112
Query: 136 DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPI--PVWRLTECRKQFSQNIFDSNLCAGGYK 193
+ +++GWG G L++ + PV + C+ + I + +C G +
Sbjct: 113 AAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYPGQITGNMICVGFLE 172
Query: 194 GGTDSC-QGDSGGPLLLQRPDKQWTIIGVVSWGIGCG---KTPGVYVQVNKYLRWIYNT 248
GG DSC QGDSGGP++ Q G+VSWG GC PGVY +V Y+ WI T
Sbjct: 173 GGKDSCSQGDSGGPVVCSNGQLQ----GIVSWGYGCSAQKNKPGVYTKVCNYVNWIQQT 227
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 81/250 (32%), Positives = 130/250 (52%), Gaps = 28/250 (11%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G ++ WPW V++ YE + CGG L++E+WVL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSIT--YEGVHVCGGSLVSEQWVLSAAHCFPSE-------HHKEA 51
Query: 71 LIVRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
V+LG + +E KV+ + + +P + ++ + DIAL+QLS+ ++ ++RP+
Sbjct: 52 YEVKLGAHQLDSYSEDAKVSTL--KDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 130 CLPQAGDFYEDQIG-IVTGWG----TLSYGGPRSDVLMEVPIPVWRLT-------ECRKQ 177
LP A + + + VTGWG ++S P+ +EVP+ + R T + + +
Sbjct: 110 SLPAAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPL-ISRETCNSLYNIDAKPE 168
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + +CAG +GG D+CQGDSGGPL + W + G+VSWG CG PGVY
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYLTGIVSWGDACGARNRPGVY 227
Query: 236 VQVNKYLRWI 245
+ Y WI
Sbjct: 228 TLASSYASWI 237
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 81/250 (32%), Positives = 130/250 (52%), Gaps = 28/250 (11%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G ++ WPW V++ YE + CGG L++E+WVL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSIT--YEGVHVCGGSLVSEQWVLSAAHCFPSE-------HHKEA 51
Query: 71 LIVRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
V+LG + +E KV+ + + +P + ++ + DIAL+QLS+ ++ ++RP+
Sbjct: 52 YEVKLGAHQLDSYSEDAKVSTL--KDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 130 CLPQAGDFYEDQIG-IVTGWG----TLSYGGPRSDVLMEVPIPVWRLT-------ECRKQ 177
LP A + + + VTGWG ++S P+ +EVP+ + R T + + +
Sbjct: 110 SLPAAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPL-ISRETCNSLYNIDAKPE 168
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + +CAG +GG D+CQGDSGGPL + W + G+VSWG CG PGVY
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYLTGIVSWGDACGARNRPGVY 227
Query: 236 VQVNKYLRWI 245
+ Y WI
Sbjct: 228 TLASSYASWI 237
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 127 bits (320), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG+Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 127 bits (320), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 84/249 (33%), Positives = 125/249 (50%), Gaps = 24/249 (9%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLG---EYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
+ + F V E + D + +E Y DIAL++L Y RP+
Sbjct: 63 NQAEIKEDTSFFGVQEIIIHD--------QYKMAESGY--DIALLKLETTVNYADSQRPI 112
Query: 130 CLPQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDS 185
CLP GD Y D VTGWG + L + IP+ EC+K++ I
Sbjct: 113 CLPSKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK 170
Query: 186 NLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLR 243
+CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVD 229
Query: 244 WIYNTAKVI 252
WI + +
Sbjct: 230 WILEKTQAV 238
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 127 bits (320), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 87/267 (32%), Positives = 138/267 (51%), Gaps = 41/267 (15%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDN----FCGGVLINERWVLTAAHCIKQKIDN---A 62
+I G +++ PW A+ ++ R CGG+LI+ W+L+AAHC +++
Sbjct: 13 RIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLT 72
Query: 63 LVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQL----SK 118
++L RT ++ E F V+ F + Y+NDIAL+QL S+
Sbjct: 73 VILGRTYRVVPGEEEQKFE-----------VEKYIVHKEFDDDTYDNDIALLQLKSDSSR 121
Query: 119 KAQYNSFVRPVCLP----QAGDFYEDQIGIVTGWGTLSYGGP-RSDVLMEVPIPVWRLTE 173
AQ +S VR VCLP Q D+ E ++ +G+G P S+ L E + ++ +
Sbjct: 122 CAQESSVVRTVCLPPADLQLPDWTECEL---SGYGKHEALSPFYSERLKEAHVRLYPSSR 178
Query: 174 CRKQ--FSQNIFDSNLCAGGYKGG------TDSCQGDSGGPLLLQRPDKQWTIIGVVSWG 225
C Q ++ + D+ LCAG + G D+CQGDSGGPL+ D + T++G++SWG
Sbjct: 179 CTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLN-DGRMTLVGIISWG 237
Query: 226 IGCGK--TPGVYVQVNKYLRWIYNTAK 250
+GCG+ PGVY +V YL WI + +
Sbjct: 238 LGCGQKDVPGVYTKVTNYLDWIRDNMR 264
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 127 bits (320), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + +IAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 127 bits (320), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PG Y +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 127 bits (320), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S+ I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSRIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 127 bits (319), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG+Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGIYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 127 bits (319), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGD+GGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 127 bits (319), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 131/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+ DSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 127 bits (318), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSAIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 127 bits (318), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG L+N +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLLNSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG+Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 127 bits (318), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 87/266 (32%), Positives = 137/266 (51%), Gaps = 41/266 (15%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDN----FCGGVLINERWVLTAAHCIKQKIDN---AL 63
I G +++ PW A+ ++ R CGG+LI+ W+L+AAHC +++ +
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 64 VLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQL----SKK 119
+L RT ++ E F V+ F + Y+NDIAL+QL S+
Sbjct: 61 ILGRTYRVVPGEEEQKFE-----------VEKYIVHKEFDDDTYDNDIALLQLKSDSSRC 109
Query: 120 AQYNSFVRPVCLP----QAGDFYEDQIGIVTGWGTLSYGGP-RSDVLMEVPIPVWRLTEC 174
AQ +S VR VCLP Q D+ E ++ +G+G P S+ L E + ++ + C
Sbjct: 110 AQESSVVRTVCLPPADLQLPDWTECEL---SGYGKHEALSPFYSERLKEAHVRLYPSSRC 166
Query: 175 RKQ--FSQNIFDSNLCAGGYKGG------TDSCQGDSGGPLLLQRPDKQWTIIGVVSWGI 226
Q ++ + D+ LCAG + G D+CQGDSGGPL+ D + T++G++SWG+
Sbjct: 167 TSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLN-DGRMTLVGIISWGL 225
Query: 227 GCGK--TPGVYVQVNKYLRWIYNTAK 250
GCG+ PGVY +V YL WI + +
Sbjct: 226 GCGQKDVPGVYTKVTNYLDWIRDNMR 251
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 127 bits (318), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGD+GGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 127 bits (318), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 131/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSYIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 131/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+ DSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 82/247 (33%), Positives = 125/247 (50%), Gaps = 20/247 (8%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
+ S++ E T + + + +E Y DIAL++L Y RP+ L
Sbjct: 63 ------NQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYTDSQRPISL 114
Query: 132 PQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNL 187
P GD Y D VTGWG + L + IP+ EC+K++ I +
Sbjct: 115 PSKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMI 172
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 173 CAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
Query: 246 YNTAKVI 252
+ +
Sbjct: 232 LEKTQAV 238
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 131/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VS G GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSWIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGD+GGP++ + G+VSWG GC + PG Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 125 bits (314), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 131/255 (51%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-DNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+C+GDSGGP +++ P + +W +G+VS G GC +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 125 bits (314), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 82/268 (30%), Positives = 140/268 (52%), Gaps = 39/268 (14%)
Query: 8 TAKIDKGQASEVNDWPWLVALKRQY--ERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
+ ++ G +++ PW+ L+ Q E CGG +I+ER++LTAAHC+ + N L
Sbjct: 116 SQRVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCV-HGLQNDLYE 174
Query: 66 RRTSDLIVRLGEYDFSKVNETK-----------VTDIPAAAMKVYPRFSEQNYENDIALV 114
+RLGE+ S + + V ++ ++ ++ ++ +DIAL+
Sbjct: 175 -------IRLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALL 227
Query: 115 QLSKKAQYNSFVRPVCLPQAGDFYE--DQIG--IVTGWGTLSYGGPRSDVLMEVPIPVWR 170
+L++ + ++P+CLP + E +QI VTGWGT + G SDVL++ +P+
Sbjct: 228 KLNRSVPFQKHIKPICLPITDELKEKAEQISTYFVTGWGT-TENGSSSDVLLQANVPLQP 286
Query: 171 LTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDK-------QWTIIGVVS 223
+ C + + + + S LC GG DSC+GDSGGP LQ P + + G+VS
Sbjct: 287 RSACSQAYRRAVPLSQLCVGG-GDLQDSCKGDSGGP--LQAPAQYLGEYAPKMVEFGIVS 343
Query: 224 WG-IGCGKT--PGVYVQVNKYLRWIYNT 248
G + CG+ PG+Y V +Y++WI +T
Sbjct: 344 QGVVTCGQISLPGLYTNVGEYVQWITDT 371
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 125 bits (314), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 82/247 (33%), Positives = 125/247 (50%), Gaps = 20/247 (8%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
+ S++ E T + + + +E Y DIAL++L Y RP+ L
Sbjct: 63 ------NQSEIAEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYTDSQRPISL 114
Query: 132 PQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNL 187
P GD Y D VTGWG + L + IP+ EC+K++ I +
Sbjct: 115 PSKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMI 172
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 173 CAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
Query: 246 YNTAKVI 252
+ +
Sbjct: 232 LEKTQAV 238
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (314), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG Y ++ Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKLCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 125 bits (314), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG DSCQGDSGGP++ + G+VSWG GC + PGVY +V Y+ WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 125 bits (313), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + CA
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGD+GGP++ + G+VSWG GC + PG Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 124 bits (312), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 81/246 (32%), Positives = 125/246 (50%), Gaps = 18/246 (7%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGI- 61
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
L + + ++ +T + + + +E Y DIAL++L Y RP+ LP
Sbjct: 62 --LNQAEIAE--DTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYADSQRPISLP 115
Query: 133 QAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNLC 188
GD Y D VTGWG + L + IP+ EC+K++ I +C
Sbjct: 116 SKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMIC 173
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIY 246
AG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWIL 232
Query: 247 NTAKVI 252
+ +
Sbjct: 233 EKTQAV 238
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 124 bits (312), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 83/253 (32%), Positives = 127/253 (50%), Gaps = 21/253 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI-KQKIDNALVLRRTS 69
I +G +E PW V L R+ ++ CG LI++RWVLTAAHCI D +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + V+PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP G VTGWG L + + VL V +P+ C+
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST 177
Query: 179 SQNIFDSNLCAGGYKGGT---DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP-- 232
I D+ CAG T D+C+GD+GGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKY 237
Query: 233 GVYVQVNKYLRWI 245
G Y V + RWI
Sbjct: 238 GFYTHVFRLKRWI 250
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 124 bits (312), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 28/249 (11%)
Query: 14 GQASEVNDWPWLVALKRQYER-DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
GQ + + WPW V+L+ +FCGG LI+ +WVLTAAHC+ + + LR
Sbjct: 4 GQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR------ 57
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V+L E ++ +P + + V+P+F DIAL++L + + +S V V LP
Sbjct: 58 VQLREQHLYYQDQL----LPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 133 QAGDFYEDQIGI-VTGWGTLSYGG--PRSDVLMEVPIPVWRLTECRKQFSQNIF------ 183
A + + + VTGWG + P L +V +P+ C ++ +
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVR 173
Query: 184 ---DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQV 238
D LCAG + DSCQGDSGGPL+ + + W GVVSWG GC + PG+Y +V
Sbjct: 174 IVRDDMLCAGNTR--RDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEGCAQPNRPGIYTRV 230
Query: 239 NKYLRWIYN 247
YL WI++
Sbjct: 231 TYYLDWIHH 239
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 124 bits (311), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 28/249 (11%)
Query: 14 GQASEVNDWPWLVALKRQYER-DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
GQ + + WPW V+L+ +FCGG LI+ +WVLTAAHC+ + + LR
Sbjct: 4 GQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR------ 57
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V+L E ++ +P + + V+P+F DIAL++L + + +S V V LP
Sbjct: 58 VQLREQHLYYQDQL----LPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 133 QAGDFYEDQIGI-VTGWGTLSYGG--PRSDVLMEVPIPVWRLTECRKQFSQNIF------ 183
A + + + VTGWG + P L +V +P+ C ++ +
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVR 173
Query: 184 ---DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQV 238
D LCAG + DSCQGDSGGPL+ + + W GVVSWG GC + PG+Y +V
Sbjct: 174 IVRDDMLCAGNTR--RDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEGCAQPNRPGIYTRV 230
Query: 239 NKYLRWIYN 247
YL WI++
Sbjct: 231 TYYLDWIHH 239
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 124 bits (311), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 28/249 (11%)
Query: 14 GQASEVNDWPWLVALKRQYER-DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
GQ + + WPW V+L+ +FCGG LI+ +WVLTAAHC+ + + LR
Sbjct: 4 GQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR------ 57
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V+L E ++ +P + + V+P+F DIAL++L + + +S V V LP
Sbjct: 58 VQLREQHLYYQDQL----LPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 133 QAGDFYEDQIGI-VTGWGTLSYGG--PRSDVLMEVPIPVWRLTECRKQFSQNIF------ 183
A + + + VTGWG + P L +V +P+ C ++ +
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVR 173
Query: 184 ---DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQV 238
D LCAG + DSCQGDSGGPL+ + + W GVVSWG GC + PG+Y +V
Sbjct: 174 IVRDDMLCAGNTR--RDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEGCAQPNRPGIYTRV 230
Query: 239 NKYLRWIYN 247
YL WI++
Sbjct: 231 TYYLDWIHH 239
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 124 bits (311), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 119/241 (49%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A NS V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + C
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 124 bits (311), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 81/247 (32%), Positives = 125/247 (50%), Gaps = 20/247 (8%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLGEYDFSKVNE-TKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
+ S++ E T + + + +E Y DIAL++L Y RP+ L
Sbjct: 63 ------NQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYTDSQRPISL 114
Query: 132 PQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNL 187
P G+ Y D VTGWG + L + IP+ EC+K++ I +
Sbjct: 115 PSKGERNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMI 172
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 173 CAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
Query: 246 YNTAKVI 252
+ +
Sbjct: 232 LEKTQAV 238
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 124 bits (310), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 87/261 (33%), Positives = 131/261 (50%), Gaps = 35/261 (13%)
Query: 14 GQASEVNDWPWLVALKRQYERDN----FCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
G +++ PW A+ Q R + CGG+LI+ WVLTAAHC ++
Sbjct: 17 GLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCFQESY-------LPD 69
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYNSF 125
L V LG K E + T V+ F + Y NDIAL+QL AQ +
Sbjct: 70 QLKVVLGRTYRVKPGEEEQT-FKVKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDS 128
Query: 126 VRPVCLPQAG----DFYEDQIGIVTGWGTLSYGGP-RSDVLMEVPIPVWRLTECRKQ--F 178
VR +CLP+A D+ E ++ +G+G P S+ L E + ++ + C + F
Sbjct: 129 VRAICLPEANLQLPDWTECEL---SGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLF 185
Query: 179 SQNIFDSNLCAGGYKGGT------DSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK-- 230
++ + ++ LCAG + G D+CQGDSGGPL+ D T++G++SWG+GCG+
Sbjct: 186 NKTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMN-DNHMTLLGIISWGVGCGEKD 244
Query: 231 TPGVYVQVNKYLRWIYNTAKV 251
PGVY +V YL WI + +
Sbjct: 245 VPGVYTKVTNYLGWIRDNMHL 265
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 124 bits (310), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 123/239 (51%), Gaps = 18/239 (7%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGI- 61
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
L + + ++ +T + + + +E Y DIAL++L Y RP+ LP
Sbjct: 62 --LNQAEIAE--DTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYADSQRPISLP 115
Query: 133 QAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDSNLC 188
GD Y D VTGWG + L + IP+ EC+K++ I +C
Sbjct: 116 SKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMIC 173
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
AG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+ WI
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 123 bits (309), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 122/242 (50%), Gaps = 24/242 (9%)
Query: 14 GQASEVNDWPWLVALKRQY-ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G AS +WPW V L + + CGG +I +W+LTAAHC +++ +LR S ++
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF-YGVESPKILRVYSGIL 62
Query: 73 VRLG---EYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
+ + F V E + D + +E Y DIAL++L Y RP+
Sbjct: 63 NQAEIKEDTSFFGVQEIIIHD--------QYKMAESGY--DIALLKLETTVNYADSQRPI 112
Query: 130 CLPQAGD---FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-SQNIFDS 185
LP GD Y D VTGWG + L + IP+ EC+K++ I
Sbjct: 113 SLPSKGDRNVIYTD--CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK 170
Query: 186 NLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLR 243
+CAG +GG D+C+GDSGGPL + ++ W ++G+ SWG GC + PGVY V +Y+
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKH-NEVWHLVGITSWGEGCAQRERPGVYTNVVEYVD 229
Query: 244 WI 245
WI
Sbjct: 230 WI 231
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 123 bits (308), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 82/255 (32%), Positives = 130/255 (50%), Gaps = 25/255 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP A G VTGWG L + G + VL V +P+ C+
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST 177
Query: 179 SQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP 232
I D+ CAG G +G D+ +GDSGGP +++ P + +W +G+VSWG G +
Sbjct: 178 RIRITDNMFCAGYKPDEGKRG--DAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDG 235
Query: 233 --GVYVQVNKYLRWI 245
G Y V + +WI
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 123 bits (308), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/249 (34%), Positives = 126/249 (50%), Gaps = 28/249 (11%)
Query: 14 GQASEVNDWPWLVALK-RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
GQ + + WPW V+L+ R +FCGG LI+ +WVLTAAHC+ + + LR
Sbjct: 4 GQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLR------ 57
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V+L E ++ +P + + V+P+F DIAL++L + +S V V LP
Sbjct: 58 VQLREQHLYYQDQL----LPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 133 QAGDFYEDQIGI-VTGWGTLSYGGPRSD--VLMEVPIPVWRLTECRKQFSQNIF------ 183
A + + + VTGWG + P L +V +P+ C ++ +
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVR 173
Query: 184 ---DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQV 238
D LCAG + DSCQGDSGGPL+ + + W GVVSWG GC + PG+Y +V
Sbjct: 174 IIRDDMLCAGNSQ--RDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEGCAQPNRPGIYTRV 230
Query: 239 NKYLRWIYN 247
YL WI++
Sbjct: 231 TYYLDWIHH 239
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 122 bits (307), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 83/253 (32%), Positives = 126/253 (49%), Gaps = 21/253 (8%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI-KQKIDNALVLRRTS 69
I +G +E PW V L R+ ++ CG LI++RWVLTAAHCI D +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFT---EN 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRP 128
DL+VR+G++ ++ + V+PR++ +N + DIAL++L K ++ ++ P
Sbjct: 58 DLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 129 VCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTECRKQF 178
VCLP G VTGWG L + + VL V +P+ C+
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST 177
Query: 179 SQNIFDSNLCAGGYKGGT---DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCGKTP-- 232
I D+ CAG T D+C+GDSGGP +++ P + +W +G+VSWG GC +
Sbjct: 178 RIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKY 237
Query: 233 GVYVQVNKYLRWI 245
G Y V + WI
Sbjct: 238 GFYTHVFRLKAWI 250
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 121 bits (304), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 83/259 (32%), Positives = 130/259 (50%), Gaps = 29/259 (11%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDN----FCGGVLINERWVLTAAHC-IKQKIDNALVL 65
I +G +E+ PW V L ++ R CG LI++RWVLTAAHC + D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFT- 59
Query: 66 RRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNS 124
+DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++
Sbjct: 60 --ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSD 117
Query: 125 FVRPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTEC 174
++ PVCLP A G VTGWG L + G + VL V +P+ C
Sbjct: 118 YIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVC 177
Query: 175 RKQFSQNIFDSNLCA-----GGYKGGTDSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGC 228
+ I D+ CA G +G D+C+GDSGGP +++ P + +W +G+VSWG GC
Sbjct: 178 KDSTRIRITDNMFCAYYKPDEGKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 235
Query: 229 GKTP--GVYVQVNKYLRWI 245
+ G Y V + +WI
Sbjct: 236 DRDGKYGFYTHVFRLKKWI 254
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 121 bits (304), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 84/258 (32%), Positives = 127/258 (49%), Gaps = 31/258 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI------KQKIDNALV 64
I +G +E PW V L R+ ++ CG LI++RWVLTAAHCI K +N
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTEN--- 57
Query: 65 LRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYN 123
DL+VR+G++ ++ + V+PR++ +N + DIAL++L K ++
Sbjct: 58 -----DLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFS 112
Query: 124 SFVRPVCLPQ----AGDFYEDQIGIVTGWGTL------SYGGPRSDVLMEVPIPVWRLTE 173
++ PVCLP G VTGWG L + + VL V +P+
Sbjct: 113 DYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 174 CRKQFSQNIFDSNLCAGGYKGGT---DSCQGDSGGPLLLQRP-DKQWTIIGVVSWGIGCG 229
C+ I D+ CAG T D+C+GDSGGP +++ P + +W +G+VS G GC
Sbjct: 173 CKASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 230 KTP--GVYVQVNKYLRWI 245
+ G Y V + RWI
Sbjct: 233 RKGKYGFYTHVFRLKRWI 250
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 121 bits (304), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 118/241 (48%), Gaps = 25/241 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L Y FCGG LIN +WV++AAHC K I
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYH---FCGGSLINSQWVVSAAHCYKSGIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE D V E I A+ V+P ++ + Y NDI L++L A S V +
Sbjct: 48 --VRLGE-DNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASIS 104
Query: 131 LPQAGDFYEDQIGIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP + Q +++GWG T S G DVL + P+ + C+ S I + C
Sbjct: 105 LPTSCASAGTQC-LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCV 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYN 247
G +GG D+CQGDSGGP++ + G+VSWG GC + PG Y +V Y+ WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQ 218
Query: 248 T 248
T
Sbjct: 219 T 219
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 121 bits (304), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 28/249 (11%)
Query: 14 GQASEVNDWPWLVALK-RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
GQ + + WPW V+L+ R +FCGG LI+ +WVLTAAHC+ + + LR
Sbjct: 4 GQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLR------ 57
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V+L E ++ +P + + V+P+F DIAL++L + +S V V LP
Sbjct: 58 VQLREQHLYYQDQL----LPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 133 QAGDFYEDQIGI-VTGWGTLSYGGPRSD--VLMEVPIPVWRLTECRKQFSQNIF------ 183
A + + + VTGWG + P L +V +P+ C ++ +
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVR 173
Query: 184 ---DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQV 238
D LCAG + DSC+GDSGGPL+ + + W GVVSWG GC + PG+Y +V
Sbjct: 174 IIRDDMLCAGNSQ--RDSCKGDSGGPLVCKV-NGTWLQAGVVSWGEGCAQPNRPGIYTRV 230
Query: 239 NKYLRWIYN 247
YL WI++
Sbjct: 231 TYYLDWIHH 239
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 121 bits (303), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 73/231 (31%), Positives = 116/231 (50%), Gaps = 19/231 (8%)
Query: 21 DWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDF 80
+ PW L + E + FCGG ++NE +VLTAAHC+ Q VR+G+ +
Sbjct: 11 ECPWQALLVNE-ENEGFCGGTILNEFYVLTAAHCLHQ----------AKRFTVRVGDRNT 59
Query: 81 SKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ----AGD 136
+ ++ +K + RF ++ Y+ DIA+++L ++ V P CLP+
Sbjct: 60 EQEEGNEMAHEVEMTVK-HSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAEAT 118
Query: 137 FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGT 196
+ GIV+G+G G S L + +P + C+ S I + CAG
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFTITPNMFCAGYDTQPE 178
Query: 197 DSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWI 245
D+CQGDSGGP + + D + + G+VSWG GC + GVY +V+ +L+WI
Sbjct: 179 DACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWI 228
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/237 (32%), Positives = 114/237 (48%), Gaps = 19/237 (8%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E +WPW +L Q++ + CG LIN W+++AAHC + A R T+ V
Sbjct: 4 GTEVEEGEWPWQASL--QWDGSHRCGATLINATWLVSAAHCFTTYKNPA---RWTASFGV 58
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+ + + V+ ++ +++ DI+L +LS Y + V VCLP
Sbjct: 59 TIKPSKMKRGLRRII---------VHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPD 109
Query: 134 AG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECR--KQFSQNIFDSNLCAG 190
A +F + VTG+G L G + L + + + T C + ++ I LCAG
Sbjct: 110 ASYEFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAG 169
Query: 191 GYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWI 245
+G TD+CQGDSGGPL+ W + G+VSWG C K PGVY +V WI
Sbjct: 170 SLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWI 226
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/229 (33%), Positives = 115/229 (50%), Gaps = 21/229 (9%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
PW L + E + FCGG +++E ++LTAAHC+ Q VR+G+ + +
Sbjct: 13 PWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKVRVGDRNTEQ 61
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
+ +K + RF+++ Y+ DIA+++L + V P LP A +
Sbjct: 62 EEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPPATGTKC 120
Query: 143 GIVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQG 201
+++GWG T S G D L + PV +C + I + C G +GG DSCQG
Sbjct: 121 -LISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQG 179
Query: 202 DSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
DSGGP++ + GVVSWG GC + PGVY +V Y++WI NT
Sbjct: 180 DSGGPVVCNG-----QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNT 223
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 119 bits (298), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 89/257 (34%), Positives = 129/257 (50%), Gaps = 28/257 (10%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERD----NFCGGVLINERWVLTAAHCIKQKIDN 61
+ ++++ G+ + W W V+L QYE+D + CGG LI WV+TA HCI
Sbjct: 7 RPSSRVVNGEDAVPYSWSWQVSL--QYEKDGAFHHTCGGSLIAPDWVVTAGHCISTS--- 61
Query: 62 ALVLRRTSDLIVRLGEYDFSKVNET-KVTDIPAAAMKVYPRFSEQNYE--NDIALVQLSK 118
RT ++ LGEYD S + + +V I A + V+P ++ NDIALV+LS+
Sbjct: 62 -----RTYQVV--LGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSR 114
Query: 119 KAQYNSFVRPVCLPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
AQ V+ LP AGD ++ ++GWG L GGP D L E +PV C +
Sbjct: 115 SAQLGDKVQLANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQY 174
Query: 178 --FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW--GIGCG--KT 231
+ + + +CAGG C GDSGGPL D W + GV S+ GC K
Sbjct: 175 DWWGITVKKTMVCAGGDT--RSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKK 232
Query: 232 PGVYVQVNKYLRWIYNT 248
P V+ +V+ ++ WI T
Sbjct: 233 PTVFTRVSAFIDWINET 249
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 119 bits (298), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 126/245 (51%), Gaps = 26/245 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E N PW VA+ R + CGGVL++ WVLTAAHC DN V ++L
Sbjct: 4 GFKCEKNSQPWHVAVYRYTQY--LCGGVLLDPNWVLTAAHCYD---DNYKVWLGKNNLFK 58
Query: 74 RLGEYDFSKVNETKVTDIPA---AAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
V +K P + M+ + RF E +Y ND+ L++LSK A V+P+
Sbjct: 59 DEPSAQHRFV--SKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKPIT 116
Query: 131 LPQAGDFYEDQIG---IVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
LP E ++G + +GWG+++ + +D L V + + +C K + + D+
Sbjct: 117 LPTE----EPKLGSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAHIEKVTDAM 172
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCGK--TPGVYVQVNKYLR 243
LCAG GG D+C+GDSGGPL+ + G+ SWG CG+ PGVY ++NK+
Sbjct: 173 LCAGEMDGGKDTCKGDSGGPLICDG-----VLQGITSWGHTPCGEPDMPGVYTKLNKFTS 227
Query: 244 WIYNT 248
WI +T
Sbjct: 228 WIKDT 232
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 119 bits (298), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 85/249 (34%), Positives = 125/249 (50%), Gaps = 25/249 (10%)
Query: 8 TAKIDKGQASEVNDWPWLVALKRQYERDNF----CGGVLINERWVLTAAHCIKQKIDNAL 63
+A++ G+ + + WPW ++L QY RDN CGG LI VLTAAHCI N L
Sbjct: 11 SARVVGGEDAIPHSWPWQISL--QYLRDNTWRHTCGGTLITPNHVLTAAHCIS----NTL 64
Query: 64 VLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYN 123
R V LG+ + +E + + V+ +++ NDIAL++L++ +
Sbjct: 65 TYR------VALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELG 118
Query: 124 SFVRPVCLPQAGDFY-EDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTEC--RKQFSQ 180
++ CLP G +D VTGWG L GP + L + PV C R +
Sbjct: 119 DTIQVACLPSEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGT 178
Query: 181 NIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG----KTPGVYV 236
+ ++ +CAGG G +C GDSGGPL Q D QW + G+VS+G G K P V+
Sbjct: 179 TVKETMVCAGG-DGVISACNGDSGGPLNCQA-DGQWDVRGIVSFGSGLSCNTFKKPTVFT 236
Query: 237 QVNKYLRWI 245
+V+ Y+ WI
Sbjct: 237 RVSAYIDWI 245
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 118 bits (296), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 84/264 (31%), Positives = 128/264 (48%), Gaps = 35/264 (13%)
Query: 1 CGRNGKQTA----KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIK 56
CGR K+ +I G +S PWL A+ Y D+FC G L++ WV++AAHC
Sbjct: 22 CGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAI---YIGDSFCAGSLVHTCWVVSAAHCFS 78
Query: 57 QKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTD-----IPAAAMKVYPRFSEQNYENDI 111
+ V LG++ F++ + T IP V+ ++D+
Sbjct: 79 HSPPR-------DSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVF-----NPSDHDL 126
Query: 112 ALVQLSKK----AQYNSFVRPVCLPQAGD-FYEDQIGIVTGWGTLSYG-GPRSDVLMEVP 165
L++L KK A + FV+P+CLP+ G F + GWG L S L E
Sbjct: 127 VLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREAL 186
Query: 166 IPVWRLTECRKQ--FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVS 223
+P+ +C + +I + LCAG + +D+CQGDSGGPL ++ + + G++S
Sbjct: 187 VPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAY-LYGIIS 245
Query: 224 WGIGCGK--TPGVYVQVNKYLRWI 245
WG GCG+ PGVY +V Y+ WI
Sbjct: 246 WGDGCGRLHKPGVYTRVANYVDWI 269
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 118 bits (296), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 83/249 (33%), Positives = 125/249 (50%), Gaps = 28/249 (11%)
Query: 14 GQASEVNDWPWLVALK-RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
GQ + + WPW V+L+ R +FCGG LI+ +WVLTAAHC+ + + LR
Sbjct: 4 GQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDLATLR------ 57
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V+L E ++ +P + + V+P+F DIAL++L + +S V V LP
Sbjct: 58 VQLREQHLYYQDQL----LPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 133 QAGDFYEDQIGI-VTGWGTLSYGGPRSD--VLMEVPIPVWRLTECRKQFSQNIF------ 183
A + + + VTGWG + P L +V +P+ C ++ +
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVR 173
Query: 184 ---DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQV 238
D LCAG + DSC+GDSGGPL+ + + W GVVSW GC + PG+Y +V
Sbjct: 174 IIRDDMLCAGNSQ--RDSCKGDSGGPLVCKV-NGTWLQAGVVSWDEGCAQPNRPGIYTRV 230
Query: 239 NKYLRWIYN 247
YL WI++
Sbjct: 231 TYYLDWIHH 239
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 118 bits (295), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 88/262 (33%), Positives = 137/262 (52%), Gaps = 29/262 (11%)
Query: 1 CGRNGKQTA-KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI 59
CG + + T +I GQ ++ D+PW V + G L+ + WVLTAAH + ++
Sbjct: 76 CGLSARTTGGRIYGGQKAKPGDFPWQVLILG----GTTAAGALLYDNWVLTAAHAVYEQK 131
Query: 60 DNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSK 118
+A S L +R+G K T + A+ ++ ++ + ++NDIAL++L+
Sbjct: 132 HDA------SALDIRMGTL---KRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNN 182
Query: 119 KAQYNSFVRPVCLP--QAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECR 175
K NS + P+CLP +A F D IG +GWG L+ G + LM V IP+ +C
Sbjct: 183 KVVINSNITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCT 241
Query: 176 KQFSQ------NIFDSNLCAGGYKGGTDSCQGDSGGPL-LLQRPDKQWTIIGVVSWG-IG 227
+ + ++ + LCAG GG DSC+GDSGG L L ++W + G+VSWG +
Sbjct: 242 AAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMN 301
Query: 228 CGKTP--GVYVQVNKYLRWIYN 247
CG+ GVY +V Y+ WI N
Sbjct: 302 CGEAGQYGVYTKVINYIPWIEN 323
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 117 bits (294), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 75/255 (29%), Positives = 122/255 (47%), Gaps = 19/255 (7%)
Query: 3 RNGKQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNA 62
R +I GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q
Sbjct: 8 RGDNNLTRIVGGQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----- 61
Query: 63 LVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQY 122
VR+G+ + + + +K + RF+++ Y+ DIA+++L +
Sbjct: 62 -----AKRFKVRVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITF 115
Query: 123 NSFVRPVCLPQ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF 178
V P CLP+ + GIV+G+G G +S L + +P C+
Sbjct: 116 RMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS 175
Query: 179 SQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYV 236
S I + CAG D+CQGDSGGP + + D + + G+VSWG GC + G+Y
Sbjct: 176 SFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYT 234
Query: 237 QVNKYLRWIYNTAKV 251
+V +L+WI + K
Sbjct: 235 KVTAFLKWIDRSMKT 249
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 117 bits (293), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 122/245 (49%), Gaps = 27/245 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERD----NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
G+ + N WPW V+L QY+ + CGG L+++ WVLTAAHCI RT
Sbjct: 4 GEDARPNSWPWQVSL--QYDSSGQWRHTCGGTLVDQSWVLTAAHCISSS--------RTY 53
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYEN--DIALVQLSKKAQYNSFVR 127
++ LG + S NE + + + V+ ++ N DIAL++L+ ++
Sbjct: 54 RVV--LGRHSLS-TNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQ 110
Query: 128 PVCLPQAGDFYEDQ-IGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ--FSQNIFD 184
CLP AG + + VTGWG L G D+L + + V C K + +
Sbjct: 111 LGCLPAAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVKT 170
Query: 185 SNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG--IGCG--KTPGVYVQVNK 240
+ +CAGG G SC GDSGGPL Q + QW + G+VS+G +GC P V+ +V+
Sbjct: 171 NMICAGG-DGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSN 229
Query: 241 YLRWI 245
Y+ WI
Sbjct: 230 YIDWI 234
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 117 bits (293), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 117 bits (293), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 117 bits (293), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 88/262 (33%), Positives = 137/262 (52%), Gaps = 29/262 (11%)
Query: 1 CGRNGKQTA-KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI 59
CG + + T +I GQ ++ D+PW V + G L+ + WVLTAAH + ++
Sbjct: 151 CGLSARTTGGQIYGGQKAKPGDFPWQVLILG----GTTAAGALLYDNWVLTAAHAVYEQK 206
Query: 60 DNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSK 118
+A S L +R+G K T + A+ ++ ++ + ++NDIAL++L+
Sbjct: 207 HDA------SALDIRMGTL---KRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNN 257
Query: 119 KAQYNSFVRPVCLP--QAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECR 175
K NS + P+CLP +A F D IG +GWG L+ G + LM V IP+ +C
Sbjct: 258 KVVINSNITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCT 316
Query: 176 KQFSQ------NIFDSNLCAGGYKGGTDSCQGDSGGPL-LLQRPDKQWTIIGVVSWG-IG 227
+ + ++ + LCAG GG DSC+GDSGG L L ++W + G+VSWG +
Sbjct: 317 AAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMN 376
Query: 228 CGKTP--GVYVQVNKYLRWIYN 247
CG+ GVY +V Y+ WI N
Sbjct: 377 CGEAGQYGVYTKVINYIPWIEN 398
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 117 bits (293), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 78/240 (32%), Positives = 119/240 (49%), Gaps = 25/240 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G ++ D+P++V++ R +CGG L+N VLTAAHC+ + +R S
Sbjct: 1 IVGGTSASAGDFPFIVSISR--NGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGS- 57
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
S+ + + + ++++V+P +S N ND+A+++LS +
Sbjct: 58 ---------LSRTSGGITSSL--SSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYAR 104
Query: 131 LPQAG-DFYEDQIGIVTGWGTLSYGGPRSDV-LMEVPIPVWRLTECRKQFSQN-IFDSNL 187
L +G D V GWG S GG + V L++V +P+ CR Q+ + I +
Sbjct: 105 LAASGSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSAITNQMF 164
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWI 245
CAG GG DSCQGDSGGP++ D T+IG VSWG GC + GVY V +I
Sbjct: 165 CAGVSSGGKDSCQGDSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 117 bits (292), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 117 bits (292), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 117 bits (292), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 117 bits (292), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 117 bits (292), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTAAEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 117 bits (292), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 117 bits (292), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 77/248 (31%), Positives = 127/248 (51%), Gaps = 17/248 (6%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
+Q +I GQ +++ ++PW V + R GG L+ +RW+LTAAH + K A
Sbjct: 85 EQRQRIIGGQKAKMGNFPWQV-FTNIHGRG---GGALLGDRWILTAAHTLYPKEHEA--- 137
Query: 66 RRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ---NYENDIALVQLSKKAQY 122
+ + L V LG + ++ K+ + P + V+P + + N+E DIAL++L
Sbjct: 138 QSNASLDVFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTL 195
Query: 123 NSFVRPVCLPQAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTE--CRKQFS 179
+ P+CLP FY+ +G V+G+G + + +P+ + E R +
Sbjct: 196 GPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNR 255
Query: 180 QNIFDSNL-CAGGYKGGTDSCQGDSGGPLLLQRPDK-QWTIIGVVSWGIGCGKTPGVYVQ 237
++F N+ CAG D+CQGDSGG ++ P+ +W G+VSWGIGC + G Y +
Sbjct: 256 MDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTK 315
Query: 238 VNKYLRWI 245
V Y+ WI
Sbjct: 316 VLNYVDWI 323
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 117 bits (292), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 116 bits (291), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 77/237 (32%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++ D+P++V++ R +CGG L+N VLTAAHC+ + +R S
Sbjct: 4 GTSASAGDFPFIVSISR--NGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGS---- 57
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
S+ + + + ++++V+P +S N ND+A+++LS + L
Sbjct: 58 ------LSRTSGGITSSL--SSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARLAA 107
Query: 134 AG-DFYEDQIGIVTGWGTLSYGGPRSDV-LMEVPIPVWRLTECRKQF-SQNIFDSNLCAG 190
+G D V GWG S GG + V L++V +P+ CR Q+ + I + CAG
Sbjct: 108 SGSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAG 167
Query: 191 GYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWI 245
GG DSCQGDSGGP++ D T+IG VSWG GC + GVY V +I
Sbjct: 168 VSSGGKDSCQGDSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 116 bits (291), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 119/243 (48%), Gaps = 19/243 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGDSGGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAK 250
+ K
Sbjct: 231 SMK 233
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 116 bits (290), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 77/248 (31%), Positives = 127/248 (51%), Gaps = 17/248 (6%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
+Q +I GQ +++ ++PW V + R GG L+ +RW+LTAAH + K A
Sbjct: 153 EQRQQIIGGQKAKMGNFPWQV-FTNIHGRG---GGALLGDRWILTAAHTLYPKEHEA--- 205
Query: 66 RRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ---NYENDIALVQLSKKAQY 122
+ + L V LG + ++ K+ + P + V+P + + N+E DIAL++L
Sbjct: 206 QSNASLDVFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTL 263
Query: 123 NSFVRPVCLPQAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTE--CRKQFS 179
+ P+CLP FY+ +G V+G+G + + +P+ + E R +
Sbjct: 264 GPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNR 323
Query: 180 QNIFDSNL-CAGGYKGGTDSCQGDSGGPLLLQRPDK-QWTIIGVVSWGIGCGKTPGVYVQ 237
++F N+ CAG D+CQGDSGG ++ P+ +W G+VSWGIGC + G Y +
Sbjct: 324 MDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTK 383
Query: 238 VNKYLRWI 245
V Y+ WI
Sbjct: 384 VLNYVDWI 391
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 115 bits (289), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 72/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ + + PW L + E + FCGG +++E ++LTAAHC+ Q V
Sbjct: 4 GQECKDGECPWQALLINE-ENEGFCGGTILSEFYILTAAHCLYQ----------AKRFKV 52
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
R+G+ + + + +K + RF+++ Y+ DIA+++L + V P CLP+
Sbjct: 53 RVGDRNTEQEEGGEAVHEVEVVIK-HNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 134 ----AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
+ GIV+G+G G +S L + +P C+ S I + CA
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYN 247
G D+CQGD+GGP + + D + + G+VSWG GC + G+Y +V +L+WI
Sbjct: 172 GYDTKQEDACQGDAGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDR 230
Query: 248 TAKV 251
+ K
Sbjct: 231 SMKT 234
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 115 bits (289), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 84/236 (35%), Positives = 122/236 (51%), Gaps = 35/236 (14%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
PW VAL + CGGVL+NERWVLTAAHC + ++ V LG
Sbjct: 13 PWQVALLSGNQL--HCGGVLVNERWVLTAAHC------------KMNEYTVHLGS---DT 55
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
+ + + I A+ +P +S Q + ND+ LV+L+ +A+ +S V+ V LP +
Sbjct: 56 LGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE-PPGTT 114
Query: 143 GIVTGWGTLSYGGPRSDV-----LMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTD 197
V+GWGT + DV LM V + + +C K + + +S LCAG +
Sbjct: 115 CTVSGWGTTT----SPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKN 170
Query: 198 SCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCGKT--PGVYVQVNKYLRWIYNTAK 250
+C GDSGGPL+ + T+ G+VSWG CG+ PGVY QV K+ +WI +T K
Sbjct: 171 ACNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMK 221
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 115 bits (289), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 76/248 (30%), Positives = 127/248 (51%), Gaps = 17/248 (6%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
+Q +I GQ +++ ++PW V + R GG L+ +RW+LTAAH + K A
Sbjct: 85 EQRQRIIGGQKAKMGNFPWQV-FTNIHGRG---GGALLGDRWILTAAHTLYPKEHEA--- 137
Query: 66 RRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ---NYENDIALVQLSKKAQY 122
+ + L V LG + ++ K+ + P + V+P + + N+E DIAL++L
Sbjct: 138 QSNASLDVFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTL 195
Query: 123 NSFVRPVCLPQAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTE--CRKQFS 179
+ P+CLP FY+ +G V+G+G + + +P+ + E R +
Sbjct: 196 GPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNR 255
Query: 180 QNIFDSNL-CAGGYKGGTDSCQGDSGGPLLLQRPDK-QWTIIGVVSWGIGCGKTPGVYVQ 237
++F N+ CAG D+CQGD+GG ++ P+ +W G+VSWGIGC + G Y +
Sbjct: 256 MDVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTK 315
Query: 238 VNKYLRWI 245
V Y+ WI
Sbjct: 316 VLNYVDWI 323
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 115 bits (289), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 72/239 (30%), Positives = 119/239 (49%), Gaps = 20/239 (8%)
Query: 14 GQASEVNDWPWLV-ALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G ++ + P++ L + + + CGG L+ E +VLTAAHC+ I+
Sbjct: 4 GHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLGSSIN------------ 51
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V LG ++ + T+ IP +P ++++ NDI L++L++KA V P+ LP
Sbjct: 52 VTLGAHNIMERERTQQV-IPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLP 110
Query: 133 QA-GDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGG 191
++ + + V GWG L P +D L EV + V +C +F I + +CAG
Sbjct: 111 RSLAEVKPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKCIARFKNYIPFTQICAGD 170
Query: 192 YKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
+S GDSGGPL+ G+VS+G G TP VY +++ +L WI++T +
Sbjct: 171 PSKRKNSFSGDSGGPLVC-----NGVAQGIVSYGRNDGTTPDVYTRISSFLSWIHSTMR 224
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 115 bits (289), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 84/236 (35%), Positives = 122/236 (51%), Gaps = 35/236 (14%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
PW VAL + CGGVL+NERWVLTAAHC + ++ V LG
Sbjct: 13 PWQVALLSGNQL--HCGGVLVNERWVLTAAHC------------KMNEYTVHLGS---DT 55
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
+ + + I A+ +P +S Q + ND+ LV+L+ +A+ +S V+ V LP +
Sbjct: 56 LGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE-PPGTT 114
Query: 143 GIVTGWGTLSYGGPRSDV-----LMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTD 197
V+GWGT + DV LM V + + +C K + + +S LCAG +
Sbjct: 115 CTVSGWGTTT----SPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKN 170
Query: 198 SCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCGKT--PGVYVQVNKYLRWIYNTAK 250
+C GDSGGPL+ + T+ G+VSWG CG+ PGVY QV K+ +WI +T K
Sbjct: 171 ACNGDSGGPLVCRG-----TLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMK 221
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 115 bits (288), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 80/242 (33%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 14 GQASEVNDWPWLVALK--RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G ++ + P++ L+ +Y CGG LI E +VLTAAHC KI
Sbjct: 4 GHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSKIQ----------- 52
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
V LG ++ K E IP + +P ++ + NDI L++L KA+ +S V+P+ L
Sbjct: 53 -VTLGAHNI-KEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNL 110
Query: 132 PQAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD--SNLC 188
P+ + V GWG L G SD L EV + V +C + + +N FD + +C
Sbjct: 111 PRRNVKVKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKC-ESYLKNYFDKANEIC 169
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNT 248
AG K S +GDSGGPL+ ++ G+VS+G G TP + +V+ +L WI T
Sbjct: 170 AGDPKIKRASFRGDSGGPLVCKK-----VAAGIVSYGQNDGSTPRAFTKVSTFLSWIKKT 224
Query: 249 AK 250
K
Sbjct: 225 MK 226
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 115 bits (288), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 77/240 (32%), Positives = 118/240 (49%), Gaps = 25/240 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G ++ D+P++V++ R +CGG L+N VLTAAHC+ + +R S
Sbjct: 1 IVGGTSASAGDFPFIVSISR--NGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGS- 57
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
S+ + + + ++++V+P +S N ND+A+++LS +
Sbjct: 58 ---------LSRTSGGITSSL--SSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYAR 104
Query: 131 LPQAG-DFYEDQIGIVTGWGTLSYGGPRSDV-LMEVPIPVWRLTECRKQF-SQNIFDSNL 187
L +G D V GWG S GG + V L++V +P+ CR Q+ + I +
Sbjct: 105 LAASGSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSAITNQMF 164
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWI 245
CAG GG DSCQGD GGP++ D T+IG VSWG GC + GVY V +I
Sbjct: 165 CAGVSSGGKDSCQGDXGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 115 bits (288), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 114/243 (46%), Gaps = 20/243 (8%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + ++P++V L + E + FCGG L + VLTAAHC+ +N + + +V
Sbjct: 4 GTRAAQGEFPFMVRLINE-ENEGFCGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVV 60
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
L KV TKV P F+++ Y D AL++L++ +P
Sbjct: 61 DLQSSSAVKVRSTKVLQAPG--------FTKETYGKDWALIKLAQPIN-----QPTLKIA 107
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY- 192
Y V GWG GG + L++ +P CR S + + + GY
Sbjct: 108 TTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYP 167
Query: 193 -KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWIYNTA 249
GG D+CQGDSGGP+ + +W +G+VSWG GC + PGVY +V+ + I + A
Sbjct: 168 DTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAA 227
Query: 250 KVI 252
+ +
Sbjct: 228 RTL 230
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 115 bits (287), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 84/248 (33%), Positives = 130/248 (52%), Gaps = 28/248 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ ++ D+PW V + G L+ + WVLTAAH + ++ +A S L +
Sbjct: 4 GQKAKPGDFPWQVLILG----GTTAAGALLYDNWVLTAAHAVYEQKHDA------SALDI 53
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRPVCLP 132
R+G K T + A+ ++ ++ + ++NDIAL++L+ K NS + P+CLP
Sbjct: 54 RMGTL---KRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLP 110
Query: 133 --QAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQ------NIF 183
+A F D IG +GWG L+ G + LM V IP+ +C + + ++
Sbjct: 111 RKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVT 169
Query: 184 DSNLCAGGYKGGTDSCQGDSGGPL-LLQRPDKQWTIIGVVSWG-IGCGKTP--GVYVQVN 239
+ LCAG GG DSC+GDSGG L L ++W + G+VSWG + CG+ GVY +V
Sbjct: 170 ANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVI 229
Query: 240 KYLRWIYN 247
Y+ WI N
Sbjct: 230 NYIPWIEN 237
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 115 bits (287), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 17/240 (7%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ +++ ++PW V + R GG L+ +RW+LTAAH + K A + + L V
Sbjct: 4 GQKAKMGNFPWQV-FTNIHGRG---GGALLGDRWILTAAHTLYPKEHEA---QSNASLDV 56
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQ---NYENDIALVQLSKKAQYNSFVRPVC 130
LG + ++ K+ + P + V+P + + N+E DIAL++L + P+C
Sbjct: 57 FLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPIC 114
Query: 131 LPQAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTE--CRKQFSQNIFDSNL 187
LP FY+ +G V+G+G + + +P+ + E R + ++F N+
Sbjct: 115 LPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNM 174
Query: 188 -CAGGYKGGTDSCQGDSGGPLLLQRPD-KQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
CAG D+CQGDSGG ++ P+ +W G+VSWGIGC + G Y +V Y+ WI
Sbjct: 175 FCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTKVLNYVDWI 234
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 114 bits (286), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 82/259 (31%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 6 KQTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVL 65
++ +I G +++ ++PW V + GG LINE WVLTAAH ++ + + +
Sbjct: 78 EEKQRIIGGSDADIKNFPWQVFFDNPW-----AGGALINEYWVLTAAHVVEGNREPTMYV 132
Query: 66 RRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSF 125
TS RL + + V P + P N++NDIALV+L +
Sbjct: 133 GSTSVQTSRLAKSKM--LTPEHVFIHPGWKLLAVPE-GRTNFDNDIALVRLKDPVKMGPT 189
Query: 126 VRPVCLPQAGDFY---EDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRK------ 176
V P+CLP Y + +G+++GWG R+ L +PV L +C++
Sbjct: 190 VSPICLPGTSSDYNLMDGDLGLISGWGRTEKRD-RAVRLKAARLPVAPLRKCKEVKVEKP 248
Query: 177 --QFSQNIFDSNL-CAGGYKGGTDSCQGDSGGPLLLQRPD--KQWTIIGVVSWGIGCGKT 231
+F N+ CAGG KG DSC+GDSGG +Q P+ ++ G+VSWG CG T
Sbjct: 249 TADAEAYVFTPNMICAGGEKG-MDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCG-T 306
Query: 232 PGVYVQVNKYLRWIYNTAK 250
G+Y +V Y+ WI T +
Sbjct: 307 YGLYTRVKNYVDWIMKTMQ 325
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 114 bits (286), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 122/250 (48%), Gaps = 31/250 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G +S PWL A+ Y D+FC G L++ WV++AAHC
Sbjct: 1 IIGGSSSLPGSHPWLAAI---YIGDSFCAGSLVHTCWVVSAAHCFSHSPPR-------DS 50
Query: 71 LIVRLGEYDFSKVNETKVTD-----IPAAAMKVYPRFSEQNYENDIALVQLSKK----AQ 121
+ V LG++ F++ + T IP V+ ++D+ L++L KK A
Sbjct: 51 VSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVF-----NPSDHDLVLIRLKKKGDRCAT 105
Query: 122 YNSFVRPVCLPQAGD-FYEDQIGIVTGWGTLSYG-GPRSDVLMEVPIPVWRLTECRKQ-- 177
+ FV+P+CLP+ G F + GWG L S L E +P+ +C
Sbjct: 106 RSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEV 165
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVY 235
+ +I + LCAG + +D+CQGDSGGPL ++ + + G++SWG GCG+ PGVY
Sbjct: 166 YGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAY-LYGIISWGDGCGRLHKPGVY 224
Query: 236 VQVNKYLRWI 245
+V Y+ WI
Sbjct: 225 TRVANYVDWI 234
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 114 bits (286), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 122/250 (48%), Gaps = 31/250 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G +S PWL A+ Y D+FC G L++ WV++AAHC
Sbjct: 1 IIGGSSSLPGSHPWLAAI---YIGDSFCAGSLVHTCWVVSAAHCFSHSPPR-------DS 50
Query: 71 LIVRLGEYDFSKVNETKVTD-----IPAAAMKVYPRFSEQNYENDIALVQLSKK----AQ 121
+ V LG++ F++ + T IP V+ ++D+ L++L KK A
Sbjct: 51 VSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVF-----NPSDHDLVLIRLKKKGDRCAT 105
Query: 122 YNSFVRPVCLPQAGD-FYEDQIGIVTGWGTLSYG-GPRSDVLMEVPIPVWRLTECRKQ-- 177
+ FV+P+CLP+ G F + GWG L S L E +P+ +C
Sbjct: 106 RSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEV 165
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK--TPGVY 235
+ +I + LCAG + +D+CQGDSGGPL ++ + + G++SWG GCG+ PGVY
Sbjct: 166 YGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAY-LYGIISWGDGCGRLHKPGVY 224
Query: 236 VQVNKYLRWI 245
+V Y+ WI
Sbjct: 225 TRVANYVDWI 234
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 114 bits (284), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 83/248 (33%), Positives = 130/248 (52%), Gaps = 28/248 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
GQ ++ D+PW V + G L+ + WVLTAAH + ++ +A S L +
Sbjct: 4 GQKAKPGDFPWQVLILG----GTTAAGALLYDNWVLTAAHAVYEQKHDA------SALDI 53
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVRPVCLP 132
R+G K T + A+ ++ ++ + ++NDIAL++L+ K NS + P+CLP
Sbjct: 54 RMGTL---KRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLP 110
Query: 133 --QAGDFYE-DQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQ------NIF 183
+A F D IG +GWG L+ G + LM V IP+ +C + + ++
Sbjct: 111 RKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVT 169
Query: 184 DSNLCAGGYKGGTDSCQGDSGGPL-LLQRPDKQWTIIGVVSWG-IGCGKTP--GVYVQVN 239
+ LCAG GG DSC+GD+GG L L ++W + G+VSWG + CG+ GVY +V
Sbjct: 170 ANMLCAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVI 229
Query: 240 KYLRWIYN 247
Y+ WI N
Sbjct: 230 NYIPWIEN 237
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 113 bits (283), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 120/241 (49%), Gaps = 28/241 (11%)
Query: 22 WPWLVALKRQYERD----NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGE 77
W W V+L QYE+D + CGG LI WV+TA HCI RT ++ LGE
Sbjct: 10 WSWQVSL--QYEKDGAFHHTCGGSLIAPDWVVTAGHCISTS--------RTYQVV--LGE 57
Query: 78 YDFSKVNET-KVTDIPAAAMKVYPRFSEQNYE--NDIALVQLSKKAQYNSFVRPVCLPQA 134
YD S + + +V I A + V+P ++ NDIALV+LS+ AQ V+ LP A
Sbjct: 58 YDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPPA 117
Query: 135 GDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRK--QFSQNIFDSNLCAGG 191
GD ++ ++GWG L GGP D L + +P C + + + + +CAGG
Sbjct: 118 GDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGITVKKTMVCAGG 177
Query: 192 YKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW--GIGCG--KTPGVYVQVNKYLRWIYN 247
C GDSGGPL D W + GV S+ GC K P V+ +V+ ++ WI
Sbjct: 178 DT--RSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWIDE 235
Query: 248 T 248
T
Sbjct: 236 T 236
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 112 bits (279), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 77/239 (32%), Positives = 121/239 (50%), Gaps = 26/239 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ +E + P++ ++ Q + CGGVL+ E+WVL+AAHC++ D + V
Sbjct: 4 GREAEAHARPYMASV--QLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQ--------V 53
Query: 74 RLGEYDFSKVNETK-VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
LG + S+ +K + D+ A +P + ++D+ L+QLS+KA VRP+
Sbjct: 54 LLGAHSLSQPEPSKRLYDVLRAVP--HPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 133 QAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQN--IFDSNLCA 189
+ D + V GWG +++ G R D L V +PV C ++ + I + +CA
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
+ DSC+GDSGGPL+ + GVVSWG G K PG+Y +V Y WI
Sbjct: 172 ESNR--RDSCKGDSGGPLVC-----GGVLEGVVSWGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 111 bits (278), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 78/243 (32%), Positives = 121/243 (49%), Gaps = 24/243 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD----NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
G+ + + WPW ++L QY ++ + CGG LI +VLTAAHCI T
Sbjct: 4 GEDARPHSWPWQISL--QYLKNDTWRHTCGGTLIASNFVLTAAHCISN----------TR 51
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
V +G+ + +E + + V+ R++ NDIAL++L++ + + ++
Sbjct: 52 TYRVAVGKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVA 111
Query: 130 CLPQAGDFY-EDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRK--QFSQNIFDSN 186
CLP+ +D VTGWG L GP +D L + PV C + + + +
Sbjct: 112 CLPEKDSLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKKTM 171
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGI--GCG--KTPGVYVQVNKYL 242
+CAGG G +C GDSGGPL Q + W + G+VS+G GC K P VY +V+ Y+
Sbjct: 172 VCAGG-DGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYI 230
Query: 243 RWI 245
WI
Sbjct: 231 DWI 233
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 110 bits (275), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 79/247 (31%), Positives = 117/247 (47%), Gaps = 24/247 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + PW V L CGG LIN WV++AAHC + ++ +
Sbjct: 1 IVGGKVCPKGECPWQVLLL--VNGAQLCGGTLINTIWVVSAAHCFDK-------IKNWRN 51
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
LI LGE+D S+ ++ A + + + +DIAL++L + V P+C
Sbjct: 52 LIAVLGEHDLSE-HDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLC 110
Query: 131 LPQAGDFYEDQIG-----IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-----SQ 180
LP+ F E + +V+GWG L G + LM + +P +C +Q S
Sbjct: 111 LPER-TFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSP 169
Query: 181 NIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQV 238
NI + CAG G DSC+GDSGGP W + G+VSWG GC GVY +V
Sbjct: 170 NITEYMFCAGYSDGSKDSCKGDSGGPHATHY-RGTWYLTGIVSWGQGCATVGHFGVYTRV 228
Query: 239 NKYLRWI 245
++Y+ W+
Sbjct: 229 SQYIEWL 235
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 110 bits (274), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 84/253 (33%), Positives = 123/253 (48%), Gaps = 40/253 (15%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDN--FCGGVLINERWVLTAAHCIKQKIDNALVLRRT 68
I G +++ PW AL R N +CG VL++ +W+LTAAHC K+ V R
Sbjct: 1 IINGSDCDMHTQPWQAAL---LLRPNQLYCGAVLVHPQWLLTAAHCRKK------VFR-- 49
Query: 69 SDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRP 128
VRLG Y S V E+ +P +S + ND+ L++L+++ + VRP
Sbjct: 50 ----VRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRP 105
Query: 129 VCL----PQAGDFYEDQIGIVTGWGTLSYGGPR---SDVLMEVPIPVWRLTECRKQFSQN 181
+ + P AG +V+GWGT P+ VL + I V C + +
Sbjct: 106 INVSSHCPSAGTKC-----LVSGWGTTK--SPQVHFPKVLQCLNISVLSQKRCEDAYPRQ 158
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCGKT--PGVYVQV 238
I D+ CAG K G DSCQGDSGGP++ ++ G+VSWG C + PGVY +
Sbjct: 159 IDDTMFCAGD-KAGRDSCQGDSGGPVVC-----NGSLQGLVSWGDYPCARPNRPGVYTNL 212
Query: 239 NKYLRWIYNTAKV 251
K+ +WI T +
Sbjct: 213 CKFTKWIQETIQA 225
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 109 bits (273), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 77/235 (32%), Positives = 113/235 (48%), Gaps = 24/235 (10%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
PW V L CGG LIN WV++AAHC + ++ +LI LGE+D S+
Sbjct: 13 PWQVLLL--VNGAQLCGGTLINTIWVVSAAHCFDK-------IKNWRNLIAVLGEHDLSE 63
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
++ A + + + +DIAL++L + V P+CLP+ F E +
Sbjct: 64 -HDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPER-TFSERTL 121
Query: 143 G-----IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF-----SQNIFDSNLCAGGY 192
+V+GWG L G + VL + +P +C +Q S NI + CAG
Sbjct: 122 AFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYS 181
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWI 245
G DSC+GDSGGP W + G+VSWG GC GVY +V++Y+ W+
Sbjct: 182 DGSKDSCKGDSGGPHATHY-RGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWL 235
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 109 bits (272), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 73/240 (30%), Positives = 123/240 (51%), Gaps = 22/240 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD-NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G ++ + P++ ++ E+ CGG+L+ + +VLTAAHC + S +
Sbjct: 4 GHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC------------QGSSIN 51
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V LG ++ + T+ IP +P ++ +N+ NDI L+QL +KA++ + VRP+ LP
Sbjct: 52 VTLGAHNIKEQERTQ-QFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLP 110
Query: 133 QA-GDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD-SNLCAG 190
+ Q+ V GWG +S + L EV + V + +C + F N + +C G
Sbjct: 111 SSKAQVKPGQLCSVAGWGYVSMST-LATTLQEVLLTVQKDCQCERLFHGNYSRATEICVG 169
Query: 191 GYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
K +GDSGGPL+ + + G++S+G G PGVY++V+ +L WI T K
Sbjct: 170 DPKKTQTGFKGDSGGPLVCKDVAQ-----GILSYGNKKGTPPGVYIKVSHFLPWIKRTMK 224
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 108 bits (271), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 84/251 (33%), Positives = 125/251 (49%), Gaps = 41/251 (16%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I +G+ + PW AL Q ER CGGVL+ +RWVLTAAHC KQK
Sbjct: 1 ILEGRECIPHSQPWQAAL-FQGER-LICGGVLVGDRWVLTAAHCKKQKYS---------- 48
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQN---YENDIALVQLSKKAQYNSFVR 127
VRLG++ ++ + +I A +P ++ N + +DI L++L A V+
Sbjct: 49 --VRLGDHSLQSRDQPE-QEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVK 105
Query: 128 PVCL----PQAGDFYEDQIGIVTGWGTLSYGGPRS---DVLMEVPIPVWRLTECRKQFSQ 180
PV L P+ G Q I++GWGT++ P+ + L + ++ +C + +
Sbjct: 106 PVQLANLCPKVG-----QKCIISGWGTVT--SPQENFPNTLNCAEVKIYSQNKCERAYPG 158
Query: 181 NIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGK--TPGVYVQ 237
I + +CAG G D+CQGDSGGPL+ + G+ SWG CGK PGVY +
Sbjct: 159 KITEGMVCAGS-SNGADTCQGDSGGPLVCDG-----MLQGITSWGSDPCGKPEKPGVYTK 212
Query: 238 VNKYLRWIYNT 248
+ +Y WI T
Sbjct: 213 ICRYTTWIKKT 223
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 72/240 (30%), Positives = 123/240 (51%), Gaps = 22/240 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD-NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G ++ + P++ ++ E+ CGG+L+ + +VLTAAHC + S +
Sbjct: 4 GHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC------------QGSSIN 51
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V LG ++ + T+ IP +P ++ +N+ N+I L+QL +KA++ + VRP+ LP
Sbjct: 52 VTLGAHNIKEQERTQ-QFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLP 110
Query: 133 QA-GDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD-SNLCAG 190
+ Q+ V GWG +S + L EV + V + +C + F N + +C G
Sbjct: 111 SSKAQVKPGQLCSVAGWGYVSMST-LATTLQEVLLTVQKDCQCERLFHGNYSRATEICVG 169
Query: 191 GYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
K +GDSGGPL+ + + G++S+G G PGVY++V+ +L WI T K
Sbjct: 170 DPKKTQTGFKGDSGGPLVCKDVAQ-----GILSYGNKKGTPPGVYIKVSHFLPWIKRTMK 224
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 82/238 (34%), Positives = 116/238 (48%), Gaps = 29/238 (12%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P++V L +R C G LI + WVLTAAHC L + S +I LG + ++
Sbjct: 13 PYMVLL--SLDRKTICAGALIAKDWVLTAAHC---------NLNKRSQVI--LGAHSITR 59
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGD-FYEDQ 141
TK + YP + E D+ L+QL++KA+ N +V + LP+ GD
Sbjct: 60 EEPTKQIMLVKKEFP-YPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGT 118
Query: 142 IGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ----FSQNIFDSNLCAGGYKGGTD 197
+ V GWG SD L EV I + C + F+ I + +CAG +GG D
Sbjct: 119 MCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRD 178
Query: 198 SCQGDSGGPLLLQRPDKQWTIIGVVSWGI--GCG--KTPGVYVQVN-KYLRWIYNTAK 250
SC GDSG PLL + GV S+G+ CG + PGVY+ ++ K+L WI T K
Sbjct: 179 SCNGDSGSPLLC-----EGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMTIK 231
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 107 bits (266), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 76/243 (31%), Positives = 121/243 (49%), Gaps = 25/243 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF--CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G+ ++ N WPW ++L+ + + CGG LI + WV+TAAHC +D+A R
Sbjct: 4 GRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHC----VDSARTWR----- 54
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYEN--DIALVQLSKKAQYNSFVRPV 129
V LGE++ NE K + ++ ++ ++ + DIAL++L+ +A NS V+
Sbjct: 55 -VVLGEHNL-NTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLA 112
Query: 130 CLPQAGDFY-EDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ--FSQNIFDSN 186
LP + + +TGWG S GGP SD L + +P C + + +
Sbjct: 113 ALPPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVKTTM 172
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW----GIGCGKTPGVYVQVNKYL 242
+CAGG G C GDSGGPL Q + + + GV S+ G K P V+ +V+ Y+
Sbjct: 173 VCAGG--GANSGCNGDSGGPLNCQV-NGSYYVHGVTSFVSSSGCNASKKPTVFTRVSAYI 229
Query: 243 RWI 245
W+
Sbjct: 230 SWM 232
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 107 bits (266), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 72/236 (30%), Positives = 111/236 (47%), Gaps = 21/236 (8%)
Query: 21 DWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDF 80
++P++V L + E + FCGG L + VLTAAHC+ +N + + +V L
Sbjct: 11 EFPFMVRLINE-ENEGFCGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVVDLQSSSA 67
Query: 81 SKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED 140
KV TKV P F+++ Y D AL++L++ +P Y
Sbjct: 68 VKVRSTKVLQAPG--------FTKETYGKDWALIKLAQPIN-----QPTLKIATTTAYNQ 114
Query: 141 QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN--LCAGGYKGGTDS 198
V GWG GG + L++ +P CR S I +N +CAG D+
Sbjct: 115 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVANEMICAGYDTKQEDT 173
Query: 199 CQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYNTAKVI 252
CQGDSGGP+ + +W +G+VSWG GC + GVY +V+ + I + A+ +
Sbjct: 174 CQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAARTL 229
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 107 bits (266), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 82/238 (34%), Positives = 116/238 (48%), Gaps = 29/238 (12%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSK 82
P++V L +R C G LI + WVLTAAHC L + S +I LG + ++
Sbjct: 13 PYMVLL--SLDRKTICAGALIAKDWVLTAAHC---------NLNKRSQVI--LGAHSITR 59
Query: 83 VNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGD-FYEDQ 141
TK + YP + E D+ L+QL++KA+ N +V + LP+ GD
Sbjct: 60 EEPTKQIMLVKKEFP-YPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGT 118
Query: 142 IGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ----FSQNIFDSNLCAGGYKGGTD 197
+ V GWG SD L EV I + C + F+ I + +CAG +GG D
Sbjct: 119 MCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRD 178
Query: 198 SCQGDSGGPLLLQRPDKQWTIIGVVSWGI--GCG--KTPGVYVQVN-KYLRWIYNTAK 250
SC GDSG PLL + GV S+G+ CG + PGVY+ ++ K+L WI T K
Sbjct: 179 SCNGDSGSPLLC-----EGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMTIK 231
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 107 bits (266), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 76/239 (31%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ +E + P++ ++ Q ++ CGGVL+ E+WVL+AAHC++ D + V
Sbjct: 4 GREAEAHARPYMASV--QVNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQ--------V 53
Query: 74 RLGEYDFSKVNETK-VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
LG + S+ +K + D+ A +P ++D+ L+QLS+KA VRP+
Sbjct: 54 LLGAHSLSQPEPSKRLYDVLRAVP--HPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 133 QAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQN--IFDSNLCA 189
+ D + V GWG +S+ G R D L V +PV C ++ + I +CA
Sbjct: 112 RVDRDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
+ DSC+GDSGGPL+ + GVV+ G G K PG+Y +V Y WI
Sbjct: 172 ESNR--RDSCKGDSGGPLVC-----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 106 bits (264), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 76/239 (31%), Positives = 120/239 (50%), Gaps = 26/239 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ +E + P++ ++ Q + CGGVL+ E+WVL+AAHC++ D + V
Sbjct: 4 GREAEAHARPYMASV--QLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQ--------V 53
Query: 74 RLGEYDFSKVNETK-VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
LG + S+ +K + D+ A +P ++D+ L+QLS+KA VRP+
Sbjct: 54 LLGAHSLSQPEPSKRLYDVLRAVP--HPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 133 QAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQN--IFDSNLCA 189
+ D + V GWG +++ G R D L V +PV C ++ + I + +CA
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CG--KTPGVYVQVNKYLRWI 245
+ DSC+GDSGGPL+ + GVV+ G CG K PG+Y +V Y WI
Sbjct: 172 ESNR--RDSCKGDSGGPLVC-----GGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWI 223
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 76/243 (31%), Positives = 121/243 (49%), Gaps = 26/243 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
+I G+ +E + P++ ++ Q + CGGVL+ E+WVL+AAHC++ D
Sbjct: 7 RILGGREAEAHARPYMASV--QLNGAHLCGGVLVAEQWVLSAAHCLEDAADG-------- 56
Query: 70 DLIVRLGEYDFSKVNETK-VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRP 128
+ V LG + S+ +K + D+ A +P ++D+ L+QLS+KA VRP
Sbjct: 57 KVQVLLGAHSLSQPEPSKRLYDVLRAVP--HPDSQPDTIDHDLLLLQLSEKATLGPAVRP 114
Query: 129 VCLPQAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQN--IFDS 185
+ + D + V GWG +++ G R D L V +PV C ++ + I +
Sbjct: 115 LPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITER 174
Query: 186 NLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYL 242
+CA + DSC+GDSGGPL+ + GVV+ G G K PG+Y +V Y
Sbjct: 175 LMCAESNR--RDSCKGDSGGPLVC-----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYA 227
Query: 243 RWI 245
WI
Sbjct: 228 AWI 230
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 105 bits (262), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 73/219 (33%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 37 FCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAM 96
CGGVLI+ WVLTAAHC K +L V LG+++ + ++ A+
Sbjct: 25 LCGGVLIHPLWVLTAAHCKK------------PNLQVFLGKHNLRQRESSQEQSSVVRAV 72
Query: 97 KVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIGI-VTGWGTLSYGG 155
++P + +++ DI L++L++ A+ + ++P LP D + + GWG + G
Sbjct: 73 -IHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSANTTSCHILGWGKTA-DG 128
Query: 156 PRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQ 215
D + I + EC + I + LCAG K G DSCQGDSGGPL+
Sbjct: 129 DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGD---- 184
Query: 216 WTIIGVVSWG-IGCG--KTPGVYVQVNKYLRWIYNTAKV 251
+ G+VSWG I CG + PGVY V +Y WI T +
Sbjct: 185 -HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQA 222
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 25/248 (10%)
Query: 17 SEVNDWPWLVALKRQY------ERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
+E ++PW+VA+ + E CGG LI VLT AHC+ N ++
Sbjct: 137 AEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVNSYQSNLDAIK---- 192
Query: 71 LIVRLGEYD-FSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
+R GE+D ++ + + ++ F+ + ND+AL+ L + + +
Sbjct: 193 --IRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTI 250
Query: 130 CLPQAGDFYEDQIGIVTGWGTLSYGGPR--SDVLMEVPIPVWRLTECRKQFSQN------ 181
CLPQ ++ +GWG +G S++L ++ +P +C+
Sbjct: 251 CLPQQSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKF 310
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRP--DKQWTIIGVVSWGIGCG--KTPGVYVQ 237
+ D G + G D+C GD G PL P ++ +G+V+WGIGCG PGVY
Sbjct: 311 VLDQTFVCAGGEQGKDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYAN 370
Query: 238 VNKYLRWI 245
V + WI
Sbjct: 371 VAHFRNWI 378
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 75/239 (31%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ +E + P++ ++ Q + CGGVL+ E+WVL+AAHC++ D + V
Sbjct: 4 GREAEAHARPYMASV--QLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQ--------V 53
Query: 74 RLGEYDFSKVNETK-VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
LG + S+ +K + D+ A +P ++D+ L+QLS+KA VRP+
Sbjct: 54 LLGAHSLSQPEPSKRLYDVLRAVP--HPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 133 QAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQN--IFDSNLCA 189
+ D + V GWG +++ G R D L V +PV C ++ + I + +CA
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
+ DSC+GDSGGPL+ + GVV+ G G K PG+Y +V Y WI
Sbjct: 172 ESNR--RDSCKGDSGGPLVC-----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 37 FCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAM 96
FCGG L+ +++VLTAAHC + + V LG ++ ET+ IP A
Sbjct: 29 FCGGFLVRDKFVLTAAHC------------KGRSMTVTLGAHNIKAKEETQQI-IPVAKA 75
Query: 97 KVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYE--DQIGIVTGWGTLSYG 154
+P ++ + NDI L++L + A+ VRP+ LP+ + D+ V GWG ++
Sbjct: 76 IPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDEC-YVAGWGKVTPD 134
Query: 155 GPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN-LCAGGYKGGTDSCQGDSGGPLLLQRPD 213
G L EV + V + C QF + +N +C G K S +GDSGGPL+ +R
Sbjct: 135 GEFPKTLHEVKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFRGDSGGPLVCKR-- 192
Query: 214 KQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
G+VS+G G P V+ +V ++ WI T K
Sbjct: 193 ---AAAGIVSYGQTDGSAPQVFTRVLSFVSWIKKTMK 226
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 104 bits (259), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 119/239 (49%), Gaps = 26/239 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ +E + P++ ++ Q + CGGVL+ E+WVL+AAHC++ D + V
Sbjct: 4 GREAEAHARPYMASV--QLNGAHLCGGVLVAEQWVLSAAHCLEDAADG--------KVQV 53
Query: 74 RLGEYDFSKVNETK-VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
LG + S+ +K + D+ A +P ++D+ L+QLS+KA VRP+
Sbjct: 54 LLGAHSLSQPEPSKRLYDVLRAVP--HPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 133 QAG-DFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQN--IFDSNLCA 189
+ D + V GWG +++ G R D L V +PV C ++ + I + +CA
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA 171
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
+ DSC+GD+GGPL+ + GVV+ G G K PG+Y +V Y WI
Sbjct: 172 ESNR--RDSCKGDAGGPLVC-----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 103 bits (257), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 80/247 (32%), Positives = 125/247 (50%), Gaps = 29/247 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF-CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G E + PW AL Y F CGG+L++ +WVLTAAHCI DN + +L
Sbjct: 4 GWECEQHSQPWQAAL---YHFSTFQCGGILVHRQWVLTAAHCIS---DNYQLWLGRHNLF 57
Query: 73 VRLGEYDFSKVNET-KVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQ-YNSFVRPVC 130
F V+E+ + ++ + R ++++Y +D+ L++L++ A V+ V
Sbjct: 58 DDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVE 117
Query: 131 LPQAGDFYEDQIG---IVTGWGTL---SYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFD 184
LP E ++G + +GWG++ ++ P D L V + + EC+K Q + D
Sbjct: 118 LPTE----EPEVGSTCLASGWGSIEPENFSFP--DDLQCVDLKILPNDECKKAHVQKVTD 171
Query: 185 SNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCG--KTPGVYVQVNKY 241
LC G +GG D+C GDSGGPL+ + GV SWG + CG P V V+V Y
Sbjct: 172 FMLCVGHLEGGKDTCVGDSGGPLMCDG-----VLQGVTSWGYVPCGTPNKPSVAVRVLSY 226
Query: 242 LRWIYNT 248
++WI +T
Sbjct: 227 VKWIEDT 233
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 77/245 (31%), Positives = 117/245 (47%), Gaps = 25/245 (10%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
K+ G + P+ AL CGGVLI+ WVLTAAHC K
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHL--LCGGVLIHPLWVLTAAHCKK------------P 46
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
+L V LG+++ + ++ A+ ++P + +++ DI L++L++ A+ + ++P+
Sbjct: 47 NLQVFLGKHNLRQQESSQEQSSVVRAV-IHPDYDAASHDQDIMLLRLARPAKLSELIQPL 105
Query: 130 CLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
L + I+ GWG + G D + I + EC + I + LCA
Sbjct: 106 PLERDCSAQTTSCHIL-GWGKTA-DGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCA 163
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCG--KTPGVYVQVNKYLRWIY 246
G K G DSCQGDSGGPL+ + G+VSWG I CG + PGVY V +Y WI
Sbjct: 164 GDEKYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQ 218
Query: 247 NTAKV 251
T +
Sbjct: 219 KTIQA 223
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 103 bits (256), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 23/218 (10%)
Query: 37 FCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAM 96
CGGVLI+ WVLTAAHC K +L V LG+++ + ++ A+
Sbjct: 25 LCGGVLIHPLWVLTAAHCKK------------PNLQVFLGKHNLGQQESSQEQSSVVRAV 72
Query: 97 KVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIGIVTGWGTLSYGGP 156
++P + +++ DI L++L++ A+ + ++P+ L + I+ GWG + G
Sbjct: 73 -IHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHIL-GWGKTA-DGD 129
Query: 157 RSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQW 216
D + I + EC + I + LCAG K G DSCQGDSGGPL+
Sbjct: 130 FPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGD----- 184
Query: 217 TIIGVVSWG-IGCG--KTPGVYVQVNKYLRWIYNTAKV 251
+ G+VSWG I CG + PGVY V +Y WI T +
Sbjct: 185 HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQA 222
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 102 bits (254), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 37 FCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAM 96
FCGG L+ +++VLTAAHC + + V LG ++ ET+ IP A
Sbjct: 29 FCGGFLVRDKFVLTAAHC------------KGRSMTVTLGAHNIKAKEETQQI-IPVAKA 75
Query: 97 KVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYE--DQIGIVTGWGTLSYG 154
+P ++ + NDI L++L + A+ VRP+ LP+ + D+ V GWG ++
Sbjct: 76 IPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDEC-YVAGWGKVTPD 134
Query: 155 GPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN-LCAGGYKGGTDSCQGDSGGPLLLQRPD 213
G L EV + V + C QF + +N +C G K S + DSGGPL+ +R
Sbjct: 135 GEFPKTLHEVKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFEEDSGGPLVCKR-- 192
Query: 214 KQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
G+VS+G G P V+ +V ++ WI T K
Sbjct: 193 ---AAAGIVSYGQTDGSAPQVFTRVLSFVSWIKKTMK 226
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 101 bits (252), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 76/245 (31%), Positives = 123/245 (50%), Gaps = 24/245 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD--NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G ++ N WP ++L+ + + CGG LI + WV+TAAHC +D L R
Sbjct: 4 GTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHC----VDRELTFR----- 54
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYEN--DIALVQLSKKAQYNSFVRPV 129
V +GE++ ++ N T+ + + V+P ++ + DIAL++L++ NS+V+
Sbjct: 55 -VVVGEHNLNQNNGTE-QYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLG 112
Query: 130 CLPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ--FSQNIFDSN 186
LP+AG + +TGWG G + L + +P C + + +S
Sbjct: 113 VLPRAGTILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSM 172
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW--GIGCGKT--PGVYVQVNKYL 242
+CAGG G CQGDSGGPL + Q+ + GV S+ +GC T P V+ +V+ Y+
Sbjct: 173 VCAGG-DGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYI 230
Query: 243 RWIYN 247
WI N
Sbjct: 231 SWINN 235
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 76/245 (31%), Positives = 123/245 (50%), Gaps = 24/245 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD--NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G ++ N WP ++L+ + + CGG LI + WV+TAAHC +D L R
Sbjct: 4 GTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHC----VDRELTFR----- 54
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYEN--DIALVQLSKKAQYNSFVRPV 129
V +GE++ ++ N T+ + + V+P ++ + DIAL++L++ NS+V+
Sbjct: 55 -VVVGEHNLNQNNGTE-QYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLG 112
Query: 130 CLPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ--FSQNIFDSN 186
LP+AG + +TGWG G + L + +P C + + +S
Sbjct: 113 VLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSM 172
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW--GIGCGKT--PGVYVQVNKYL 242
+CAGG G CQGDSGGPL + Q+ + GV S+ +GC T P V+ +V+ Y+
Sbjct: 173 VCAGG-DGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYI 230
Query: 243 RWIYN 247
WI N
Sbjct: 231 SWINN 235
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 101 bits (251), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 78/259 (30%), Positives = 121/259 (46%), Gaps = 30/259 (11%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNAL 63
KI G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D +
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIV 82
Query: 64 VLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK---- 119
L R+ GE F N D A + + NDIAL+++ K
Sbjct: 83 YLGRSRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRC 133
Query: 120 AQYNSFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTE 173
AQ + ++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 134 AQPSRTIQTICLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQ 191
Query: 174 CRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KT 231
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC
Sbjct: 192 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDK 250
Query: 232 PGVYVQVNKYLRWIYNTAK 250
PGVY +V+ +L WI + K
Sbjct: 251 PGVYTRVSHFLPWIRSHTK 269
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 101 bits (251), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 76/253 (30%), Positives = 119/253 (47%), Gaps = 39/253 (15%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
+I G+ +++ D PW VA+K CGG+ I W+LTAAHC++ + + T
Sbjct: 321 RIVGGKRAQLGDLPWQVAIKDA--SGITCGGIYIGGCWILTAAHCLRASKTHRYQIWTT- 377
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRP- 128
+V D ++ V I + ++ Y+NDIAL+++ K P
Sbjct: 378 --VVDWIHPDLKRIVIEYVDRII-----FHENYNAGTYQNDIALIEMKKDGNKKDCELPR 430
Query: 129 ---VCLPQAGDFYE-DQIGIVTGWG---------TLSYGGPRSDVLMEVPIPVWRLTECR 175
C+P + ++ + IV+GWG +L +G EV + ++ C
Sbjct: 431 SIPACVPWSPYLFQPNDTCIVSGWGREKDNERVFSLQWG--------EVKL----ISNCS 478
Query: 176 KQFSQNIFDSNL-CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--P 232
K + ++ + CAG Y G D+C+GDSGGPL+ + + GVVSWG CGK P
Sbjct: 479 KFYGNRFYEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFP 538
Query: 233 GVYVQVNKYLRWI 245
GVY +V Y WI
Sbjct: 539 GVYTKVANYFDWI 551
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 100 bits (250), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 77/255 (30%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 77/240 (32%), Positives = 106/240 (44%), Gaps = 23/240 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ + P++ ++ QY + CGGVLI+ +WVLTAAHC + + V
Sbjct: 6 GKEVSPHSRPFMASI--QYGGHHVCGGVLIDPQWVLTAAHCQYR-------FTKGQSPTV 56
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
LG + SK NE + + R + NDI LV+L A+ N V+ + +
Sbjct: 57 VLGAHSLSK-NEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRS 115
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECRKQFSQN----IFDSNLC 188
VTGWG R SD L EV + V C Q N I +C
Sbjct: 116 KTSLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVC 175
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVN-KYLRWI 245
AG KG DSC+GD+GGPL+ + +VS G CG PG+Y + KY WI
Sbjct: 176 AGDAKGQKDSCKGDAGGPLIC-----KGVFHAIVSGGHECGVATKPGIYTLLTKKYQTWI 230
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 77/250 (30%), Positives = 120/250 (48%), Gaps = 36/250 (14%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKID-----NALVLRRT 68
G E N PW VA+ Y++++ CGGVL++ WVLTAAHC + + N L
Sbjct: 4 GFNCEKNSQPWQVAV--YYQKEHICGGVLLDRNWVLTAAHCYVDQYEVWLGKNKLFQEEP 61
Query: 69 SD---LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSF 125
S L+ + + ++ + IP A ++ +D+ L++LSK A
Sbjct: 62 SAQHRLVSKSFPHPGFNMSLLMLQTIPPGA----------DFSDDLMLLRLSKPADITDV 111
Query: 126 VRPVCLPQAGDFYEDQIG---IVTGWGTLSYGG-PRSDVLMEVPIPVWRLTECRKQFSQN 181
V+P+ LP E + G + +GWG+++ + D L V I + C K + Q
Sbjct: 112 VKPIALPTK----EPKPGSKCLASGWGSITPTRWQKPDDLQCVFITLLPNENCAKVYLQK 167
Query: 182 IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCGK--TPGVYVQV 238
+ D LCAG GG D+C+ DSGGPL+ + G S+G + CGK P +Y +
Sbjct: 168 VTDVMLCAGEMGGGKDTCRDDSGGPLICDG-----ILQGTTSYGPVPCGKPGVPAIYTNL 222
Query: 239 NKYLRWIYNT 248
K+ WI +T
Sbjct: 223 IKFNSWIKDT 232
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 75/245 (30%), Positives = 122/245 (49%), Gaps = 24/245 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD--NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G ++ N WP ++L+ + + CGG LI + WV+TAAHC +D L R
Sbjct: 4 GTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHC----VDRELTFR----- 54
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYEN--DIALVQLSKKAQYNSFVRPV 129
V +GE++ ++ N+ + + V+P ++ + DIAL++L++ NS+V+
Sbjct: 55 -VVVGEHNLNQ-NDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLG 112
Query: 130 CLPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQ--FSQNIFDSN 186
LP+AG + +TGWG G + L + +P C + + +S
Sbjct: 113 VLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSM 172
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW--GIGCGKT--PGVYVQVNKYL 242
+CAGG G CQGDSGGPL + Q+ + GV S+ +GC T P V+ +V+ Y+
Sbjct: 173 VCAGG-DGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYI 230
Query: 243 RWIYN 247
WI N
Sbjct: 231 SWINN 235
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 80/256 (31%), Positives = 120/256 (46%), Gaps = 46/256 (17%)
Query: 13 KGQASEVNDWPWLVALKR--QYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
+ Q N PW VA+ R +Y+ CGGVL++ WVLTAAHC K
Sbjct: 6 QSQVDCENSQPWHVAVYRFNKYQ----CGGVLLDRNWVLTAAHCYNDKYQ---------- 51
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-----------EQNYENDIALVQLSKK 119
V LG+ +F + + + + A+ +P F+ E +Y ND+ L++LSK
Sbjct: 52 --VWLGKNNFLEDEPSDQHRLVSKAIP-HPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKP 108
Query: 120 AQYNSFVRPVCLPQAGDFYEDQIG---IVTGWG-TLSYGGPRSDVLMEVPIPVWRLTECR 175
A V+P+ LP E ++G + +GWG T D L V + + +C
Sbjct: 109 ADITDVVKPITLPTE----EPKLGSTCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCD 164
Query: 176 KQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGI-GCGKT--P 232
K + D+ LCAG GG+ +C+ DSGGPL+ + G+ SWG CG+ P
Sbjct: 165 KAHEMKVTDAMLCAGEMDGGSYTCEHDSGGPLICDG-----ILQGITSWGPEPCGEPTEP 219
Query: 233 GVYVQVNKYLRWIYNT 248
VY ++ K+ WI T
Sbjct: 220 SVYTKLIKFSSWIRET 235
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 99.0 bits (245), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 70/236 (29%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 21 DWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDF 80
++P++V L CGG L + VLTAAHC+ +N + + +V L
Sbjct: 11 EFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVVDLQSSSA 62
Query: 81 SKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED 140
KV TKV P F+++ Y D AL++L++ +P Y
Sbjct: 63 VKVRSTKVLQAPG--------FTKETYGKDWALIKLAQPIN-----QPTLKIATTTAYNQ 109
Query: 141 QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN--LCAGGYKGGTDS 198
V GWG GG + L++ +P CR S I +N +CAG D+
Sbjct: 110 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVANEMICAGYDTKQEDT 168
Query: 199 CQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYNTAKVI 252
CQGDSGGP+ + +W +G+VSWG GC + GVY +V+ + I + A+ +
Sbjct: 169 CQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAARTL 224
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 68/243 (27%), Positives = 104/243 (42%), Gaps = 27/243 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + ++P++V L CGG L + VLTAAHC+ +N + + +V
Sbjct: 4 GTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVV 55
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
L KV TKV P D AL++L++ +P
Sbjct: 56 DLQSSSAVKVRSTKVLQAPG----------YNGTGKDWALIKLAQPIN-----QPTLKIA 100
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY- 192
Y V GWG GG + L++ +P CR + + + GY
Sbjct: 101 TTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYP 160
Query: 193 -KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWIYNTA 249
GG D+CQGDSGGP+ + +W +G+VSWG GC + PGVY +V+ + I + A
Sbjct: 161 DTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAA 220
Query: 250 KVI 252
+ +
Sbjct: 221 RTL 223
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 30/259 (11%)
Query: 10 KIDKGQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNAL 63
KI G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D +
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIV 74
Query: 64 VLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK---- 119
L R+ GE F N D A + + NDIAL+++ K
Sbjct: 75 YLGRSRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRC 125
Query: 120 AQYNSFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTE 173
AQ + ++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 126 AQPSRTIQTISLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQ 183
Query: 174 CRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KT 231
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC
Sbjct: 184 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDK 242
Query: 232 PGVYVQVNKYLRWIYNTAK 250
PGVY +V+ +L WI + K
Sbjct: 243 PGVYTRVSHFLPWIRSHTK 261
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 75/255 (29%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TD+CQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 75/250 (30%), Positives = 117/250 (46%), Gaps = 30/250 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWI 245
+V+ +L WI
Sbjct: 232 TRVSHFLPWI 241
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 75/250 (30%), Positives = 117/250 (46%), Gaps = 30/250 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWI 245
+V+ +L WI
Sbjct: 232 TRVSHFLPWI 241
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 75/250 (30%), Positives = 117/250 (46%), Gaps = 30/250 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ +CLP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTICLPSM--YNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWI 245
+V+ +L WI
Sbjct: 232 TRVSHFLPWI 241
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 67/235 (28%), Positives = 103/235 (43%), Gaps = 26/235 (11%)
Query: 21 DWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDF 80
++P++V L CGG L + VLTAAHC+ +N + + +V L
Sbjct: 11 EFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVVDLQSSSA 62
Query: 81 SKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED 140
KV TKV P D AL++L++ +P Y
Sbjct: 63 VKVRSTKVLQAPG----------YNGTGKDWALIKLAQPIN-----QPTLKIATTTAYNQ 107
Query: 141 QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIF-DSNLCAGGYKGGTDSC 199
V GWG GG + L++ +P CR + + + +CAG GG D+C
Sbjct: 108 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYDTGGVDTC 167
Query: 200 QGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWIYNTAKVI 252
QGDSGGP+ + +W +G+VSWG GC + GVY +V+ + I + A+ +
Sbjct: 168 QGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAARTL 222
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 68/243 (27%), Positives = 103/243 (42%), Gaps = 27/243 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + ++P++V L CGG L + VLTAAHC+ +N + + +V
Sbjct: 4 GTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVV 55
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
L KV TKV P D AL++L++ +P
Sbjct: 56 DLQSSSAVKVRSTKVLQAPG----------YNGTGKDWALIKLAQPIN-----QPTLKIA 100
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY- 192
Y V GWG GG + L++ +P CR + + + GY
Sbjct: 101 TTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYP 160
Query: 193 -KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWIYNTA 249
GG D CQGDSGGP+ + +W +G+VSWG GC + PGVY +V+ + I + A
Sbjct: 161 DTGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAA 220
Query: 250 KVI 252
+ +
Sbjct: 221 RTL 223
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 97.4 bits (241), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 68/243 (27%), Positives = 104/243 (42%), Gaps = 27/243 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G + ++P++V L CGG L + VLTAAHC+ +N + + +V
Sbjct: 4 GTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSIT--ATGGVV 55
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
L KV TKV P D AL++L++ +P
Sbjct: 56 DLQSGAAVKVRSTKVLQAPG----------YNGTGKDWALIKLAQPIN-----QPTLKIA 100
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY- 192
Y V GWG GG + L++ +P CR + + + GY
Sbjct: 101 TTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYP 160
Query: 193 -KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWIYNTA 249
GG D+CQGDSGGP+ + +W +G+VSWG GC + PGVY +V+ + I + A
Sbjct: 161 DTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAA 220
Query: 250 KVI 252
+ +
Sbjct: 221 RTL 223
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTIALPSM--YNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTIALPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 97.1 bits (240), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTIALPSM--YNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 97.1 bits (240), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTISLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 97.1 bits (240), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTISLPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 70/216 (32%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 38 CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMK 97
CGG LI + +VLTAAHC I+ V LG ++ K E IP
Sbjct: 29 CGGFLIRDDFVLTAAHCWGSSIN------------VTLGAHNI-KEQEPTQQFIPVKRPI 75
Query: 98 VYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ-AGDFYEDQIGIVTGWGTLSYGGP 156
+P ++ +N+ NDI L+QL +KA+ V+P+ LP Q V GWG + G
Sbjct: 76 PHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGK 135
Query: 157 RSDVLMEVPIPVWRLTECRKQFSQNIFDSN--LCAGGYKGGTDSCQGDSGGPLLLQRPDK 214
S L EV + V +C ++ +DS LC G + S +GDSGGPL+ +
Sbjct: 136 HSHTLQEVKMTVQEDRKCESDL-RHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNK--- 191
Query: 215 QWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
G+VS+G G P +V+ ++ WI T K
Sbjct: 192 --VAQGIVSYGRNNGMPPRACTKVSSFVHWIKKTMK 225
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 70/216 (32%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 38 CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMK 97
CGG LI + +VLTAAHC I+ V LG ++ K E IP
Sbjct: 29 CGGFLIQDDFVLTAAHCWGSSIN------------VTLGAHNI-KEQEPTQQFIPVKRPI 75
Query: 98 VYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ-AGDFYEDQIGIVTGWGTLSYGGP 156
+P ++ +N+ NDI L+QL +KA+ V+P+ LP Q V GWG + G
Sbjct: 76 PHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGK 135
Query: 157 RSDVLMEVPIPVWRLTECRKQFSQNIFDSN--LCAGGYKGGTDSCQGDSGGPLLLQRPDK 214
S L EV + V +C ++ +DS LC G + S +GDSGGPL+ +
Sbjct: 136 HSHTLQEVKMTVQEDRKCESDL-RHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNK--- 191
Query: 215 QWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
G+VS+G G P +V+ ++ WI T K
Sbjct: 192 --VAQGIVSYGRNNGMPPRACTKVSSFVHWIKKTMK 225
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 96.3 bits (238), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 75/255 (29%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG LI+ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTIALPSM--YNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGD+GGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWIYNTAK 250
+V+ +L WI + K
Sbjct: 232 TRVSHFLPWIRSHTK 246
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 74/236 (31%), Positives = 105/236 (44%), Gaps = 23/236 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G +N+ P+LVAL C G LIN WVLTAAHC ++ I +
Sbjct: 4 GDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIR------------I 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+LG + + NE + +P + DI L++L + Y++ + PV LP
Sbjct: 52 KLGMHSKNIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPS 111
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDS-NLCAGGY 192
+ I+ GWG +S DV I + + C + DS LCAG
Sbjct: 112 RSRGVGSRCRIM-GWGKISTTT-YPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGIL 169
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGI-GCGK--TPGVYVQVNKYLRWI 245
KGG D+C GDSGGPL+ + G+V+ G CG+ P VY +V Y WI
Sbjct: 170 KGGRDTCHGDSGGPLIC-----NGEMHGIVAGGSEPCGQHLKPAVYTKVFDYNNWI 220
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 95.1 bits (235), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 74/250 (29%), Positives = 116/250 (46%), Gaps = 30/250 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF---CGGVLINERWVLTAAHCI---KQKIDNALVLRR 67
G+ + + + PW A+ R++ + CGG L++ WV++A HC +K D + L R
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGR 63
Query: 68 TSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKK----AQYN 123
+ GE F N D A + + NDIAL+++ K AQ +
Sbjct: 64 SRLNSNTQGEMKFEVENLILHKDYSADTLA---------HHNDIALLKIRSKEGRCAQPS 114
Query: 124 SFVRPVCLPQAGDFYEDQIGI---VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQ 177
++ + LP + + Q G +TG+G + Y P + V + R +
Sbjct: 115 RTIQTIALPSM--YNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 172
Query: 178 FSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVY 235
+ + LCA + TDSCQGDSGGPL+ + T+ G+VSWG GC PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRM-TLTGIVSWGRGCALKDKPGVY 231
Query: 236 VQVNKYLRWI 245
+V+ +L WI
Sbjct: 232 TRVSHFLPWI 241
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 94.7 bits (234), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 117/239 (48%), Gaps = 21/239 (8%)
Query: 14 GQASEVNDWPWLVALKRQYER-DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G+ S + P++ L+ Q + CGG L+ E +VLTAAHC I+
Sbjct: 4 GRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNIN------------ 51
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V LG ++ + T+ I A +P+++++ +NDI L+QLS++ + N V PV LP
Sbjct: 52 VTLGAHNIQRRENTQ-QHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALP 110
Query: 133 QAGD-FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGG 191
+A + + V GWG +S +D L EV + V R +C + F +C G
Sbjct: 111 RAQEGLRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGD 169
Query: 192 YKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
+ + +GDSGGPLL G+VS+G G P V+ +V+ +L WI T +
Sbjct: 170 RRERKAAFKGDSGGPLLCNN-----VAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMR 223
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 94.7 bits (234), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 117/239 (48%), Gaps = 21/239 (8%)
Query: 14 GQASEVNDWPWLVALKRQYER-DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G+ S + P++ L+ Q + CGG L+ E +VLTAAHC I+
Sbjct: 4 GRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNIN------------ 51
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V LG ++ + T+ I A +P+++++ +NDI L+QLS++ + N V PV LP
Sbjct: 52 VTLGAHNIQRRENTQ-QHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALP 110
Query: 133 QAGD-FYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGG 191
+A + + V GWG +S +D L EV + V R +C + F +C G
Sbjct: 111 RAQEGLRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGD 169
Query: 192 YKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNTAK 250
+ + +GDSGGPLL G+VS+G G P V+ +V+ +L WI T +
Sbjct: 170 RRERKAAFKGDSGGPLLCNN-----VAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMR 223
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 94.7 bits (234), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 21/233 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ + V +P+ V+L+ + CG +++ VLTAAHC+ L + L V
Sbjct: 4 GKDAPVGKYPYQVSLR--LSGSHRCGASILDNNNVLTAAHCVDG-------LSNLNRLKV 54
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+G S+ + V D+ A V + + ND+ALV L+ ++N V+P+ L
Sbjct: 55 HVGTNYLSESGD--VYDVEDAV--VNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLST 110
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYK 193
+ E +TGWG+ GG + L E+ + V +C + + DS++C K
Sbjct: 111 NDEDLESNPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERD-QWRVIDSHICT-LTK 168
Query: 194 GGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG-KTPGVYVQVNKYLRWI 245
G +C GDSGGPL+ IG+VS+G C P VY +V+ ++ WI
Sbjct: 169 RGEGACHGDSGGPLV-----ANGAQIGIVSFGSPCALGEPDVYTRVSSFVSWI 216
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 32/248 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + PW AL E + FC GVL++ +WVL+AAHC + +
Sbjct: 1 IINGEDCSPHSQPWQAALVM--ENELFCSGVLVHPQWVLSAAHCFQ------------NS 46
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
+ LG + E + A+ +P ++ ND+ L++L + + +R +
Sbjct: 47 YTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSIS 106
Query: 131 L----PQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
+ P AG+ +V+GWG L+ G VL V + V C K + S
Sbjct: 107 IASQCPTAGNSC-----LVSGWGLLA-NGRMPTVLQCVNVSVVSEEVCSKLYDPLYHPSM 160
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGK--TPGVYVQVNKYLR 243
CAGG + DSC GDSGGPL+ + G+VS+G CG+ PGVY + K+
Sbjct: 161 FCAGGGQDQKDSCNGDSGGPLICNG-----YLQGLVSFGKAPCGQVGVPGVYTNLCKFTE 215
Query: 244 WIYNTAKV 251
WI T +
Sbjct: 216 WIEKTVQA 223
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++N+ P+L L Y FCG LIN+ WV+TAAHC +++ +
Sbjct: 4 GDECDINEHPFLAFL---YSHGYFCGLTLINQEWVVTAAHC------------DSTNFQM 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+LG + +NE + T P + + + DI L++L K + + P+ LP
Sbjct: 49 QLGVHSKKVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLP- 107
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ + + GWG+++ DV I + C+ ++ + LCAG
Sbjct: 108 SNPPSVGSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTTLCAGVL 167
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
+GG D+C GDSGGPL+ + Q+ G+VS+G G G PG+Y V Y WI
Sbjct: 168 EGGKDTCVGDSGGPLIC---NGQFQ--GIVSYGAHSCGQGPKPGIYTNVFDYTDWI 218
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G +N+ +LVAL R FCGG LIN+ WVLTAAHC ++ + +
Sbjct: 4 GDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRK------------NFRI 51
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNY---ENDIALVQLSKKAQYNSFVRPVC 130
+LG + NE + T +P S +NY + DI L++L + + + P
Sbjct: 52 KLGMHSKKVPNEDEQTRVPKEKFFC---LSSKNYTLWDKDIMLIRLDSPVKNSKHIAPF- 107
Query: 131 LPQAGDFYEDQIGIVTGWGTLS-YGGPRSDVLMEVPIPVWRLTECRK---QFSQNIFDSN 186
+ + + GWG +S G DV V I + CR +F
Sbjct: 108 SLPSSPPSVGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRT 167
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGKT--PGVYVQVNKYLR 243
LCAG +GG D+C+GDSGGPL+ G+ SWG C + P Y +V +L
Sbjct: 168 LCAGILEGGKDTCKGDSGGPLICNG-----QFQGIASWGDDPCAQPHKPAAYTKVFDHLD 222
Query: 244 WIYN 247
WI N
Sbjct: 223 WIEN 226
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 77/258 (29%), Positives = 112/258 (43%), Gaps = 50/258 (19%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKI-----------DNA 62
G E N PW VA+ +Y CGGVLI+ WV+TAAHC D
Sbjct: 4 GYKCEKNSQPWQVAVINEY----LCGGVLIDPSWVITAAHCYSNNYQVLLGRNNLFKDEP 59
Query: 63 LVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQY 122
RR R D+ + T T+ P ++ ND+ L+ LS+ A
Sbjct: 60 FAQRRLVRQSFR--HPDYIPLIVTNDTEQPV-----------HDHSNDLMLLHLSEPADI 106
Query: 123 NSFVRPVCLPQAGDFYEDQIG---IVTGWGTLSYGGPRSDVLME----VPIPVWRLTECR 175
V+ + LP E ++G + +GWG+ + P V+ V I + +C
Sbjct: 107 TGGVKVIDLPTK----EPKVGSTCLASGWGSTN---PSEMVVSHDLQCVNIHLLSNEKCI 159
Query: 176 KQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG-IGCG--KTP 232
+ + N+ D LCAG +GG D+C GDSGGPL+ + G+ S G C KTP
Sbjct: 160 ETYKDNVTDVMLCAGEMEGGKDTCAGDSGGPLICDG-----VLQGITSGGATPCAKPKTP 214
Query: 233 GVYVQVNKYLRWIYNTAK 250
+Y ++ K+ WI K
Sbjct: 215 AIYAKLIKFTSWIKKVMK 232
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 88.6 bits (218), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 30/232 (12%)
Query: 24 WLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKV 83
W+V+L+ Y + CGG LI E WVLTA C R D LG +D
Sbjct: 13 WMVSLR--YRNKHICGGSLIKESWVLTARQCFPS--------RDLKDYEAWLGIHDVHGR 62
Query: 84 NETKVTDIPAAAMKVY-PRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
+ K + + VY P S D+ L++L++ A + FV + LP G ++
Sbjct: 63 GDEKCKQVLNVSQLVYGPEGS------DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKT 116
Query: 143 GI-VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIF--DSNLCAGGYKGGT 196
V GWG ++Y G +L + + +C + + +S +CAG K G+
Sbjct: 117 SCSVYGWGYTGLINYDG----LLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGS 172
Query: 197 DSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIY 246
C+GD GGPL+ ++ K ++GV+ G GC PG++V+V Y +WI+
Sbjct: 173 GPCEGDYGGPLVCEQ-HKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIH 223
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 88.6 bits (218), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 30/232 (12%)
Query: 24 WLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKV 83
W+V+L+ Y + CGG LI E WVLTA C R D LG +D
Sbjct: 13 WMVSLR--YRNKHICGGSLIKESWVLTARQCFPS--------RDLKDYEAWLGIHDVHGR 62
Query: 84 NETKVTDIPAAAMKVY-PRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQI 142
+ K + + VY P S D+ L++L++ A + FV + LP G ++
Sbjct: 63 GDEKCKQVLNVSQLVYGPEGS------DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKT 116
Query: 143 GI-VTGWG---TLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIF--DSNLCAGGYKGGT 196
V GWG ++Y G +L + + +C + + +S +CAG K G+
Sbjct: 117 SCSVYGWGYTGLINYDG----LLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGS 172
Query: 197 DSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWIY 246
C+GD GGPL+ ++ K ++GV+ G GC PG++V+V Y +WI+
Sbjct: 173 GPCEGDYGGPLVCEQ-HKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIH 223
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G +N+ +L + Y + CGG LIN+ WVLTA HC + ++ +
Sbjct: 4 GDECNINEHRFLALV---YANGSLCGGTLINQEWVLTARHCDR------------GNMRI 48
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
LG ++ +N+ + P ++ ++ DI L++L++ + ++ + P+ LP
Sbjct: 49 YLGMHNLKVLNKDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLP- 107
Query: 134 AGDFYEDQIGIVTGWGTL-SYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGY 192
+ + + GWGT+ S DV I + C+ + + + + LCAG
Sbjct: 108 SNPPSVGSVCRIMGWGTITSPNATLPDVPHCANINILDYAVCQAAY-KGLAATTLCAGIL 166
Query: 193 KGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG--KTPGVYVQVNKYLRWI 245
+GG D+C+GDSGGPL+ + +G G C + PG+Y +V Y WI
Sbjct: 167 EGGKDTCKGDSGGPLICNGQFQGILSVG----GNPCAQPRKPGIYTKVFDYTDWI 217
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 86.3 bits (212), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 35 DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAA 94
FCGG LI +VLTAAHC + I V LG ++ ++ +T +
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGRSI------------TVTLGAHNITEEEDT-WQKLEVI 73
Query: 95 AMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED-QIGIVTGWGTLSY 153
+P+++ +DI L++L +KA V + P +F ++ V GWG
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGV 133
Query: 154 GGPRSDVLMEVPIPVWRLTECR--KQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQR 211
P SD L EV + + C + F N+ LC G + + +GDSGGPLL
Sbjct: 134 LKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSAFKGDSGGPLLCAG 190
Query: 212 PDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
+ G+VS+G K P V+ +++ Y WI
Sbjct: 191 AAQ-----GIVSYGRSDAKPPAVFTRISHYQPWI 219
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 26/237 (10%)
Query: 14 GQASEVNDWPWLVALKRQYER--DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G S+ + P++ L+ FCGG LI +VLTAAHC + I
Sbjct: 4 GTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSI------------ 51
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
V LG ++ ++ +T + +P+++ +DI L++L +KA V +
Sbjct: 52 TVTLGAHNITEEEDT-WQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPF 110
Query: 132 PQAGDFYED-QIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECR--KQFSQNIFDSNLC 188
P +F ++ V GWG P SD L EV + + C + F N+ LC
Sbjct: 111 PSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLC 167
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
G + + +GDSGGPLL G+VS+G K P V+ +++ Y WI
Sbjct: 168 VGNPRKTKSAFKGDSGGPLLC-----AGVAQGIVSYGRSDAKPPAVFTRISHYRPWI 219
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/244 (26%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 14 GQASEVNDWPWLVALKRQYER-DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G + ++PW ++ +RQ + CG L++ L+A+HC+ + N ++
Sbjct: 4 GTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPN--------NIR 55
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
V G + S + T+ ++ + M +Y NDIA++ L+ ++ LP
Sbjct: 56 VIAGLWQQSDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLP 115
Query: 133 -QAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQF----SQNIFDSNL 187
+ Y +++GWG D+L + IPV +C NI+D+++
Sbjct: 116 ANNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNHI 175
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG------KTPGVYVQVNKY 241
C G T +C GDSGGP L PD ++GV SW + G P VY +V+ Y
Sbjct: 176 CVQDPAGNTGACNGDSGGP--LNCPDGGTRVVGVTSWVVSSGLGACLPDYPSVYTRVSAY 233
Query: 242 LRWI 245
L WI
Sbjct: 234 LGWI 237
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 71/230 (30%), Positives = 104/230 (45%), Gaps = 25/230 (10%)
Query: 20 NDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYD 79
N WP AL + FCGG LI+ W+LTAAHC +D A + V LG ++
Sbjct: 10 NSWPHQAALF--IDDMYFCGGSLISPEWILTAAHC----MDGAGFVD------VVLGAHN 57
Query: 80 FSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYE 139
+ T+VT I + V+ ++ NDIA+++L + + V LP D
Sbjct: 58 IREDEATQVT-IQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPST-DVGV 115
Query: 140 DQIGIVTGWGTLSYGG-PRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDS 198
+ TGWG S SDVL +V +P+ +C + + D N+C GG +
Sbjct: 116 GTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGI-VTDGNICIDS-TGGKGT 173
Query: 199 CQGDSGGPLLLQRPDKQWTIIGVVSWGIGCG---KTPGVYVQVNKYLRWI 245
C GDSGGPL + G+ S+G G P + +V +L WI
Sbjct: 174 CNGDSGGPL-----NYNGLTYGITSFGAAAGCEAGYPDAFTRVTYFLDWI 218
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 35 DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAA 94
FCGG LI +VLTAAHC + I V LG ++ ++ +T +
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGRSI------------TVTLGAHNITEEEDT-WQKLEVI 73
Query: 95 AMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED-QIGIVTGWGTLSY 153
+P+++ +DI L++L +KA V + P +F ++ V GWG
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGV 133
Query: 154 GGPRSDVLMEVPIPVWRLTECR--KQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQR 211
P SD L EV + + C + F N+ LC G + + +GDSGGPLL
Sbjct: 134 LKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSAFKGDSGGPLLCAG 190
Query: 212 PDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
+ G+VS+G K P V+ +++ Y WI
Sbjct: 191 AAQ-----GIVSYGRSDAKPPAVFTRISHYQPWI 219
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 25/233 (10%)
Query: 20 NDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYD 79
+ P++ +L+R + CGGVL++ +WVLTAAHC+ Q R + L + LG +
Sbjct: 10 HSRPYMASLQRNGS--HLCGGVLVHPKWVLTAAHCLAQ---------RMAQLRLVLGLHT 58
Query: 80 FSKVNETKVTDIPAAAMKVYPRFSE-QNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFY 138
T I AA +PR+ END+AL+QL K + + +RP+ LP
Sbjct: 59 LDSPGLT--FHIKAAIQ--HPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVV 114
Query: 139 EDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVW--RLTECRKQFSQNIFDSNLCAGGYKGG 195
+ GWG GG S VL E+ + V R+ + ++ ++ S +C
Sbjct: 115 AAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKD 174
Query: 196 TDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK---TPGVYVQVNKYLRWI 245
C+GDSGGPL+ K + GV+S+ P V V Y+ WI
Sbjct: 175 QAPCKGDSGGPLVC---GKGRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWI 224
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 85.1 bits (209), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 35 DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAA 94
FCGG LI +VLTAAHC + I V LG ++ ++ +T +
Sbjct: 29 SKFCGGFLIRRNFVLTAAHCAGRSI------------TVTLGAHNITEEEDT-WQKLEVI 75
Query: 95 AMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED-QIGIVTGWGTLSY 153
+P+++ +DI L++L +KA V + P +F ++ V GWG
Sbjct: 76 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGV 135
Query: 154 GGPRSDVLMEVPIPVWRLTECR--KQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQR 211
P SD L EV + + C + F N+ LC G + + +GDSGGPLL
Sbjct: 136 LKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSAFKGDSGGPLLC-- 190
Query: 212 PDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
G+VS+G K P V+ +++ Y WI
Sbjct: 191 ---AGVAQGIVSYGRSDAKPPAVFTRISHYRPWI 221
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 35 DNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAA 94
FCGG LI +VLTAAHC + I V LG ++ ++ +T +
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGRSI------------TVTLGAHNITEEEDT-WQKLEVI 73
Query: 95 AMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYED-QIGIVTGWGTLSY 153
+P+++ +DI L++L +KA V + P +F ++ V GWG
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGV 133
Query: 154 GGPRSDVLMEVPIPVWRLTECR--KQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQR 211
P SD L EV + + C + F N+ LC G + + +GDSGGPLL
Sbjct: 134 LKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSAFKGDSGGPLLC-- 188
Query: 212 PDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
G+VS+G K P V+ +++ Y WI
Sbjct: 189 ---AGVAQGIVSYGRSDAKPPAVFTRISHYRPWI 219
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 84.3 bits (207), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 31/240 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++N+ +LVA FCGG LIN WV+TAAHC ++D +
Sbjct: 4 GNECDINEHRFLVAFFNTTGF--FCGGTLINPEWVVTAAHC------------DSTDFQM 49
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+LG + +NE + T P + + + + DI L++L K + + P+
Sbjct: 50 QLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPL-SLP 108
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVP----IPVWRLTECRKQFSQNIFD-SNLC 188
+ + + GWG+++ P + +VP I + C+ + + + + LC
Sbjct: 109 SSPPSVGSVCRIMGWGSIT---PVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLC 165
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
AG +GG D+C GDSGGPL+ + Q+ G+VS+G G G PG+Y V Y WI
Sbjct: 166 AGIVQGGKDTCGGDSGGPLIC---NGQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWI 220
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 84.0 bits (206), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 11/146 (7%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC-IKQKIDNALVLRRTS 69
I +GQ +EV PW V L R+ ++ CG LI++RWVLTAAHC + D +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTV---D 57
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAA-AMKVYPRFS-EQNYENDIALVQLSKKAQYNSFVR 127
DL+VR+G++ ++ E KV I + ++PR++ ++N + DIAL++L + + + ++
Sbjct: 58 DLLVRIGKHSRTRY-ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 116
Query: 128 PVCLPQ----AGDFYEDQIGIVTGWG 149
PVCLP A + G VTGWG
Sbjct: 117 PVCLPDKQTAAKLLHAGFKGRVTGWG 142
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 25/233 (10%)
Query: 20 NDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYD 79
+ P++ +L+R + CGGVL++ +WVLTAAHC+ Q R + L + LG +
Sbjct: 10 HSRPYMASLQRNGS--HLCGGVLVHPKWVLTAAHCLAQ---------RMAQLRLVLGLHT 58
Query: 80 FSKVNETKVTDIPAAAMKVYPRFSE-QNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFY 138
T I AA +PR+ EN++AL+QL K + + +RP+ LP
Sbjct: 59 LDSPGLT--FHIKAAIQ--HPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVV 114
Query: 139 EDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVW--RLTECRKQFSQNIFDSNLCAGGYKGG 195
+ GWG GG S VL E+ + V R+ + ++ ++ S +C
Sbjct: 115 AAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKD 174
Query: 196 TDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK---TPGVYVQVNKYLRWI 245
C+GDSGGPL+ K + GV+S+ P V V Y+ WI
Sbjct: 175 QAPCKGDSGGPLVC---GKGRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWI 224
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 52/144 (36%), Positives = 74/144 (51%), Gaps = 14/144 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + WPW V+L+ + +FCGG LINE WV+TAAHC TSD
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGF-HFCGGSLINENWVVTAAHC----------GVTTSD 49
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
++V GE+D +E K+ + A + +++ NDI L++LS A ++ V VC
Sbjct: 50 VVVA-GEFDQGSSSE-KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVC 107
Query: 131 LPQAG-DFYEDQIGIVTGWGTLSY 153
LP A DF + TGWG Y
Sbjct: 108 LPSASDDFAAGTTCVTTGWGLTRY 131
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 33/241 (13%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF-CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G +N+ LV L + + F CGG LIN+ WV+TAAHC +++
Sbjct: 4 GDECNINEHRSLVVL---FNSNGFLCGGTLINQDWVVTAAHC------------DSNNFQ 48
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
+ G + +NE + T P R + + DI L++L + + P+
Sbjct: 49 LLFGVHSKKILNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPL-SL 107
Query: 133 QAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVP----IPVWRLTECRKQFS-QNIFDSNL 187
+ + + GWG P ++ +VP I + CR +S + + ++ L
Sbjct: 108 PSSPPSVGSVCRIMGWGKTI---PTKEIYPDVPHCANINILDHAVCRTAYSWRQVANTTL 164
Query: 188 CAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW-GIGCGK--TPGVYVQVNKYLRW 244
CAG +GG D+C DSGGPL+ G+VSW G CG+ PGVY +V YL W
Sbjct: 165 CAGILQGGRDTCHFDSGGPLICNG-----IFQGIVSWGGHPCGQPGEPGVYTKVFDYLDW 219
Query: 245 I 245
I
Sbjct: 220 I 220
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 68/240 (28%), Positives = 112/240 (46%), Gaps = 31/240 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G ++N+ +LVA FCGG LIN WV+TAAHC +++ +
Sbjct: 4 GNECDINEHRFLVAFFNTTGF--FCGGTLINPEWVVTAAHC------------DSTNFQM 49
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+LG + +NE + T P + + + + DI L++L K + + P+
Sbjct: 50 QLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPL-SLP 108
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVP----IPVWRLTECRKQFSQNIFD-SNLC 188
+ + + GWG+++ P + +VP I + C+ + + + + LC
Sbjct: 109 SSPPSVGSVCRIMGWGSIT---PVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLC 165
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
AG +GG D+C GDSGGPL+ + Q+ G+VS+G G G PG+Y V Y WI
Sbjct: 166 AGIVQGGKDTCGGDSGGPLIC---NGQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWI 220
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 82.4 bits (202), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 19/152 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI------KQKIDNALV 64
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ K +N
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN--- 57
Query: 65 LRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFS-EQNYENDIALVQLSKKAQYN 123
DL+VR+G++ ++ + ++PR++ +N + DIAL++L K ++
Sbjct: 58 -----DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 124 SFVRPVCLPQ----AGDFYEDQIGIVTGWGTL 151
++ PVCLP A G VTGWG L
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNL 144
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 73/248 (29%), Positives = 115/248 (46%), Gaps = 32/248 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G E + PW V + + CGGVL++ +WVLTAAHCI+ K + ++L R S
Sbjct: 4 GWECEKHSQPWQVLVASRGR--AVCGGVLVHPQWVLTAAHCIRNK--SVILLGRHS---- 55
Query: 74 RLGEYDFSKVNETKVT-DIPAAAMKVYP-RFSE--QNYENDIALVQLSKKAQYNSFVRPV 129
D +V + + P M + RF + +D+ L++LS+ A+ V+ +
Sbjct: 56 LFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVM 115
Query: 130 CLPQAGDFYEDQIGIV---TGWGTLS---YGGPRSDVLMEVPIPVWRLTECRKQFSQNIF 183
LP E +G +GWG++ + P+ L V + V C + Q +
Sbjct: 116 DLPTQ----EPALGTTCYASGWGSIEPEEFLTPKK--LQCVDLHVISNDVCAQVHPQKVT 169
Query: 184 DSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNK 240
LCAG + GG +C GDSGGPL+ + G+ SWG + P +Y +V
Sbjct: 170 KFMLCAGRWTGGKSTCSGDSGGPLVCNG-----VLQGITSWGSEPCALPERPSLYTKVVH 224
Query: 241 YLRWIYNT 248
Y +WI +T
Sbjct: 225 YRKWIKDT 232
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 79.7 bits (195), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 31/240 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G +N+ LVA FC G LINE WVLTAAHC DN ++ +
Sbjct: 4 GDECNINEHRSLVAFFNS--TGFFCSGTLINEEWVLTAAHC-----DN-------TNFQM 49
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
+LG + +NE + T P + +++ + DI L++L + + + P+
Sbjct: 50 KLGVHSKKVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPL-SLP 108
Query: 134 AGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVP----IPVWRLTECRKQFSQNIFD-SNLC 188
+ + + GWG+++ P +VP I + C+ + + + + LC
Sbjct: 109 SSPPSVGSVCHIMGWGSIT---PIKVTYPDVPYCAYINLLDDAVCQAGYPELLTEYRTLC 165
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWG---IGCGKTPGVYVQVNKYLRWI 245
AG +GG D+C GDSGGPL+ + Q+ G+VS+G G G PGVY +V Y WI
Sbjct: 166 AGILEGGKDTCGGDSGGPLIC---NGQFQ--GIVSFGAHPCGQGLKPGVYTKVFDYNHWI 220
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 28 LKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETK 87
+ Q +R +CGG LI+ +W+LTAAHC+ + ++V LG S V
Sbjct: 20 ITLQDQRRVWCGGSLIDNKWILTAAHCVHDAV----------SVVVYLG----SAVQYEG 65
Query: 88 VTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDF---YEDQIGI 144
+ + + + F+ Y ND+AL+++ +Y ++P+ LP + +E+
Sbjct: 66 EAVVNSERIISHSMFNPDTYLNDVALIKI-PHVEYTDNIQPIRLPSGEELNNKFENIWAT 124
Query: 145 VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSG 204
V+GWG + +L V C +++ I + G G C GDSG
Sbjct: 125 VSGWGQ---SNTDTVILQYTYNLVIDNDRCAQEYPPGIIVESTICGDTSDGKSPCFGDSG 181
Query: 205 GPLLLQRPDKQWTIIGVVSW--GIGC--GKTPGVYVQVNKYLRWI 245
GP +L DK +IGVVS+ G GC GK G + +V Y+ WI
Sbjct: 182 GPFVLS--DKN-LLIGVVSFVSGAGCESGKPVG-FSRVTSYMDWI 222
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 79.0 bits (193), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 22/235 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERD--NFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDL 71
G S + P++ L E+ CGG LI+ ++VLTAAHC + ++
Sbjct: 4 GVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHC------------KGREI 51
Query: 72 IVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL 131
V LG +D K E+ I ++ ++ +DI L++L KK + V V L
Sbjct: 52 TVILGAHDVRK-RESTQQKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPL 110
Query: 132 PQAGDF-YEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAG 190
P DF + + GWG P S L EV + + C + + +C G
Sbjct: 111 PSPSDFIHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKAC-VDYRYYEYKFQVCVG 169
Query: 191 GYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
+ GDSGGPLL G+VS+G K P ++ +V+ Y+ WI
Sbjct: 170 SPTTLRAAFMGDSGGPLLC-----AGVAHGIVSYGHPDAKPPAIFTRVSTYVPWI 219
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 50/141 (35%), Positives = 74/141 (52%), Gaps = 14/141 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ + WPW V+L+ + +FCGG LI+E WV+TAAHC +TSD++V
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGF-HFCGGSLISEDWVVTAAHC----------GVKTSDVVV 49
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQ 133
GE+D +E + + A + P+F+ NDI L++L+ AQ++ V VCLP
Sbjct: 50 A-GEFD-QGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPN 107
Query: 134 A-GDFYEDQIGIVTGWGTLSY 153
DF + TGWG Y
Sbjct: 108 VDDDFPPGTVCATTGWGKTKY 128
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 78.2 bits (191), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 23/242 (9%)
Query: 11 IDKGQASEVNDWPWLVALK-RQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTS 69
I G ++ + P++ +L+ R +FCGG LI+ +VLTAAHC++ + +R
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRD------IPQRLV 54
Query: 70 DLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPV 129
+++ LG ++ T+ + A + +N NDI L+QLS A ++ V V
Sbjct: 55 NVV--LGAHNVRTQEPTQQHF--SVAQVFLNNYDAENKLNDILLIQLSSPANLSASVATV 110
Query: 130 CLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LPQ + GWG + P + VL E+ + V CR N+C
Sbjct: 111 QLPQQDQPVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTFF-CRPH--------NIC 161
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKTPGVYVQVNKYLRWIYNT 248
+ C GDSGGPL+ + I V WG P + +V Y+ WI +T
Sbjct: 162 TFVPRRKAGICFGDSGGPLICDGIIQ--GIDSFVIWGCATRLFPDFFTRVALYVDWIRST 219
Query: 249 AK 250
+
Sbjct: 220 LR 221
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 26/237 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + +P+L +++ Q +FCGG LI+ R+V+TAA C + +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGR--HFCGGALIHARFVMTAASCFQSQNPGVST------ 52
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
V LG YD + ++M +QN ND+ L+QL ++A S V +
Sbjct: 53 --VVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNL-NDLMLLQLDREANLTSSVTILP 109
Query: 131 LPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP E V GWG+ GG S V + V +CR +N+C
Sbjct: 110 LPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP--------NNVCT 161
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGKTPGVYVQVNKYLRWI 245
G C GD G PL+ + GV S+ +G CG+ P + +V + WI
Sbjct: 162 GVLTRRGGICNGDQGTPLVC-----EGLAHGVASFSLGPCGRGPDFFTRVALFRDWI 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 26/237 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + +P+L +++ Q +FCGG LI+ R+V+TAA C + +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGR--HFCGGALIHARFVMTAASCFQSQNPGVST------ 52
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
V LG YD + ++M +QN ND+ L+QL ++A S V +
Sbjct: 53 --VVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNL-NDLMLLQLDREANLTSSVTILP 109
Query: 131 LPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP E V GWG+ GG S V + V +CR +N+C
Sbjct: 110 LPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP--------NNVCT 161
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGKTPGVYVQVNKYLRWI 245
G C GD G PL+ + GV S+ +G CG+ P + +V + WI
Sbjct: 162 GVLTRRGGICNGDGGTPLVC-----EGLAHGVASFSLGPCGRGPDFFTRVALFRDWI 213
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 17/139 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G N P+ V+L +FCGG LIN +WV++AAHC K +I
Sbjct: 1 IVGGYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYKSRIQ---------- 47
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
VRLGE++ V E I AA + +P F+ +NDI L++LS A NS V V
Sbjct: 48 --VRLGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVS 104
Query: 131 LPQAGDFYEDQIGIVTGWG 149
LP++ + +++GWG
Sbjct: 105 LPRSCAAAGTEC-LISGWG 122
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 50/144 (34%), Positives = 74/144 (51%), Gaps = 14/144 (9%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + WPW V+L+ + +FCGG LI+E WV+TAAHC +TSD
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGF-HFCGGSLISEDWVVTAAHC----------GVKTSD 49
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
++V GE+D +E + + A + P+F+ NDI L++L+ AQ++ V V
Sbjct: 50 VVVA-GEFD-QGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVS 107
Query: 131 LPQA-GDFYEDQIGIVTGWGTLSY 153
LP DF + TGWG Y
Sbjct: 108 LPNVDDDFPPGTVCATTGWGKTKY 131
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 74.7 bits (182), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 38 CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMK 97
C G LI +V+TAAHC + I V LG ++ KV E +
Sbjct: 30 CSGFLIRRNFVMTAAHCAGRSI------------TVLLGAHN-KKVKEDTWQKLEVEKQF 76
Query: 98 VYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL-PQAGDFYEDQIGIVTGWGTLSYGGP 156
+P++ ++ NDI L++L +KA V + + ++ ++ GWG + P
Sbjct: 77 PHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISAKSNSIPPGRVCRAVGWGRTNVNEP 136
Query: 157 RSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQW 216
SD L EV + + C K F + LC G K + +GDSGGPLL
Sbjct: 137 PSDTLQEVKMRILDPQAC-KHFEDFHQEPQLCVGNPKKIRNVYKGDSGGPLLC-----AG 190
Query: 217 TIIGVVSWGIGCGKTPGVYVQVNKYLRWI 245
G+ S+ + K P V+ +++ Y WI
Sbjct: 191 IAQGIASYVLRNAKPPSVFTRISHYRPWI 219
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 74.3 bits (181), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 23/235 (9%)
Query: 23 PWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIVRLGE-YDFS 81
PW V+L R + +FCGG L+ E+W+LTA C + V LG +
Sbjct: 10 PWTVSL-RNRQGQHFCGGSLVKEQWILTARQCFSS------CHMPLTGYEVWLGTLFQNP 62
Query: 82 KVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQ 141
+ E + +P A M P S+ + L++L + N V +CLP ++Y
Sbjct: 63 QHGEPSLQRVPVAKMVCGPSGSQ------LVLLKLERSVTLNQRVALICLPP--EWYVVP 114
Query: 142 IGI---VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDS 198
G + GWG + G VL + V EC + + +S +C G +
Sbjct: 115 PGTKCEIAGWGE-TKGTGNDTVLNVALLNVISNQECNIKHRGRVRESEMCTEGLLAPVGA 173
Query: 199 CQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGKT--PGVYVQVNKYLRWIYNTAKV 251
C+GD GGPL W + G++ C ++ P V+ +V+ ++ WI+ ++
Sbjct: 174 CEGDYGGPLACFT-HNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWIHKVMRL 227
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 74.3 bits (181), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 73/275 (26%), Positives = 109/275 (39%), Gaps = 63/275 (22%)
Query: 7 QTAKIDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLR 66
Q +I G +PW + + + G LINE+W+LT A +
Sbjct: 99 QVQRIMGGSLDAKGSFPWQAKMISHHNLTS--GATLINEQWLLTTAKNL----------- 145
Query: 67 RTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPR-----------FSEQNYENDIALVQ 115
RLG N+TK DI A +++Y F N DI L++
Sbjct: 146 -------RLGHK-----NDTKAKDI-APTLRLYVGKKQEVEIEKVIFHPDNSTVDIGLIK 192
Query: 116 LSKKAQYNSFVRPVCLPQAGDFYEDQIGIVTGWG---TLSYGGPRSDVLMEVPIPVWRLT 172
L +K N V P+CLP +G V+GWG L++ ++ L V +PV
Sbjct: 193 LKQKVPVNERVMPICLPSKDYVNVGLVGYVSGWGRNANLNF----TEHLKYVMLPVADQE 248
Query: 173 ECRKQFS----------------QNIFDSN-LCAGGYKGGTDSCQGDSGGPLLLQ-RPDK 214
+C + + Q I + + CAG K D+C GD+G + + D
Sbjct: 249 KCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKDDD 308
Query: 215 QWTIIGVVSWGIGCGKTP-GVYVQVNKYLRWIYNT 248
W G++S+ C GVYV+V L WI T
Sbjct: 309 TWYAAGILSFDKSCRTAEYGVYVRVTSILDWIQTT 343
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 74.3 bits (181), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/237 (27%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + +P+L +++ Q + CGG LI+ R+V+TAA C + +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHE--CGGALIHARFVMTAASCFQSQNPGVST------ 52
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
V LG YD + ++M +QN ND+ L+QL ++A S V +
Sbjct: 53 --VVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNL-NDLMLLQLDREANLTSSVTILP 109
Query: 131 LPQAGDFYEDQIGI-VTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP E V GWG+ GG S V + V +CR +N+C
Sbjct: 110 LPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP--------NNVCT 161
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGKTPGVYVQVNKYLRWI 245
G C GD G PL+ + GV S+ +G CG+ P + +V + WI
Sbjct: 162 GVLTRRGGICNGDGGTPLVC-----EGLAHGVASFSLGPCGRGPDFFTRVALFRDWI 213
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/245 (26%), Positives = 115/245 (46%), Gaps = 29/245 (11%)
Query: 14 GQASEVNDWPWLVALKRQY--ERDNFCGGVLINERWVLTAAHCI-KQKIDNALVLRRTSD 70
G+ +++ PW VA+ R Y E CGG ++++ +VLTAAHC+ QK + ++ +++
Sbjct: 3 GEKTDIKQVPWTVAV-RTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVIQYESTN 61
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSF-VRPV 129
L G+ D P + + ++ ENDIA+++LS+ + + +P
Sbjct: 62 LWEDPGKSD------------PYVSHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPA 109
Query: 130 CLPQAGDFYEDQIG---IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSN 186
LP + + G +V+G+G P+ L + V L ECR ++ IF S
Sbjct: 110 KLPDIE--FRPKTGSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECRTKYG-PIFLSL 166
Query: 187 LCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGCGK-TPGVYVQVNKYLRWI 245
K G GD+G P + +Q T++GV ++ + P V+ +V Y+ WI
Sbjct: 167 QVFCAQKVGVSLESGDAGDPTV-----QQDTLVGVAAYFPKRPEGAPEVFTKVGSYVSWI 221
Query: 246 YNTAK 250
+ K
Sbjct: 222 QDIIK 226
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 71.2 bits (173), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 38/87 (43%), Positives = 51/87 (58%), Gaps = 5/87 (5%)
Query: 161 LMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIG 220
L + +P+ +C+K + I D CAG G DSC GDSGGPL+ Q+ D WT+ G
Sbjct: 9 LQQAALPIVSEADCKKSWGSKITDVMTCAGAS--GVDSCMGDSGGPLVCQK-DGVWTLAG 65
Query: 221 VVSWGIG-CG-KTPGVYVQVNKYLRWI 245
+VSWG G C TPGVY +V + W+
Sbjct: 66 IVSWGSGVCSTSTPGVYSRVTALMPWV 92
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 69/253 (27%), Positives = 116/253 (45%), Gaps = 42/253 (16%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF-CGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLI 72
G E + PW VA+ Y + +F CGGVL++ +WVLTAAHC+ + D
Sbjct: 4 GWECEKHSKPWQVAV---YHQGHFQCGGVLVHPQWVLTAAHCM------------SDDYQ 48
Query: 73 VRLGEYDFSKVNET----KVTDI---PAAAMKVYPRFSEQNYE---NDIALVQLSKKAQY 122
+ LG ++ SK +T +V+D P + + + + Y+ +D+ L++L++ A+
Sbjct: 49 IWLGRHNLSKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARI 108
Query: 123 NSFVRPVCLPQAGDFYEDQIG---IVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECRKQF 178
V+ + LP E ++G +GWG +S R S L V + + +C + +
Sbjct: 109 TDAVKILDLPTQ----EPKLGSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCARAY 164
Query: 179 SQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIG-CGKTPG--VY 235
+ + + LCA C GDSGG L+ G+ SWG C V+
Sbjct: 165 PEKMTEFVLCATHRDDSGSICLGDSGGALICDG-----VFQGITSWGYSECADFNDNFVF 219
Query: 236 VQVNKYLRWIYNT 248
+V + +WI T
Sbjct: 220 TKVMPHKKWIKET 232
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 159 DVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTI 218
D L + +P+ T C+K + I D+ +CAG G SC GDSGGPL+ ++ + WT+
Sbjct: 5 DRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKK-NGAWTL 61
Query: 219 IGVVSWGIG-CG-KTPGVYVQVNKYLRWIYNT 248
+G+VSWG C TPGVY +V + W+ T
Sbjct: 62 VGIVSWGSSTCSTSTPGVYARVTALVNWVQQT 93
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 159 DVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTI 218
D L + +P+ T C+K + I D+ +CAG G SC GDSGGPL+ ++ + WT+
Sbjct: 4 DRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKK-NGAWTL 60
Query: 219 IGVVSWGIG-CG-KTPGVYVQVNKYLRWIYNT 248
+G+VSWG C TPGVY +V + W+ T
Sbjct: 61 VGIVSWGSSTCSTSTPGVYARVTALVNWVQQT 92
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 37/87 (42%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 161 LMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIG 220
L + +P+ +C+K + I D CAG G DSC GDSGGPL+ Q+ D WT+ G
Sbjct: 9 LQQAALPIVSEADCKKSWGSKITDVMTCAGAS--GVDSCMGDSGGPLVCQK-DGVWTLAG 65
Query: 221 VVSWGIG-CG-KTPGVYVQVNKYLRWI 245
+VSWG G C TP VY +V + W+
Sbjct: 66 IVSWGSGVCSTSTPAVYSRVTALMPWV 92
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + + WP++V+L Q +FCG LI +V++AAHC+
Sbjct: 1 IVGGRRARPHAWPFMVSL--QLRGGHFCGATLIAPNFVMSAAHCVANV--------NVRA 50
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPR-FSEQNYENDIALVQLSKKAQYNSFVRPV 129
+ V LG ++ S+ T+ A +++ + N NDI ++QL+ A N+ V+
Sbjct: 51 VRVVLGAHNLSRREPTRQV---FAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVA 107
Query: 130 CLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP G + + + GWG L + VL E+ + V + CR+ SN+C
Sbjct: 108 QLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRR--------SNVC 158
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW---GIGCGKTPGVYVQVNKYLRWI 245
C GDSG PL+ I G+ S+ G G P + V +++ WI
Sbjct: 159 TLVRGRQAGVCFGDSGSPLVC-----NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 68.2 bits (165), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + + WP++V+L Q +FCG LI +V++AAHC+
Sbjct: 1 IVGGRRARPHAWPFMVSL--QLRGGHFCGATLIAPNFVMSAAHCVANV--------NVRA 50
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPR-FSEQNYENDIALVQLSKKAQYNSFVRPV 129
+ V LG ++ S+ T+ A +++ + N NDI ++QL+ A N+ V+
Sbjct: 51 VRVVLGAHNLSRREPTRQV---FAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVA 107
Query: 130 CLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP G + + + GWG L + VL E+ + V + CR+ SN+C
Sbjct: 108 QLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRR--------SNVC 158
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW---GIGCGKTPGVYVQVNKYLRWI 245
C GDSG PL+ I G+ S+ G G P + V +++ WI
Sbjct: 159 TLVRGRQAGVCFGDSGSPLVC-----NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 67.8 bits (164), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + + WP++V+L Q +FCG LI +V++AAHC+
Sbjct: 1 IVGGRRARPHAWPFMVSL--QLRGGHFCGATLIAPNFVMSAAHCVANV--------NVRA 50
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
+ V LG ++ S+ T+ + A + N NDI ++QL+ A N+ V+
Sbjct: 51 VRVVLGAHNLSRREPTR--QVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 131 LPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP G + + + GWG L + VL E+ + V + CR+ SN+C
Sbjct: 109 LPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRR--------SNVCT 159
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW---GIGCGKTPGVYVQVNKYLRWI 245
C GDSG PL+ I G+ S+ G G P + V +++ WI
Sbjct: 160 LVRGRQAGVCFGDSGSPLVC-----NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + + WP++V+L Q +FCG LI +V++AAHC+
Sbjct: 1 IVGGRRARPHAWPFMVSL--QLAGGHFCGATLIAPNFVMSAAHCVANV--------NVRA 50
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVC 130
+ V LG ++ S+ T+ + A + N NDI ++QL+ A N+ V+
Sbjct: 51 VRVVLGAHNLSRREPTR--QVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 131 LPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCA 189
LP G + + + GWG L + VL E+ + V + CR+ SN+C
Sbjct: 109 LPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRR--------SNVCT 159
Query: 190 GGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW---GIGCGKTPGVYVQVNKYLRWI 245
C GDSG PL+ I G+ S+ G G P + V +++ WI
Sbjct: 160 LVRGRQAGVCFGDSGSPLVC-----NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 67.0 bits (162), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/243 (25%), Positives = 113/243 (46%), Gaps = 41/243 (16%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
AS+ PW V +K + + C G LI+++WVLTAAHC + D++L D
Sbjct: 235 ANASDQERTPWHVTIKPKSQET--CRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKS 292
Query: 74 RLG-EYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL- 131
+ G E+ K + D+ A + F Y +DIAL++L++K + ++ RP+CL
Sbjct: 293 QWGKEFLIEKAVISPGFDVFAKKNQGILEF----YGDDIALLKLAQKVKMSTHARPICLP 348
Query: 132 -----------PQAGDFYEDQIGIVTGWGT----LSYGGPRSDVLMEVPIPVWRLTECRK 176
PQ + + ++ ++ G + ++ +++ + W T C +
Sbjct: 349 CTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVE-W--TSCAE 405
Query: 177 QFSQN-------------IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVS 223
SQ + D LC+G + + C+G+SGG + L+R + + +G+VS
Sbjct: 406 VVSQEKTMFPNLTDVREVVTDQFLCSGTQEDES-PCKGESGGAVFLERRFRFFQ-VGLVS 463
Query: 224 WGI 226
WG+
Sbjct: 464 WGL 466
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 67.0 bits (162), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/243 (25%), Positives = 113/243 (46%), Gaps = 41/243 (16%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
AS+ PW V +K + + C G LI+++WVLTAAHC + D++L D
Sbjct: 227 ANASDQERTPWHVTIKPKSQET--CRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKS 284
Query: 74 RLG-EYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCL- 131
+ G E+ K + D+ A + F Y +DIAL++L++K + ++ RP+CL
Sbjct: 285 QWGKEFLIEKAVISPGFDVFAKKNQGILEF----YGDDIALLKLAQKVKMSTHARPICLP 340
Query: 132 -----------PQAGDFYEDQIGIVTGWGT----LSYGGPRSDVLMEVPIPVWRLTECRK 176
PQ + + ++ ++ G + ++ +++ + W T C +
Sbjct: 341 CTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVE-W--TSCAE 397
Query: 177 QFSQN-------------IFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVS 223
SQ + D LC+G + + C+G+SGG + L+R + + +G+VS
Sbjct: 398 VVSQEKTMFPNLTDVREVVTDQFLCSGTQEDES-PCKGESGGAVFLERRFRFFQ-VGLVS 455
Query: 224 WGI 226
WG+
Sbjct: 456 WGL 458
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 105 QNYENDIALVQLSKKAQYNSFVRPVCLPQAGDFYEDQIGIV---TGWGTLSYGGPR---S 158
++Y +D+ L++L A+ V+ + LP E ++G +GWG++ G
Sbjct: 4 KDYSHDLMLLRLQSPAKITDAVKVLELPTQ----EPELGSTCEASGWGSIEPGPDDFEFP 59
Query: 159 DVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTI 218
D + V + + + T C + +S LCAG GG D+C GDSGGPL+ + W
Sbjct: 60 DEIQCVQLTLLQNTFCADAHPDKVTESMLCAGYLPGGKDTCMGDSGGPLIC---NGMWQ- 115
Query: 219 IGVVSWG---IGCGKTPGVYVQVNKYLRWIYNT 248
G+ SWG G P +Y ++ YL WI +T
Sbjct: 116 -GITSWGHTPCGSANKPSIYTKLIFYLDWIDDT 147
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 152 SYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQR 211
S G +L + PV + C+ + I + +C G +GG DSCQGDSGGP++
Sbjct: 1 SSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVCNG 60
Query: 212 PDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+ G+VSWG GC + PGVY +V Y+ WI T
Sbjct: 61 -----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQT 94
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 32/240 (13%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSD 70
I G+ + + WP++V+L Q +FCG LI +V++AAHC+
Sbjct: 1 IVGGRRARPHAWPFMVSL--QLRGGHFCGATLIAPNFVMSAAHCVANV--------NVRA 50
Query: 71 LIVRLGEYDFSKVNETKVTDIPAAAMKVYPR-FSEQNYENDIALVQLSKKAQYNSFVRPV 129
+ V LG ++ S+ T+ A +++ + N NDI ++QL+ A N+ V+
Sbjct: 51 VRVVLGAHNLSRREPTRQV---FAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVA 107
Query: 130 CLPQAGDFYEDQIG-IVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLC 188
LP G + + + GWG L + VL E+ + V + CR+ SN+C
Sbjct: 108 QLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRR--------SNVC 158
Query: 189 AGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSW---GIGCGKTPGVYVQVNKYLRWI 245
C GD G PL+ I G+ S+ G G P + V +++ WI
Sbjct: 159 TLVRGRQAGVCFGDXGSPLVC-----NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 152 SYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGTDSCQGDSGGPLLLQR 211
S G +L + PV + C+ + I + +C G +GG DSCQGDSGGP++
Sbjct: 1 SSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVCNG 60
Query: 212 PDKQWTIIGVVSWGIGCGK--TPGVYVQVNKYLRWIYNT 248
+ G+VSWG GC + PGVY +V Y+ WI T
Sbjct: 61 -----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQT 94
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIKQKIDNALVLRRTSDLIV 73
G+ S++ PW V + + FCGG ++ +V+TAA C+ + SD+ +
Sbjct: 4 GKKSDITKEPWAVGV--LVDEKPFCGGSILTANFVITAAQCVDG--------TKPSDISI 53
Query: 74 RLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNS-FVRPVCLP 132
G S TK T + A + + R+ +N+ A+++ + + + + LP
Sbjct: 54 HYG----SSYRTTKGTSVMAKKIYIV-RYHPLTMQNNYAVIETEMPIKLDDKTTKKIELP 108
Query: 133 Q-AGDFYEDQIGIVTGWGTLSYGGPR-SDVLMEVPIPVWRLTECRKQFSQ-----NIFDS 185
D D +V+GWG+ ++ S LME V C +Q+ Q I+D
Sbjct: 109 SLLYDPEPDTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIYDG 168
Query: 186 NLCAGGYKGGTDSCQGDSGGPLLLQRPDKQWTIIGVVSWGIGC-GKTPGVYVQVNKYL 242
CAGG T GD+G P + + T++GV S+ + P V+++V Y+
Sbjct: 169 VFCAGGEYDETYIGYGDAGDPAV-----QNGTLVGVASYISSMPSEFPSVFLRVGYYV 221
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 56/253 (22%)
Query: 13 KGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI----KQKIDNALVLRRT 68
KG W +++ R + C G +++E +VLTAAHC K+ V
Sbjct: 20 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK 79
Query: 69 SDLIVRLGEYDFS-KVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVR 127
DL + + + + +N K IP + Y+ D+AL++L K +Y +R
Sbjct: 80 RDLEIEVVLFHPNYNINGKKEAGIP------------EFYDYDVALIKLKNKLKYGQTIR 127
Query: 128 PVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS-QNIFDSN 186
P+CLP E + T + + ++L I ++E K+ + + ++ N
Sbjct: 128 PICLPCT----EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKN 183
Query: 187 -------------------------------LCAGGYKGGTD--SCQGDSGGPLLLQRPD 213
LC GG D +C+GDSGGPL++ +
Sbjct: 184 GDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRS 243
Query: 214 KQWTIIGVVSWGI 226
+ + +GV+SWG+
Sbjct: 244 R-FIQVGVISWGV 255
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 56/253 (22%)
Query: 13 KGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI----KQKIDNALVLRRT 68
KG W +++ R + C G +++E +VLTAAHC K+ V
Sbjct: 452 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK 511
Query: 69 SDLIVRLGEYDFS-KVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVR 127
DL + + + + +N K IP + Y+ D+AL++L K +Y +R
Sbjct: 512 RDLEIEVVLFHPNYNINGKKEAGIP------------EFYDYDVALIKLKNKLKYGQTIR 559
Query: 128 PVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS-QNIFDSN 186
P+CLP E + T + + ++L I ++E K+ + + ++ N
Sbjct: 560 PICLPCT----EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKN 615
Query: 187 -------------------------------LCAGGYKGGTD--SCQGDSGGPLLLQRPD 213
LC GG D +C+GDSGGPL++ +
Sbjct: 616 GDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRS 675
Query: 214 KQWTIIGVVSWGI 226
+ + +GV+SWG+
Sbjct: 676 R-FIQVGVISWGV 687
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 160 VLMEVPIPVWRLTECRKQFSQNIFDSNLCAGGYKGGT----DSCQGDSGGPLLLQRP-DK 214
VL V +P+ C+ I D+ CAG YK G D+C+GDSGGP +++ P +
Sbjct: 9 VLQVVNLPLVERPVCKASTRIRITDNMFCAG-YKPGEGKRGDACEGDSGGPFVMKSPYNN 67
Query: 215 QWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWI 245
+W +G+VSWG GC + G Y V + +WI
Sbjct: 68 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 100
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 56/253 (22%)
Query: 13 KGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI----KQKIDNALVLRRT 68
KG W +++ R + C G +++E +VLTAAHC K+ V
Sbjct: 461 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK 520
Query: 69 SDLIVRLGEYDFS-KVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVR 127
DL + + + + +N K IP + Y+ D+AL++L K +Y +R
Sbjct: 521 RDLEIEVVLFHPNYNINGKKEAGIP------------EFYDYDVALIKLKNKLKYGQTIR 568
Query: 128 PVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS-QNIFDSN 186
P+CLP E + T + + ++L I ++E K+ + + ++ N
Sbjct: 569 PICLPCT----EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKN 624
Query: 187 -------------------------------LCAGGYKGGTD--SCQGDSGGPLLLQRPD 213
LC GG D +C+GDSGGPL++ +
Sbjct: 625 GDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRS 684
Query: 214 KQWTIIGVVSWGI 226
+ + +GV+SWG+
Sbjct: 685 R-FIQVGVISWGV 696
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 56/253 (22%)
Query: 13 KGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI----KQKIDNALVLRRT 68
KG W +++ R + C G +++E +VLTAAHC K+ V
Sbjct: 471 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK 530
Query: 69 SDLIVRLGEYDFS-KVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVR 127
DL + + + + +N K IP + Y+ D+AL++L K +Y +R
Sbjct: 531 RDLEIEVVLFHPNYNINGKKEAGIP------------EFYDYDVALIKLKNKLKYGQTIR 578
Query: 128 PVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS-QNIFDSN 186
P+CLP E + T + + ++L I ++E K+ + + ++ N
Sbjct: 579 PICLPCT----EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKN 634
Query: 187 -------------------------------LCAGGYKGGTD--SCQGDSGGPLLLQRPD 213
LC GG D +C+GDSGGPL++ +
Sbjct: 635 GDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRS 694
Query: 214 KQWTIIGVVSWGI 226
+ + +GV+SWG+
Sbjct: 695 R-FIQVGVISWGV 706
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 58/254 (22%)
Query: 13 KGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC--IKQKIDNALVL----R 66
KG W +++ R + C G +++E +VLTAAHC + K + V +
Sbjct: 219 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK 278
Query: 67 RTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFV 126
R ++ V L +++ +N K IP + Y+ D+AL++L K +Y +
Sbjct: 279 RDLEIEVVLFHPNYN-INGKKEAGIP------------EFYDYDVALIKLKNKLKYGQTI 325
Query: 127 RPVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS-QNIFDS 185
RP+CLP E + T + + ++L I ++E K+ + + ++
Sbjct: 326 RPICLPCT----EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 381
Query: 186 N-------------------------------LCAGGYKGGTD--SCQGDSGGPLLLQRP 212
N LC GG D +C+GDSGGPL++ +
Sbjct: 382 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR 441
Query: 213 DKQWTIIGVVSWGI 226
+ + +GV+SWG+
Sbjct: 442 SR-FIQVGVISWGV 454
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 58/254 (22%)
Query: 13 KGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC--IKQKIDNALVL----R 66
KG W +++ R + C G +++E +VLTAAHC + K + V +
Sbjct: 227 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK 286
Query: 67 RTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFV 126
R ++ V L +++ +N K IP + Y+ D+AL++L K +Y +
Sbjct: 287 RDLEIEVVLFHPNYN-INGKKEAGIP------------EFYDYDVALIKLKNKLKYGQTI 333
Query: 127 RPVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFS-QNIFDS 185
RP+CLP E + T + + ++L I ++E K+ + + ++
Sbjct: 334 RPICLPCT----EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 389
Query: 186 N-------------------------------LCAGGYKGGTD--SCQGDSGGPLLLQRP 212
N LC GG D +C+GDSGGPL++ +
Sbjct: 390 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR 449
Query: 213 DKQWTIIGVVSWGI 226
+ + +GV+SWG+
Sbjct: 450 SR-FIQVGVISWGV 462
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 57.8 bits (138), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 27/181 (14%)
Query: 15 QASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC--IKQKIDNALVLRRTSDLI 72
+A ++ D PW V L +D FCGGV+I E +VLT A C + + I RTS
Sbjct: 98 RAPDLQDLPWQVKLTNSEGKD-FCGGVIIRENFVLTTAKCSLLHRNITVKTYFNRTSQDP 156
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
+ + K+T + V+ R+ END++L++L Q PVC P
Sbjct: 157 LMI-----------KITHV-----HVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTP 200
Query: 133 QAGDFYEDQI-----GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNL 187
+ DF E + G+++GW G + L P+ + EC + + +
Sbjct: 201 EK-DFAEHLLIPRTRGLLSGWA--RNGTDLGNSLTTRPVTLVEGEECGQVLNVTVTTRTY 257
Query: 188 C 188
C
Sbjct: 258 C 258
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 57.4 bits (137), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 160 VLMEVPIPVWRLTECRKQFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-D 213
VL V +P+ C+ I D+ CAG G +G D+C+GDSGGP +++ P +
Sbjct: 5 VLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFN 62
Query: 214 KQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWI 245
+W +G+VSWG GC + G Y V + +WI
Sbjct: 63 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 96
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 160 VLMEVPIPVWRLTECRKQFSQNIFDSNLCAG-----GYKGGTDSCQGDSGGPLLLQRP-D 213
VL V +P+ C+ I D+ CAG G +G D+C+GDSGGP +++ P +
Sbjct: 5 VLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRG--DACEGDSGGPFVMKSPFN 62
Query: 214 KQWTIIGVVSWGIGCGKTP--GVYVQVNKYLRWI 245
+W +G+VSWG GC + G Y V + +WI
Sbjct: 63 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 96
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 27/181 (14%)
Query: 15 QASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHC--IKQKIDNALVLRRTSDLI 72
+A ++ D PW V L +D FCGGV+I E +VLT A C + + I RTS
Sbjct: 57 RAPDLQDLPWQVKLTNSEGKD-FCGGVIIRENFVLTTAKCSLLHRNITVKTYFNRTSQDP 115
Query: 73 VRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRPVCLP 132
+ + K+T + V+ R+ END++L++L Q PVC P
Sbjct: 116 LMI-----------KITHV-----HVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTP 159
Query: 133 QAGDFYEDQI-----GIVTGWGTLSYGGPRSDVLMEVPIPVWRLTECRKQFSQNIFDSNL 187
+ DF E + G+++GW G + L P+ + EC + + +
Sbjct: 160 EK-DFAEHLLIPRTRGLLSGWA--RNGTDLGNSLTTRPVTLVEGEECGQVLNVTVTTRTY 216
Query: 188 C 188
C
Sbjct: 217 C 217
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 50.1 bits (118), Expect = 1e-06, Method: Composition-based stats.
Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 14/78 (17%)
Query: 11 IDKGQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCI------KQKIDNALV 64
I +G +E+ PW V L R+ ++ CG LI++RWVLTAAHC+ K +N
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN--- 57
Query: 65 LRRTSDLIVRLGEYDFSK 82
DL+VR+G++ ++
Sbjct: 58 -----DLLVRIGKHSRTR 70
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization,
Patterson Search, Structure Determination, Refinement,
Structure And Comparison With Its Components And With
The Bovine Trypsin- Pancreatic Trypsin Inhibitor
Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 47.8 bits (112), Expect = 6e-06, Method: Composition-based stats.
Identities = 23/42 (54%), Positives = 28/42 (66%), Gaps = 4/42 (9%)
Query: 14 GQASEVNDWPWLVALKRQYERDNF-CGGVLINERWVLTAAHC 54
G+ E N PW VA+ Y +F CGGVL+N +WVLTAAHC
Sbjct: 4 GRECEKNSHPWQVAI---YHYSSFQCGGVLVNPKWVLTAAHC 42
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 44.3 bits (103), Expect = 7e-05, Method: Composition-based stats.
Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 2/81 (2%)
Query: 69 SDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSKKAQYNSFVRP 128
S + VRLGE++ V E I AA + +P F+ +NDI L++LS A NS V
Sbjct: 1 SRIQVRLGEHNID-VLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVAT 59
Query: 129 VCLPQAGDFYEDQIGIVTGWG 149
V LP++ + +++GWG
Sbjct: 60 VSLPRSCAAAGTEC-LISGWG 79
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 43.5 bits (101), Expect = 1e-04, Method: Composition-based stats.
Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 5/59 (8%)
Query: 98 VYPRFS-EQNYENDIALVQLSKKAQYNSFVRPVCLPQ----AGDFYEDQIGIVTGWGTL 151
++PR++ +N + DIAL++L K ++ ++ PVCLP A G VTGWG L
Sbjct: 13 IHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNL 71
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 40.0 bits (92), Expect = 0.001, Method: Composition-based stats.
Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 14 GQASEVNDWPWLVALKRQYERDNFCGGVLINERWVLTAAHCIK 56
G N P+ V+L +FCGG LIN +WV++AAHC K
Sbjct: 4 GYTCAANSIPYQVSLN---SGSHFCGGSLINSQWVVSAAHCYK 43
>pdb|3OML|A Chain A, Structure Of Full-Length Peroxisomal Multifunctional
Enzyme Type 2 From Drosophila Melanogaster
Length = 613
Score = 31.2 bits (69), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 29/117 (24%), Positives = 55/117 (47%), Gaps = 13/117 (11%)
Query: 59 IDNALVLRRTSDLIVRLGEYDFSKVNETKVTDIPAAAMKVYPRFSEQNYENDIALVQLSK 118
++NA +LR S +V+ E D++ VN+ + +P +QNY I + S
Sbjct: 107 VNNAGILRDRS--LVKTSEQDWNLVNDVHLKGSFKCTQAAFPYMKKQNYGRII--MTSSN 162
Query: 119 KAQYNSFVRPVCLPQAGDFYEDQIGIVTGWGTLSYGGPRSDVLMEVPIPVW--RLTE 173
Y +F + ++ ++G++ T++ G R++VL V +P R+TE
Sbjct: 163 SGIYGNFGQV-------NYTAAKMGLIGLANTVAIEGARNNVLCNVIVPTAASRMTE 212
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.138 0.442
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,223,839
Number of Sequences: 62578
Number of extensions: 351706
Number of successful extensions: 2182
Number of sequences better than 100.0: 358
Number of HSP's better than 100.0 without gapping: 355
Number of HSP's successfully gapped in prelim test: 3
Number of HSP's that attempted gapping in prelim test: 590
Number of HSP's gapped (non-prelim): 374
length of query: 252
length of database: 14,973,337
effective HSP length: 97
effective length of query: 155
effective length of database: 8,903,271
effective search space: 1380007005
effective search space used: 1380007005
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 50 (23.9 bits)